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Figure 1 Overview of distribution and developement of different tyes of twin gestations.
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Twin pregnancies occur in approximately 2% of all pregnancies in the Netherlands.[1] As 
shown in figure 1, two-third of these pregnancies result in dizygotic- or non-identical twins 
and one-third result in monozygotic- or identical twins. Dizygotic twins develop from two 
fertilized eggs and generally have their own placenta and membranes and are thus always 
dichorionic. Monozygotic twin pregnancies develop from one fertilized egg and chorionicity 
and amnionicity depend on the moment of division into two embryos. When division occurs 
within three days after fertilization, the pregnancy will develop into dichorionic twins. This 
group accounts for approximately 33% of monozygotic twin pregnancies. In about 77% 
of all monozygotic twins, division takes place between 3 and 8 days after fertilization 
which leads to a monochorionic (MC) diamniotic twin pregnancy. These pregnancies are 
characterized by two fetuses with their own amniotic sac, sharing one placenta and 
chorionic sac. A small group of monozygotic twins, less than 1%, divide after 8 days and 
develop into monochorionic monoamniotic (MA) twins, sharing both the placenta, chorionic- 
and amniotic sac.
Figure 2  Photo of a monochorionic twin placenta showing different types of anastomoses. AA = arterio-arterial 
anstomoses, AV = arterio-venous anastomoses.
Compared to singleton pregnancies, twin pregnancies have a higher risk of developing 
complications. The risk of adverse pregnancy outcome in monochorionic twins is twice as 
high as dichorionic twins and even four times as high as singleton pregnancies. A perinatal 
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mortality rate of approximately 11% has been reported.[2, 3] This increased risk is attributed 
to the presence of a shared blood circulation. The monochorionic twin placenta, shared 
by both twins, is characterized by superficial vascular anastomoses.[3] These are direct 
connections of blood vessels from both fetuses (figure 2). Three types of placental 
anastomoses can be distinguished, artery-to-vein (AV), artery-to-artery (AA) and vein-to-vein 
(VV). Direction of flow over an anastomosis is dependent on the pressure gradient. When 
an artery (high pressure) is connected to a vein (lower pressure), blood will flow in the 
direction of the vein. With AA or VV anastomoses, the flow can be bidirectional. In most 
monochorionic twin pregnancies the net flow from one fetus to the other is balanced but 
in about 10%, at some point during gestation, an imbalance occurs leading to twin-twin 
transfusion syndrome (TTTS). 
TTTS
Imbalanced blood flow over one or more anastomoses, in time, leads to hypovolemia with 
subsequent oligohydramnios in the donor twin, and hypervolemia with polyhydramnios in 
the recipient twin (figure 3). TTTS is detected on ultrasound scans based on the twin
Figure 3a  Schematic drawing of a TTTS complicated monochorionic twin pregnancy describing the diagnostic 








Figure 3b  Schematic drawing of a  normal monochorionic twin pregnancy and a TTTS complicated pregnancy. 
The arrows represent the amount of flow over the anastomoses. R represents the recipient twin, D is the donor 
twin.
oligo-polyhydramnios sequence. Further ultrasound staging of the disease is based on 
identification of the donor bladder, abnormal flow in the umbilical artery, fetal hydrops and 
single fetal demise. Adverse perinatal outcome in TTTS is mainly attributed to intrauterine 
death due to heart failure, and premature birth due to rupture of membranes or cervical 
shortening. Untreated TTTS is associated with a perinatal mortality rate between 80% 
and 100%.[4] In the Netherlands, approximately 775 monochorionic twin pregnancies are 
seen yearly. With an incidence of about 10%, each year on average 77 cases of TTTS 
need treatment.[1] Until two and a half decades ago symptomatic treatment by (serial) 
amniodrainage, where amniotic fluid is drained from the amniotic sac of the recipient, 
Normal monochorionic twin pregnancy
Twin-twin transfusion syndrome complicated pregnancy
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decreasing pressure and maternal discomfort, was the only option. In 1990, doctor De Lia 
was the first to describe fetoscopic laser surgery as a causal treatment strategy for TTTS.
[5]
LASER SURGERY
Fetoscopic laser surgery is considered the ‘gold standard’ for treating TTTS. The rationale of 
this procedure is to divide both fetal circulations by occluding all vascular anastomoses on 
the placental surface. This is done by introducing a small endoscope, usually with a diameter 
Figure 4 Fetoscopic laser surgery for TTTS
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of 3-4mm, through the maternal abdominal- and uterine wall into the amniotic sac of the 
recipient twin (figure 4). With this endoscope the vascular equator (the line that divides 
the placenta at the point where all anastomoses meet) is identified and all anastomoses 
are first selectively coagulated with a high powered medical laser. Subsequently, a line is 
drawn from one placenta margin to the other along the vascular equator connecting all 
coagulated anastomoses making sure even the smallest anastomoses are lasered.[6] Finally, 
excessive amniotic fluid is drained from the recipient amniotic sac by amniodrainage until a 
deepest vertical pool of 6-7cm is achieved. In general, the procedure is performed under 
local anesthesia with sedation of the mother.
Compared to (serial) amnioreduction fetoscopic laser surgery improved perinatal survival of 
both fetuses from 26% up to 65% and survival of at least one fetus from 51% up to 88%.[7, 
8] However still, of all surviving children, 6-18% show neurodevelopmental complications 
and 4-16% show signs of cerebral injury.[9, 10] It is evident that still room for improvement 
in outcome exists. Gaining better insight in all steps and technical aspects of the procedure 
might help bringing outcomes to an even higher level.
TECHNICAL ASPECTS
Different types of endoscopes are used for laser surgery for TTTS. Semi rigid fiberscopes 
(1-2.2mm) with a remote eye-piece, through an operating sheath with a working channel 
that allows for a 400-600μm laser fiber are mainly used. Currently 3.3mm endoscopes 
with integrated fiber optic and two working channels are gaining popularity (figure 5). Scopes 
or working channels are available straight or curved, curved scopes allow for increased 
maneuverability and better access to the anastomoses in case of anterior placenta position.
[11] 
Figure 5  Karl Storz Miniature Straight Forward telescope 0o 11506AAK and the Miniature Curved Forward 
Telescope 0o 11508AAK. Both with a 4 Fr. and a 3 Fr. working chanel.
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Laser types that are used for fetoscopic laser surgery for TTTS are mainly Nd:YAG 
(neodymium-doped ytrium aluminium garnet; Nd:Y3Al5O12) with a 1064nm wavelength or 
a 940nm wavelength diode laser. Both laser types have similar absorption characteristics 
for hemoglobin and water (figure 6) that make them ideal for coagulation of blood vessels 
and highly perfused tissue. Both are continuously emitting laser systems with a power range 
of up to 80-100 Watt. The optical penetration depth of the photons emitted by the diode 
laser is substantially lower than that of the Nd:YAG laser.[12] Another laser type that is 
sometimes used is potassium titanyl phosphate (KTiOPO4) or KTP laser with a wavelength 
532nm. Laser power is one of the variables that can be adjusted by the operator and 
determines the amount of energy in Joule that is delivered per second. A certain amount 
of focused laser energy is needed for successful coagulation of a vessel. This amount is 
highly dependent on the diameter of the vessel, the flow in the vessel and the distance 
between the laser tip and the vessel wall.  Another factor that is thought to significantly 
impact the energy needed for coagulation is the angle at which the laser fiber is aimed at 
the vessel.[13] Although the vessel is bulging up from the placental surface, a perpendicular 
approach is desirable.
Figure 6  Absorption coefficients of water (H2O), hemoglobin (Hb) and oxygenated hemoglobin (HbO) for 
different laser wavelengths and types (KTP, Nd:YAG and Diode)
Over the years’ different laser techniques have been described and used. The rationale for 
the selective laser technique[14], now adopted by most fetal treatment centers, is to save 
as much functioning placenta tissue as possible by coagulating only true inter-twin vascular 
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done in the early years. Sequential selective laser[15] is an adaptation of this technique 
whereby anastomoses are coagulated in a specific order. The theoretical aim is to obliterate 
the anastomoses in a sequence that allows, at least partly, an inter-operative correction 
of the hypoperfusion of the donor and hyperperfusion of the recipient.[16] Recently an 
international multi-center randomized controlled trial showed that an adaptation of the 
selective technique, called the Solomon technique, lead to a significant reduction of 
recurrence of TTTS and post laser twin anemia polycythemia sequence (TAPS).[6] With this 
technique, in addition to selectively coagulating all anastomoses, a line is drawn with the 
laser from one placenta margin to the other connecting all laser spots.
LEARNING NEW TECHNIQUES
Training a new generation of fetal therapists for laser surgery for TTTS is challenging, even 
in large centers the annual number of procedures is low and gaining supervised hands-on 
experience is difficult. For centers starting up a laser program this problem is even bigger 
since, most often, a local experienced mentor is lacking and surgeons in training need to 
travel to an established center in order to get some experience. Therefore, we set out 
to develop a standardized training program for fetoscopic laser surgery on a high fidelity 
fetoscopy simulator model and an evidence based procedure specific evaluation tool.
OUTLINE OF THIS THESIS
Technical aspects of laser surgery for Twin-Twin Transfusion Syndrome. Fetoscopic laser 
surgery is currently considered the best treatment strategy for TTTS and is gaining 
popularity worldwide. It has evident advantages over alternative treatments such as serial 
amniodrainage.[7] Although perinatal outcome has advanced significantly, still room for 
improvement exists. In this thesis we evaluate current practice and investigate different 
techniques and technical aspects of the procedure and its impact on perinatal outcome. 
Furthermore, we propose a standardized tool that will aid training the next generation of 
fetal therapists performing laser surgery for TTTS.
GI
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Chapter 1
Twenty-Five Years of Fetoscopic Laser Coagulation 




The aim of this study was to assess the perinatal outcome of pregnancies with twin-twin 
transfusion syndrome (TTTS) treated with laser therapy over the past 25 years, and in 
relation to different techniques used in this time period. 
Methods
A systematic review of studies reporting on perinatal outcome according to the Meta-
Analysis of Observational Studies in Epidemiology (MOOSE) guidelines was conducted. 
The MEDLINE, Embase and Cochrane Library databases were systematically searched. 
Comparisons were made in respect to time period and laser technique. 
Results
In total, 34 studies reporting on 3,868 monochorionic twin pregnancies were included. 
The mean survival of both twins increased from 35 to 65% (p = 0.012) and for at least one 
twin from 70 to 88% (p = 0.009) over the past 25 years. Mean gestational age at birth 
remained stable over the years at 32 weeks gestation. Also, we showed a significantly 
improved perinatal survival with the evolution of the laser technique from non-selective 
to selective, selective sequential and the Solomon technique (p = 0.010). 
Discussion
Since the introduction of laser therapy for TTTS more than two decades ago, perinatal 
survival improved significantly. Improved outcome is probably associated with several 
factors, including evolution of the laser technique, learning curve effect, better referral 
and improved early neonatal care.
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INTRODUCTION
Monochorionic twin pregnancies are at a 10% risk of developing twin-twin transfusion 
syndrome (TTTS) [1, 2] due to vascular anastomoses on a shared placenta. Before De Lia 
et al. [3] proposed fetoscopic laser coagulation of the placental vessels in 1990, serial 
amnioreduction was considered the only treatment option of polyhydramnios, the most 
prominent feature of TTTS. Serial amnioreduction was associated with mortality rates 
up to 60%, a median gestational age (GA) at delivery around 28 weeks and up to 50% 
severe neurodevelopment impairment in survivors [4]. Survival significantly improved after 
the introduction of laser coagulation by addressing the cause of the problem, making 
it the accepted treatment of choice for TTTS [5]. However, results are still far from 
satisfactory, with mortality rates ranging from 20 to 48%, and significant complications, 
including iatrogenic preterm premature rupture of membranes (PPROM) [6] resulting in 
preterm delivery before 32 weeks gestation, twin anemia-polycythemia sequence (TAPS) [7], 
recurrence or reversal of TTTS [8] and adverse long-term neurodevelopmental outcome in 
6–18% of survivors [9].
Since the first publications on fetoscopic laser surgery, several technical modifications 
have been described. Coagulation of all vessels crossing the inter-twin membrane was 
abandoned because it led to unnecessary placental loss [10]. In 1998, Quintero et al. [11] 
introduced the selective laser coagulation technique. This technique, which was rapidly 
adopted by most fetal therapy centers, aims to save as much functioning placenta tissue 
as possible by coagulating only true inter-twin vascular anastomoses instead of every 
vessel crossing the membranous equator. In 2007 the same group proposed the sequential 
selective laser coagulation technique [12].
Sequential selective laser is an adaptation whereby anastomoses are coagulated in a 
specific order. The aim is to obliterate the anastomoses in a sequence that allows, at least 
partly, an intraoperative correction of the hypoperfusion of the donor and hyperperfusion 
of the recipient. This is achieved by first closing the arteriovenous anastomoses from donor 
to recipient, starting with the largest ones, followed by the closure of the vein-to-artery 
anastomoses (e.g. the vessels with a blood flow towards the donor) as the last part of the 
procedure. In 2008 the Solomon trial [13] was started, introducing a new adaptation to the 
selective technique. The rationale of the Solomon technique is coagulation of the whole 
vascular equator from one placenta margin to the other. 
1











De Lia 1995 26 1988-1994 Prospective single 
center cohort
35 32.2 (2.8)
Ville 1995 45 1992-1994 Prospective single 
center cohort
36 35.0 (3.8)
De Lia 1999 67 1995-1998 Prospective single 
center cohort
57 30.0 (5.0)
Hecher 2000 ¥* 200 1995-1999 Prospective single 
center cohort
48 34.0 (2.7) Early versus late se-




89 1994-1999 Prospective multi-
center cohort
39 32.0 (2.5) Non-selective laser 
versus selective laser
Gray 2006 31 2002-2003 Prospective single 
center cohort
39 34.0 (4.5)
Huber 2006 200 1999-2003 Prospective single 
center cohort
60 34.3 (2.9)










193 2003-2005 Prospective single 
center cohort





33 2003-2006 Prospective single 
center cohort
27 32.0 (3.8)
Stirneman 2008 287 1999-2005 Retrospective single 
center cohort
42 32.0 (3.6)
Cincotta 2009 100 2002-2007 Prospective single 
center cohort
66 31.0 (3.2)
Nakata 2009 ¥ 52 2002-2006 Prospective multi-
center cohort
50 32.0 (4.2) Excluded for time 
based analysis but in-
cluded for technique 
based analysis due to 
overlap.
Ruano 2009 19 2006-2008 Retrospective single 
center cohort
26 32.1 (3.0)
Chmait 2010 ¥ 99 2006-2008 Prospective single 
center cohort
68 32.2 (4.5 Sequential laser 
versus standard selec-
tive laser
Meriki 2010 75 2003-2008 Retrospective single 
center cohort
60 32.0 (2.7)
Morris 2010 164 2004-2009 Prospective single 
center cohort
38 33.2 (1.3)














Delabaere 2011 49 2006-2008 Retrospective single 
center cohort
59 32.0 (2.6) Article in French
Hernandez-An-
drade 2011
35 2008-2009 Retrospective single 
center cohort
49 32.0 (3.7) Article in Spanish
Lombardo 
2011
70 2000-2010 Retrospective single 
center cohort
59 32.1 (NA)
Tchirikov 2011 80 2006-2011 Retrospective single 
center cohort




100 2004-2010 Retrospective single 
center cohort
52 32.6 (3.8)
Chang 2012 * 44 2005-2010 Retrospective single 
center cohort
50 30.6 (5.9)
Liu 2012 33 2003-2010 Retrospective single 
center cohort
52 31.0 (6.0) Excluded in tech-
nique based analysis 
due to  unclear 




152 2002-2010 Retrospective single 
center cohort
63 33.0 (NA)
Rustico 2012 * 150 2004-2009 Retrospective single 
center cohort
41 32.1 (2.2)





85 2005-2010 Retrospective single 
center cohort
45 32.0 (2.5)
Valsky 2012 334 2006-2009 Retrospective multi-
center cohort
68 33.2 (3.0) GA at laser 16-26 
weeks versus >26 
weeks
Baschat 2013 ¥ 147 2005-2011 Retrospective single 
center cohort
60 32.6 (3.5) Selective laser versus 
Solomon laser
Baud 2013 325 1999-2012 Retrospective single 
center cohort
63 31.3 (4.0) GA at laser <16 weeks 
versus 16-26 weeks 
versus >26 weeks.
Ruano 2013 ¥ 102 2010-2012 Retrospective multi-
center cohort




272 2008-2012 Multicenter RCT 62 32.3 (3.3) Selective laser versus 
Solomon laser
Table 1 Included studies in the review. *These studies described more series over different time periods and 
were split up in the time-based analyses. ¥These studies described comparisons between different techniques. 
GA= gestational age. Figures for GA at birth are mean ± SD. NA = Not assessed; RCT = randomized controlled 
trial.
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With the Solomon technique, all laser spots are connected by drawing a laser line, 
minimizing the chance of residual anastomoses. The study showed that this technique was 
associated with significantly less residual anastomoses, thereby reducing the risk for TAPS 
and recurrence of TTTS.
This study focuses on perinatal outcome after laser therapy over the past 25 years and on 
the impact of the above-mentioned changes in laser treatment strategies on the outcome 
results. We systematically reviewed all published series since the introduction of laser 
treatment of TTTS with respect to survival, GA at birth and procedural or postoperative 
complications in relation to the time and the laser technique used.
METHODS
Data Sources
Before conduct of the systematic review a detailed protocol that included the search 
strategies, inclusion and exclusion criteria, outcome parameters and methods of statistical 
analysis was created. This systematic literature review was performed according to the 
Meta-Analysis of Observational Studies in Epidemiology (MOOSE) [14], and the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [15] where 
applicable.
Figure 1 Flow chart of study selection 
according to the MOOSE guideline.
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An initial literature search on survival after laser coagulation for TTTS was conducted in 
MEDLINE, Embase and the Cochrane Library using the PubMed and OVID search engines 
without restriction on the language or type of publication. Key words and free text searches 
were performed with combinations of the following key words: survival, perinatal survival, 
twin-to-twin transfusion syndrome, TTTS, twin-twin transfusion syndrome, fetofetal 
transfusion, placental anastomoses, laser, laser therapy, laser ablation, SLPCV, SQLPCV, 
sequential laser, selective laser, fetoscopy, FLOC and photocoagulation. Additionally, 
reference sections of eligible studies were hand-reviewed for potential eligible studies. Our 
search included articles published up to May 2014 that reported on pregnancy outcomes 
after fetoscopic laser coagulation of placental vascular anastomoses.
Inclusion and Exclusion Criteria
Randomized trials and comparative studies as well as prospective and retrospective case 
series were considered eligible for inclusion. Reasons for exclusion were studies with 
insufficient or overlapping data, letters, conference abstracts, review articles and case 
reports.
Selection and Data Extraction
All references were independently screened by two reviewers (J. Akkermans and S.H.P. 
Peeters). Disagreement on the eligibility of a study was resolved by discussion until consensus 
was reached. Studies presenting data on twin pregnancies with confirmed monochorionicity 
by first trimester ultrasound, affected by TTTS according to the Eurofoetus criteria [5] or 
the Quintero criteria [16] treated with fetoscopic laser coagulation of vascular anastomoses 
were included.
Studies were selected when presenting at least the number of patients treated and either 
survival rate of both twins, survival rate of one twin, survival rate of at least one twin 
or GA at birth. Other important parameters were complications, such as PPROM, GA at 
laser and laser technique used. In the sporadic event that study results contained also 
outcomes of triplets (e.g. monochorionic twins affected by TTTS and a singleton), we 
used the perinatal outcome results of the twins for analysis. To prevent double counting 
of cases, we excluded studies reporting outcomes from pregnancies that were treated in 
overlapping years with other published series from the same centers.
Differences in dual survival, single survival and at least one survival as well as GA at birth 
were analyzed on a timeline. Five-year intervals were chosen to analyze studies over time. 
1
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For categorization we used the year the study was concluded as a cut-off value. Survival 
was analyzed per laser technique used in the series to show the impact of the proposed 
technical adaptations of the laser treatment.
Statistical Analysis
Continuous variables were reported as median (range) or mean ± standard deviation (SD); 
for synthesis of data, medians (range) were recalculated as means ± SD using the method 
described by Hozo et al. [17].
For comparing survival outcomes of different techniques, a cumulative survival rate was 
calculated and the 95% confidence intervals (CIs) were estimated using binomial distribution. 
The survival rates were pooled using the DerSimonian and Laird random-effects models 
with heterogeneity estimated from the Mantel-Haenszel model. The results of multiple 
groups were compared using analysis of variance (ANOVA) statistics. Results of categorical 
variables were compared using Fisher’s exact test or χ2 test, as appropriate. Student’s t test 
was used to compare normally distributed values between two groups. The Mann-Whitney 
U test was used to compare non-parametric variables. A p value <0.05 was considered to 
indicate statistical significance. Statistical analysis was performed using SPSS (IBM SPSS 
Statistics 20 for Windows; IBM, New York, N.Y., 2011) and MS Excel (Microsoft Excel 2010; 
Microsoft, Redmond, Wash., 2010). This being a literature review, no approval from our 
Ethics Committee was needed before performing this study.
RESULTS
Flow of Study Inclusion
Figure 1 shows a flow diagram according to the PRISMA statement [15] with the total 
number of citations retrieved by the search strategy and the number included in the review. 
After full-text analysis a total of 34 studies were included in the time-based analysis [10, 
12, 13, 18– 48]. Twelve studies [5, 49–59] presented data overlapping other series, of which 
one presented data relevant for the technique-based analysis [58].
Study Characteristics
The characteristics of all included studies are shown in table 1. One of the studies enrolled 
was a randomized controlled trial [13]; there were 13 prospective single- center cohort 
studies [10, 12, 18–20, 22–26, 28, 30, 32], 18 retrospective single-center cohort studies 
[27, 29, 31, 33– 44, 46, 47, 59], 2 prospective multicenter cohort studies [21, 58] and 3 
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retrospective multicenter cohort studies [45, 48, 55]. The studies were from the United 
States, Belgium, Australia, Canada, Spain, Poland, Italy, Taiwan, Germany, The Netherlands, 
Denmark, the United Kingdom, France, Japan, Mexico, Brazil, China and Chile. The primary 
outcomes – perinatal survival of at least one or both twins and GA at birth – were well 
defined in all included studies. 
There were three non-English language articles [34, 35, 40]. The language skills of the 
authors and co-workers (Chinese) were sufficient to analyze these articles.Three authors 
described their series in two separate cohorts in order to display their learning curve [20, 
39, 42]. Eight studies compared different (adaptations of) laser techniques [12, 13, 20, 21, 
30, 46, 48, 58]. Baud et al. [47] compared the outcomes of early, late and conventional 
selective laser surgery defined as performed before 17 weeks gestation, after 26 weeks 
gestation and between 17 and 26 weeks.
For the overlapping series of Nakata et al. [58] and Murakoshi et al. [41], we used the latter 
for the time-based analysis and the former for the technique-based analysis. For the study 
of Liu et al. [40] it was unclear what technique was used and therefore it was excluded in 
the technique-based analysis.
Primary Outcome
A total of 3,868 women with a monochorionic twin pregnancy complicated by TTTS 
treated with fetoscopic laser coagulation were included in the time-based analysis; the 
sample size per study ranged from 19 to 334 women. The median time span of study 
inclusion for all studies was 4 years (interquartile range 2–6).
The mean GA at the time of surgery was 20.9 ± 1.9 weeks. Combining all series, the mean 
perinatal survival of both twins, one twin and at least one twin was 52 ± 14.8%, 29 ± 10.5% 
and 81 ± 8.3%, respectively. The overall survival of fetuses was 5,348/7,736 (69.1%). Figure 
2a displays a forest plot with double twin survival rates in all included studies subdivided 
into time groups based on their study period, and the difference between the time periods. 
Figure 2b displays the forest plot of single twin survival rates. For both twins survival rates 
significantly increased from 31% (1990–1995) to 62% (2011–2014) (p < 0.001), and survival 
rates for at least one twin significantly increased from 70% (1990–1995) to 88% (2011–2014) 
(p = 0.009). No significant change in survival of one twin was seen between 1990 and 1995 
(39%) and between 2011 and 2014 (26%) (p = 0.09). The overall mean GA at birth of all 
series was 32.4 ± 1.3 weeks. GA at birth did not change in time for the included series (p = 
0.226).
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Laser Technique
Thirty-four studies clearly specified their laser technique and eight of these studies 
compared two groups for which different laser techniques were used [12, 13, 20, 21, 30, 46, 
48, 58]. These groups were analyzed separately, resulting in 41 subgroups describing survival 
results for different laser techniques. The non-selective laser technique was used in five 
series [10, 18–21], 28 series used the selective laser technique [12, 20–39, 42, 43, 45–48, 58], 
the selective sequential technique was used in five series [12, 13, 30, 41, 44], and three series 
used the Solomon technique [13, 46, 48].
Figure 3a shows a forest plot with the individual studies and the inter-study heterogeneity 
per technique as well as the subgroup difference and heterogeneity between the subgroups 
for double twin survival. Figure 3b shows a forest plot with the results for single twin 
survival. Survival of both twins improved significantly (p = 0.0001) over the course of the 
introduction of new or modified techniques to the detriment of survival of only one twin 
(p = 0.01). Overall a gradual improvement in survival of at least one twin was seen for the 
newer techniques (p = 0.004).
Complications
Reports on post-treatment complications after laser therapy were not readily available 
in all studies. Only 12 (33%) of the included studies reported data on PPROM. Definitions 
ranged from ‘<37 weeks gestation’ to ‘within 7 days after fetoscopy’, making comparison of 
these results impossible [13, 27, 29, 31, 32, 35, 36, 38, 39, 42, 46, 47].
DISCUSSION
In this review of all published series reporting on outcomes after fetoscopic laser treatment 
for TTTS, we found a significant improvement in survival of both twins and at least one twin 
over the past 25 years. This study also shows a significant improvement in survival of both 
twins with the more recently developed laser techniques. In 1990, De Lia et al. [3] published 
the first results of fetoscopic laser therapy as an alternative for serial amnioreduction for 
the treatment of TTTS. Since then the technique has undergone a variety of modifications.
The shown improvement in survival is likely multifactorial and potentially affected by 
different forms of bias. There are several important hypotheses to explain the improvement 
in perinatal survival after laser treatment in time. First of all, adaptations in laser technique 
such as indicated above are likely to affect survival, however the only way to demonstrate 
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this true effect is to perform a randomized controlled trial adequately powered for 
perinatal survival.
Previous two pages figure 2 a Forest plot showing double twin survival rates over 25 years of laser therapy for 
TTTS subdivided into 5-year time periods. b Forest plot showing single twin survival rates over 25 years of laser 
therapy for TTTS subdivided into 5-year time periods.
Secondly, an important factor affecting treatment results is the learning curve effect. In 
principle, novice surgeons are assumed to perform surgery less safely and efficiently than 
more experienced colleagues. A learning curve represents the improvement of both the 
operators, from experience and practice, and, equally as important, the performance of 
the entire team at managing pregnancies with TTTS. Better teamwork, multidisciplinary 
discussion with colleagues from the neonatology department (including international 
audits), stimulation, controllability and continuity may have been beneficial factors [57].
Furthermore, since laser therapy has been accepted as the preferred treatment option, 
knowledge and awareness in remote centers not offering this highly specialized treatment 
has grown. Increased awareness may have resulted in improved timely referral and a 
decreasing number of cases with advanced disease and poor outcomes.
With the acceptance of laser surgery as the best treatment thus far, over the years 
increasing number of centers started to offer this procedure. Since TTTS is rare and both 
the surgical procedure as well as careful selection of cases and optimal timing of treatment 
is complex, concentration of care in specialized maternal-fetal medicine centers has been 
advocated. With the most recent survival rates as a benchmark, (real-time) monitoring and 
quality control are essential to prevent a more widespread use of this technique, at least 
temporarily, from leading to less favorable outcome due to learning curve effects and 
small numbers.
The finding that newer techniques have better perinatal survival results could be attributable 
to a true improvement in the technique. However this effect could be positively affected 
by the fact that new techniques are, in general, introduced and adopted sooner by the 
more experienced therapists after completion of their learning 
curve and thus likely perform better. Another important factor influencing this improved 
survival is based on case selection in series comparing two techniques, which was evident in 
some studies on the sequential laser technique [60].
With this study we hope to set a benchmark level which established and starting centers 
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can compare their individual results with. Regular structural reflection on one’s own 
practice is essential to prevent late detection of suboptimal performance. If less favorable 
outcomes are noticed, a quality cycle including further education, supervision of practice 
and improvement of learning environment should be initiated. We encourage starting up 
centers as well as established centers to share their performance for peer review and to 
publish their series in order to keep updating the benchmark for other centers [61].
Unfortunately, data on post-treatment complications such as TAPS, recurrent TTTS or 
PPROM were often not available in the reported studies or lacked uniform definitions. 
Iatrogenic PPROM is generally assumed to be one of the most important causes of premature 
delivery after laser therapy [6]. To gain better insight into the important complications of 
laser treatment, it is crucial that we use systematic methods of reporting. Incidences are 
low and knowledge is largely based on small series. In order to conduct systematic reviews 
in these areas, definitions need to be uniform when it comes to perinatal survival (e.g. alive 
at 28 days after birth), PPROM (e.g. before 32 weeks gestation), TAPS and recurrent TTTS.
This study has some important limitations. Our findings could be influenced by publication 
bias. Centers that are still in their learning curve, or otherwise have less favorable results, 
might be hesitant to publish their series when they underperform compared to the published 
series of established centers. Also, the data may reflect selection bias. Less experienced 
centers may only treat less difficult cases and refer difficult cases to experienced centers, 
resulting in better survival in their centers and decreased survival in the latter.
The past decades have also shown significant improvements regarding (early) neonatal care 
resulting in overall better outcomes after preterm birth [62–64]. The effect of the above-
mentioned factors are very difficult to quantify and should be taken into account when 
interpreting the results of this study.
Another limitation is the inclusion of series that have a large time span of data collection. 
This might have decreased the differences in survival over time when later series include 
the learning curve phase of the center.
Evaluation of technical or other adaptations of surgical techniques using historic controls 
is hampered by bias caused by increasing experience over time, the learning curve effect 
and improved neonatal care. The value of meta-analysis is highly dependent on the quality 
of the included studies. Most of the introduced techniques and adaptations have not been 
evaluated in randomized controlled trials. Comparison of survival outcomes of different 
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techniques based on data from non-comparative observational studies is potentially 
hampered by high interstudy heterogeneity, as found in this study. Due to the nature of 
the data, statistical correction is impossible. Interpretation of the results should be done 
with caution and can only be used to generate hypotheses.
Previous two pages figure 3 a Forest plot showing double twin survival rates subdivided by the laser technique 
used. b Forest plot showing single twin survival rates subdivided by the laser technique used.
The treatment of TTTS yielded a fair improvement in perinatal survival with the introduction 
of laser surgery over two decades ago. This review shows a significant increase in perinatal 
survival since then. Combining all published series, as a benchmark, perinatal survival of at 
least one twin after laser therapy can be achieved in 81– 88% of pregnancies and survival 
of both twins in 52–54% of pregnancies. The median GA at delivery in these series was 32.4 
weeks. Nevertheless, we believe that significant improvement opportunities prevail and we 
see challenges in improving instrumentation and technology for the treatment of TTTS 
to increase survival of both twins and, almost equally important, in prolonging pregnancies 
beyond 34 weeks gestation. Survival and short-term neonatal morbidity should not be 
the only goals. The ultimate goal should be ‘disease-free survival’ and focus on reducing 
the rate of neurodevelopmental impairment. We suggest institutions to focus on long-
term pediatric neurodevelopmental outcomes. Follow-up into childhood is indispensable to 
determine outcome in terms of motor, cognitive and behavioral development [65].
Fetoscopic laser treatment is often hindered by technical difficulties such as reduced 
visibility due to stained amniotic fluid or poor accessibility of some anastomoses due to 
placenta location or the position of fetal parts on the vascular equator [66]. Possibly, such 
limitations may affect the outcome results of the treatment. Technological innovations 
may aid us to overcome these limitations and help us improve our outcomes. Remarkably, 
technological innovations in instrumentation and equipment, common in the field of 
laparoscopic surgery, appear to be virtually absent in the fetoscopic treatment of TTTS. 
The equipment used 25 years ago is almost identical to what we use today. A lack of 
interest from commercial companies paired with complicated licensing issues for use in 
pregnancy may play a role.
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To evaluate differences between international fetal centers in their treatment of twin–
twin transfusion syndrome (TTTS) by fetoscopic placental laser coagulation.
Methods
Fetal therapy centers worldwide were sent a web-based questionnaire. Participants were 
identified through networks and through scientific presentations and papers. Questions 
included physician and center demographics, treatment criteria, operative technique and 
instrumentation. Laser treatment was compared between low-volume (< 20 procedures/
year) and high-volume (≥ 20 procedures/year) centers. Data were analyzed using descriptive 
statistics.
Results
Of 106 fetal therapy specialists approached, 76 (72%) from 64 centers in 25 countries 
responded. Of these, 48% (31/64) of centers and 63% (48/76) of operators performed 
fewer than 20 laser procedures annually. Comparison of low- and high-volume centers 
showed differences in technique, gestational age limits for treatment and geography. High-
volume centers more often used the Solomon technique and applied wider gestational 
age limits for treatment. Europe and Asia had more high-volume centers, whereas South 
America, the Middle East and Australia had mainly low-volume centers.
Conclusion 
This survey revealed significant differences between fetal centers in several aspects of 
fetoscopic placental laser therapy for TTTS. Increasing awareness of TTTS, and of laser 
coagulation as its preferred treatment, will lead to an increase in centers offering this 
modality, especially in Asia, Africa, South America and the Middle East. Considering the 
rarity of TTTS and the relative complexity of the procedure, developing international 
guidelines for techniques, instrumentation and suggested minimum volumes per center may 
aid in optimizing perinatal outcome.
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INTRODUCTION
Since the acceptance of laser coagulation of placental vascular anastomoses as the best 
treatment for twin–twin transfusion syndrome (TTTS), perinatal morbidity and mortality 
associated with this condition have substantially reduced.1 However, results are still far 
from ideal, with overall mortality rates varying from 26% to 48% and significant attendant 
complications, such as iatrogenic preterm prelabor rupture of membranes, extremely 
premature delivery, twin anemia–polycythemia sequence (TAPS) and recurrence of TTTS.2,3 
Fetoscopic surgery is now routinely offered in fetal medicine centers across the world. 
Since TTTS is relatively rare and the surgical procedure is quite complex, concentration of 
care in these specialized centers has been advocated.4 Several authors have documented 
the treatment criteria and techniques5,6 and (minor) modifications to the technique have 
been made over the years,3,7,8 but as yet no literature that systematically documents the 
specific implementation of fetal therapy worldwide exists. 
With the economic growth in developing countries, an increasing number of centers wishing 
to offer this procedure is expected. This raises some concern that a more widespread use 
of laser treatment may, at least temporarily, lead to less favorable outcomes owing to 
‘learning-curve’ effects.9,10 Because of the absence of uniform guidelines, centers base their 
practice on personal and mentor experience and individual preferences. Without the use 
of quality-monitoring systems, substandard care and errors may easily be underestimated. 
Therefore, we advocate the development of evidence-based guidelines for fetoscopic laser 
treatment of TTTS. 
Today, differences appear to exist between centers in their specific approaches, 
instrumentation and guidelines for accepting patients for laser surgery, making it difficult 
to compare results between centers. With this international survey, we hope to take an 
important first step in the process of developing evidence-based international guidelines by 
evaluating differences between international fetal centers in their treatment of TTTS by 
fetoscopic placental laser coagulation.
METHODS
A participant database of e-mail addresses was created from the International Fetal 
Medicine and Surgery Society (IFMSS), the North American Fetal Therapy Network and 
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the Eurofetus group. Furthermore, in 2013 fetal therapists were approached at the IFMSS 
annual meeting in Jerusalem and at the International Conference of Prenatal Diagnosis 
and Therapy in Lisbon. Finally, fetal therapists who published on intrauterine therapeutic 
procedures indexed in PubMed were contacted. From this database, a list of 106 fetal 
medicine specialists was generated.
The specialists identified were asked to participate in an anonymous survey if they were 
actively involved in the evaluation and treatment of pregnancies complicated by TTTS. A 
web-based questionnaire was sent by e-mail between May and August 2013. Reminders 
were sent out to non-responders or responders with incomplete survey responses every 
2 weeks up to 3 months after the initial invitation. E-mail addresses of all potential 
participants were linked to a unique key to track automatically responses and match blindly 
respondents from the same center.
The survey was designed de novo and consisted of three domains: specialist and center-
specific demographics, laser technique for TTTS and instrumentation. Questions were 
generated through a discussion of fetal therapy specialists of the Leiden University Medical 
Center, Leiden, The Netherlands and the Fetal Medicine Unit of the Mount Sinai Hospital, 
University of Toronto, Toronto, Canada. The demographics included type of practice, 
geographical location, experience, number of TTTS cases evaluated and treated per year 
and number of fetal surgeons per center (Appendix S1). The technique domain of the survey 
consisted of questions on inclusion and exclusion criteria for laser therapy, anesthesia, 
entry technique, laser technique, cerclage and amnioreduction policy and postpartum 
placenta color-dye injection (Appendix S2). The instrumentation section of the survey 
consisted of questions regarding the fetoscopes and operating sheaths used in different 
clinical situations and the types of laser used (Appendix S3). The questionnaire gathered 
both quantitative and qualitative data from categorical, multiple choice and open-ended 
questions. A free-text field accompanied all questions to gather additional information 
and comments from the participants. The survey was pretested for face validity before 
distribution by an expert panel of five experienced colleagues. Survey entries were not 
eligible if the respondent did not perform laser treatment for TTTS.The total response 
rate was based on the number of fully completed eligible surveys.
The data were exported into an Excel spreadsheet (MS Office 2010; Microsoft 
Corp.,Mountain View, CA, USA) and descriptive statistics were undertaken using SPSS 20 
v. 20.0 (IBM Corp., Armonk, NY, USA). Data were analyzed per respondent and per center. 
For the center analysis, responses from operators from the same center were grouped. 
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When discrepancies existed, the mean was used in numerical variables and in the case of 
categorical data; the centers’ predominant answer was used.
For additional analysis, all centers were categorized into two groups depending on the 
number of laser procedures performed annually. Centers that performed ≥20 procedures 
annually were considered ‘high-volume’ centers and compared with ‘low-volume’ centers 
performing<20 procedures per year. Continuous variables are reported as mean (SD) or 
median (range); group differences were compared using the Mann–Whitney U-test or 
independent Student’s t-test. Proportions were compared using the chi-square test 
or Fisher’s exact test, as appropriate, and P≤0.05 was considered to indicate statistical 
significance.
RESULTS
Of 106 fetal therapy specialists approached, 76 (72%) responded. In total, 64 centers from 
25 countries participated. Most centers were located in North America (n=22 (34%)) and 
Europe (n=19 (30%)) (Figure 1).
Figure 1  Geographical location of respondents and corresponding distribution of low-volume (n = 31, 48%) 
( ) vs high-volume (n = 33, 52%) ( ) fetal therapy centers offering laser treatment for twin–twin transfusion 
syndrome.
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The majority (80%) were based in university medical centers. Figure 2 shows the annual 
mean number of laser procedures carried out per center and the total number of laser 
procedures per geographical area. Thirty-one (48%) centers performed <20 procedures per 
year and were classified as low volume, compared with 33 (52%) that were classified as high 
volume. Forty-eight (63%) fetal therapists who responded performed <20 procedures per 
annum and 59 (78%) were older than 45 years of age and had a median of 20 (range, 4–37) 
years’ experience in their field of practice. They had a median of 9 (range, 0.5–25) years’ 
experience with laser procedures in TTTS. Almost all performed other twin-pregnancy 
related invasive procedures. 
Figure 2  Total number of reported annual laser procedures ( ) according to geographical area and 
corresponding mean number of procedures per center ( ) in fetal therapy centers offering laser treatment for 
twin–twin transfusion syndrome.
Table 1 describes the demographics of the respondents. No significant differences in 
geographic distribution existed between responders and non-responders. For anterior 
placentae, the median lower gestational age (GA) limit for laser surgery treatment was 
16+0 weeks (31/64; 48%), ranging from 14+0 to 20+0 weeks and the median upper limit was 
26+0 weeks (31/64; 48%), ranging from 22+0 to 32+0 weeks. For posterior placentae, the 
median lower GA limit was 16+0 weeks (34/64; 53%), ranging from 14+0 to 20+0 weeks, 
and the median upper limit was also 26+0 weeks (31/64; 48%), ranging from 24+0 to 32+0 
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weeks. Fifteen of the centers (23%) offered laser surgery before 16 weeks and 22 (34%) 
after 26 weeks’ gestation.
The majority of centers preferred operating with the patient under local anesthesia with or 
without intravenous (IV) sedation (n=38 (59%)). In five (8%) of the centers, general anesthesia 
was the preferred form of anesthesia. The majority of procedures were performed in a 
general operating room (n=45 (70%)). Thirteen centers (20%) had a dedicated fetal surgery 
room and six (9%) a dedicated obstetric operating room available. Direct percutaneous 
trocar insertion was the preferred entry type in 50 (78%) centers and the Seldinger 
technique was preferred in 12 (19%) centers, although in three of the latter it was specified 
that, in certain circumstances, the direct percutaneous technique was used; minilaparotomy 
was used in two (3%) centers as their preferred technique for trocar insertion. Cervical 
cerclage was never performed in the same session as the laser procedure in 20 (31%) of 
the centers and the majority considered cerclage only in cases with cervical shortening 
or dilatation (n=43 (67%)). Cerclage was part of the standard treatment procedure in only 
one center. Table 2 presents the center-specific differences. Irrespective of the placental 
location, selective laser coagulation, in which all true anastomoses crossing the vascular 







< 36 years —
36–45 years 17 (22)
46–55 years 38 (50)
≥ 56 years 21 (28)
Medical specialty 
Maternal–fetal medicine 72 (95)
Pediatric surgery 4 (5)
Years of experience with invasive obstetric procedures 18 (13–23)







≥ 50 5 (7)
Table 1 Demographic characteristics 
of study population of 76 fetal 
therapy specialists. Data are given 
as  n  (%), median interquartile 
range or mean ± SD.
54
in 26 (41%) centers. A sequential technique, first lasering arteriovenous anastomoses 
from donor to recipient, and aiming to minimize hemodynamic fluctuation, was used in 33 
(52%) cases that had a posterior placenta and 30 (47%) that had an anterior placenta. The 
Solomon laser technique, i.e. lasering the complete vascular equator, was used in 18 (28%) 
cases that had a predominantly posterior placenta and in 15 (23%) cases that had an anterior 
placenta. Eleven (17%) centers combined sequential and Solomon techniques. Almost half 
of the responding centers (n=29 (45%)) used placental dye injection postnatally to assess 
completeness of the laser procedure. 
A diode laser was used in 36 (56%) of the centers and a neodymium-doped yttrium aluminum 
garnet (Nd:YAG) laser in 23 (36%). Four (6%) centers used both diode and Nd:YAG lasers, and 
one center used potassium titanyl phosphate (KTP) laser in selected cases. Scope diameter 
used in procedures under 16 weeks’ gestation ranged from 1.0 mm (3 Fr) to 3.8 mm (11 Fr), 
with 51% between 1.0 mm and 1.4 mm (4 Fr). Sheath diameter used in procedures under 
16 weeks’ gestation ranged from 1.0 mm to 3.8 mm, with 46% between 3.0 mm (9 Fr) and 
3.4 mm (10 Fr). In procedures after 16 weeks’ gestation, scope diameter ranged from 1.0 
mm to 3.8 mm, with 57% between 2.0 mm (6 Fr) and 2.4 mm (7 Fr). Sheath diameter used 
in procedures after 16 weeks’ gestation ranged from 2.0 mm to 4.0 mm (12 Fr), with 58% 
between 3.0 mm and 3.4 mm. 
Short cervical length was not considered as a contraindication to laser treatment in 
37 (58%) centers, nor was a large maternal body mass index (n=60 (94%)). A previous 
amnioreduction was a contraindication for laser in four (6%) centers and triplet pregnancies 
were a contraindication in six (9%) of the centers. In 35 (55%) centers selective termination 
of pregnancy via cord occlusion was offered as a first-line alternative to laser therapy in 
cases of TTTS. Of the 29 centers that did not offer termination of pregnancy, five stated 
that they could not offer this owing to legal restrictions. In monochorionic twins with 
severe growth discordance, defined as an estimated fetal weight below the 10th percentile 
in the smaller twin and above the 10th percentile in the larger one11 in the absence of 
diagnostic criteria for TTTS, laser therapy was offered as a first-line treatment in 28 (44%) 
centers. 
We identified 33 high-volume and 31 low-volume centers, based on whether they performed 
≥20 or <20 procedures annually, respectively. A striking difference between the two groups 
was their geographic location, low-volume centers being more frequently located in South 
America, Australia and the Middle East (P<0.01) (Figure 1). The number of fetal surgeons per 
center was higher in high-volume centers than in low-volume ones (P=0.03).
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Anesthesia  0.020 
Local with/without sedation 38 (59) 23 (70) 15 (48)
Regional (epidural/spinal) 19 (30) 8 (24) 11 (35)
General anesthesia 5 (8) — 5 (16)
Other (50% local, 50% regional) 2 (3) 2 (6) —
Entry type 0.263 
Percutaneous via direct trocar insertion 50 (78) 28 (85) 22 (71)
Percutaneous via Seldinger technique 12 (19) 5 (15) 7 (23)
Minilaparotomy 2 (3) — 2 (6)
Laser type 0.682 
Diode 36 (56) 19 (58) 17 (55)
Nd:YAG 23 (36) 10 (30) 13 (42)
KTP 1 (2) 1 (3) —
Both Nd:YAG and diode 4 (6) 3 (9) 1 (3)
GA upper limit > 26 + 0 weeks
Anterior placenta 18 (28) 12 (36) 6 (19) 0.130 
Posterior placenta 22 (34) 14 (42)  8 (26)  0.162 
GA lower limit < 16 + 0 weeks
Anterior placenta 12 (19) 7 (21) 5 (16) 0.603 
Posterior placenta 15 (23)  8 (24)  7 (23)  0.875 
Solomon laser technique
Anterior placenta 15 (23) 11 (33) 4 (13) 0.054 
Posterior placenta 18 (28) 13 (39)  5 (16)  0.039 
Sequential laser technique
Anterior placenta 30 (47) 16 (48) 14 (45) 0.790 
Posterior placenta 33 (52) 18 (55) 15 (48)  0.622 
Amnioreduction  1.000 
Until DVP 4 cm 4 (6) 2 (6) 2 (6)
Until DVP 6 cm 38 (59) 19 (58) 19 (61)
Until DVP 8 cm 21 (33) 11 (33) 10 (32)
Other 1 (2) 1 (3) —
Cerclage policy 0.891 
Never 20 (31) 10 (30) 10 (32)
Always 1 (2) — 1 (3)
When dilatation or shortening 43 (67) 23 (70) 20 (65)
BMI limit exclusion for laser 4 (6) 2 (6) 2 (6) 1.000 
Laser in MC twins with severe growth discordance 28 (44) 17 (52) 11 (35)  0.196 
Short cervix not an exclusion for laser treatment 37 (58) 22 (67) 15 (48)  0.139 
Placental dye injection 29 (45) 15 (45) 14 (45)  0.981 
Table 2 Fetal therapy center-specific differences, including comparison of high- vs low-volume centers. Data 
are given as n  (%). * High-volume defined as centers carrying out ≥ 20 laser procedures/year. †Low-volume 
defined as centers carrying out < 20 laser procedures/year. BMI, body mass index; DVP, deepest vertical pocket; 
GA, gestational age; KTP, potassium titanyl phosphate (laser); MC, monochorionic; Nd:YAG, neodymium-doped 
yttrium aluminum garnet (laser).
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Data on the annual number of procedures performed per center, with respect to the 
number of fetal surgeons per center, are presented in Figure 3. Anesthetic technique 
was quite different between the groups (P=0.02), general anesthesia being used as first 
choice in only five (16%) of the low-volume centers. For posterior placentae, high-volume 
centers more frequently used a Solomon laser technique (in some centers combined with 
a selective sequential technique) than did low-volume centers (39% (13/33) vs 16% (5/31), 
respectively) (P=0.04). GA limits for treatment were less strict in the high-volume centers, 
with an upper limit of >26+0weeks in 42% (14/33), compared with 26% (8/31) in the low-
volume centers, but these results were not statistically significantly different (P=0.16). 
Comparisons between high- and low-volume centers are presented in detail in Table 2.
Figure 3 Box-and-whisker plots of number of surgeons per fetal therapy center according to number of 
procedures performed annually in centers offering laser treatment for twin–twin transfusion syndrome. Boxes 
represent median and interquartile range, whiskers are range excluding outliers and circles are outliers.
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DISCUSSION
This is the first study to identify and compare differences in fetal therapeutic techniques 
and protocol for TTTS between centers worldwide. We demonstrate considerable 
variations in patient characteristics, instrumentation and techniques, which appear to be, at 
least partially, related to the volume of patients treated and geographical circumstances 
of the centers. 
Throughout the world, different criteria for laser therapy are used among established 
fetal medicine centers. In particular, there are differences in GA limits and cervical length 
at which laser therapy is offered. Differences in patient selection, referral and treatment 
options may significantly affect perinatal outcome data. These variations hamper the 
interpretation and comparability of results from single centers. 
Sixty-three percent of fetal therapists and 48% of centers perform <20 procedures per 
annum. Even though there is limited evidence concerning the ideal number of procedures 
that should be performed to maintain high-quality results10, many studies have investigated 
the relationship between hospital volume data and postoperative surgical outcomes in 
other fields of surgery. Better outcomes have been reported in high-volume institutions for 
high-risk procedures.12–14 ‘Learning-curve’ and monitoring studies show that approximately 
20–30 procedures per year (per operator) are needed to maintain a requisite skill level.9,10. 
To optimize surgical outcomes and to decrease the incidence of medical error, we propose 
the implementation of a continuous audit system, allowing timely feedback at each center. 
If fewer surgical procedures are performed annually, lower-volume centers will be at risk 
of late recognition of substandard care or the incidence of complications. 
Concentration of care for this highly specialized procedure has been advocated,4 although 
geographical circumstances can justify the need for low-volume centers, since timely 
referral and treatment are associated with improved dual-twin survival and decreased 
neurodevelopmental delay.15 However, Tchirikov et al.16 showed that the advantages of 
state-of-the-art laser treatment in a specialized medical center outweigh the risks of long 
distance (air) transportation for TTTS patients. Since laser coagulation has been shown to 
be the treatment of choice for TTTS, the benefits of offering it, albeit in lower-volume 
centers, must be carefully weighed against offering only amnioreduction. In certain parts 
of the world, and for some patients, referral to larger, more experienced centers for laser 
treatment may not be possible. 
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Regardless of the number of fetal surgeons or number of procedures performed, 
infrastructure in the management of TTTS is of major importance. Success rates depend 
on performance of the entire team in the management of TTTS patients, as well as post-
procedure follow-up by referring specialists. Teamwork, discussion (including international 
audits), stimulation and continuity may be factors that could help to optimize outcomes. 
Since laser therapy was first introduced, several modifications have been described. 
Improvements in instrumentation and laser technique seem to have improved the 
success rate of placental dichorionization and thereby decreased the rate of subsequent 
complications. The use of smaller instruments to prevent iatrogenic damage to the 
membranes has been proposed once the learning curve has been overcome.17 Recently an 
international randomized trial showed that complete coagulation of the vascular equator 
using the Solomon technique reduces the risk of recurrent TTTS and TAPS.3 
In 55% of fetal medicine centers selective termination is available as an option, but it is 
not clear whether this should be offered routinely, or only in specific situations (such as 
in cases of discordant lethal anomalies or a moribund cotwin). In some centers selective 
termination is not possible, often because of legal restrictions. Whether or not this 
modality is available obviously influences several of the outcome parameters, hampering 
comparison between centers.
Currently in the USA the Food and Drug Administration only permits the use of the Karl 
Storz fetoscopic set for the treatment of TTTS between the GA limits of 16 and 26 weeks. 
This restricts the USA centers in using wider GA limits for treating TTTS or using laser 
treatment for other indications such as discordant growth restriction and TAPS. 
Interestingly, we found that despite the lack of evidence for its efficacy, a large 
proportion (44%) of centers offer laser therapy for severe discordant growth restriction 
without evidence of TTTS. Before this new treatment option becomes assimilated into our 
therapeutic armamentarium, we suggest that it be evaluated as a matter of urgency by an 
appropriately powered, international, multicenter randomized controlled trial.
Our study has some limitations. Despite the use of fetal medicine networks to select 
participants, small start-up centers might not have been included in this survey. However, 
with a response rate of 72% (76/106) of fetal medicine specialists at the forefront of fetal 
therapy, we think that the majority of centers are well represented. For this study, the 
number of questions was limited and we relied on self-reporting of respondents, rather 
than documentation of their practice. The study reflects current practice and is of value 
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in generating hypotheses and identifying areas for future research, but cannot be used as a 
guideline, thus our results should be interpreted with caution. 
It should be borne in mind that many cases of TTTS worldwide go untreated, emphasizing 
the importance of ongoing education regarding TTTS. This study may serve as a starting 
point for further discussion regarding the optimal treatment strategies for TTTS and may 
provide a means of evaluating current therapeutic practices for patients with TTTS. Future 
studies should focus on the development of evidence-based guidelines for a standardized 
approach to the provision of laser treatment for TTTS.
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APPENDICES
Therapist and center section Options
Gender • Male
• Female
Age • < 35 years
• 36-45 years
• 46-55 years
• > 56 years
What is your medical specialty? • Obstetrics/Gynaecology
• Pediatric Surgery
• Other, please specify below
Years of practice in OB/Gyn or Pediatric Surgery after 
residency or training period.
• 1-5 years
• 6-10 years
• > 10 years
Which best describes your current center? • University hospital
• Private hospital tertiary care facility
• Private practice referral center
• Other





How many TTTS cases does your center see yearly? • 0-20 cases
• 21-60 cases
• 61-100 cases
• > 100 cases





• > 100 procedures








How many years have you been performing ultrasound 
guided invasive obstetric procedures? (intra uterine 
transfusion, chorionic villus sampling, amniocentesis)
• 1-5 years
• 6-10 years
• > 10 years




• > 10 years




• > 60 procedures
Do you perform other interventions in twin pregnancies 
(IUT, RFA, cord coagulation, etc)? If yes, please specify.
• Yes
• No
Where is the laser procedure performed at your center? • Dedicated fetal surgery room
• General operating room
• Other, please specify below
Appendix S1 Therapist and center section
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Techniques section Options
What is your cerclage policy in case of laser treatment? • Never
• Only with a cervical length 15-25mm
• Only in case of dilatation
• Always
• Other, please specify below
What is the preferred type of anaesthesia used during 
the procedure?
• General anaesthesia
• Regional anaesthesia (epidural/spinal)
• Local anaesthesia with sedation
• Local anaesthesia without sedation
• Other, please specify below
What is the preferred entry type used for the fetoscope? • Percutaneous via trocar insertion
• Percutaneous via Seldinger technique
• Mini laparotomy
• Other, please specify below
What is the preferred laser technique used in case of 
posterior placenta position?
• Selective laser coagulation of placental 
vessels
• Selective sequential laser coagulation of 
placental vessels
• Solomon technique with sequential laser 
coagulation
• Solomon technique
• Other, please specify below
What is the preferred laser technique used in case of 
anterior placenta position?
• Selective laser coagulation of placental 
vessels
• Selective sequential laser coagulation of 
placental vessels
• Solomon technique with sequential laser 
coagulation
• Solomon technique
• Other, please specify below
In case of amnioreduction during laser procedure, how 
much amniotic fluid is drained?
• Until SDP ≤ 8 cm
• Until SDP ≤ 6 cm
• Until SDP ≤ 4 cm
• Other, please specify below
Is post-partum placental color dye injection standard 




Appendix S2 Techniques section
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Instrumentation section Options
What type and diameter of endoscope is used under 16 weeks 
gestation?
What type and diameter of operating sheat / trocar is used under 16 
weeks gestation?
What type and diameter of endoscope is used after 16 weeks gestation 
in case of posterior placenta?
What type and diameter of operating sheat / trocar is used after 16 
weeks gestation in case of posterior placenta?
What type and diameter of endoscope is used after 16 weeks gestation 
in case of anterior placenta?
What type and diameter of operating sheat / trocar is used after 16 
weeks gestation in case of anterior placenta?
What type of laser is used at your center? (multiple selection possible) • Nd:YAG laser
• Diode laser
• Other, please specify below
Is there a cervical length below which you will NOT offer/perform laser 




Is there a BMI level above which you will NOT offer/perform laser for 









Will you offer/ perform laser for TTTS in Triplets? • 
• No
• Yes
Excluding PPROM and active labour. Are there any other criteria which 










Will you offer laser in cases of severe MC growth discordance 




For an anterior placenta, what is the upper limit at which you will offer/
perform laser for TTTS? Specify: wks/days
 
…weeks …days
For a posterior placenta, what is the upper limit at which you will offer/
perform laser for TTTS? Specify: wks/days
 
…weeks …days
For an anterior placenta, what is the lower limit at which you will offer/
perform laser for TTTS? Specify: wks/days
 
…weeks …days
For a posterior placenta, what is the lower limit at which you will offer/
perform laser for TTTS? Specify: wks/days
 
…weeks …days
Appendix S3 Instrumentation section
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Is the Sequential Laser Technique for Twin-to-Twin 
Transfusion Syndrome Truly Superior to the 




To investigate the efficacy of sequential laser coagulation in the treatment of twin-twin 
transfusion syndrome (TTTS). 
Data Sources
MEDLINE, EMBASE and the Cochrane Library were systematically searched for comparative 
studies on the efficacy of sequential versus standard selective laser coagulation for TTTS. 
The primary outcome measure in these studies was survival of at least one twin, both twins 
and fetal demise. 
Results
Three cohort studies comparing the selective laser treatment technique (n = 120) versus 
the sequential technique (n = 224) in 344 monochorionic twin pregnancies were included. 
Mean survival of at least one twin was 88% in the selective group versus 92% (p = 0.22) in 
the sequential group. Mean survival of both twins was lower in the selective group (52%) 
than in the sequential group (75%) (p = 0.002). Donor fetal demise decreased from 34% in 
the selective to 10% in the sequential group (p < 0.01), and recipient fetal demise decreased 
from 16 to 7% (p = 0.02). 
Conclusion
Limited evidence suggests improved double neonatal survival as well as decreased donor 
and recipient fetal demise with the use of the sequential technique. However, these results 
are based on small non-randomized studies with evident forms of bias and methodological 
limitations. A randomized controlled trial to assess the efficacy of sequential laser 
technique is therefore required.
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INTRODUCTION
Laser surgery is the accepted treatment of choice for twin-twin transfusion syndrome 
(TTTS). However, results are still far from satisfactory, with mortality rates varying from 
20 to 48% [1] and significant neurodevelopmental problems in 6–18% of surviving children 
[2, 3]. Important complications include iatrogenic preterm premature rupture of membranes 
[4] resulting in preterm delivery, twin anemia-polycythemia sequence [5] and recurrence or 
reversal of TTTS [6].
Since the first publications on fetoscopic laser surgery by De Lia et al. [7] in 1990, several 
technical and surgical modifications have been described. In 1998, Quintero et al. [8] 
introduced the selective laser coagulation technique and in 2007 they proposed the 
sequential selective laser coagulation technique [9]. The rationale for selective laser, now 
adopted by most fetal treatment centers, is to save as much functioning placenta tissue as 
possible by coagulating only true inter-twin vascular anastomoses, instead of every vessel 
crossing the membranous equator as was commonly done in the early years. Sequential 
selective laser is an adaptation of this technique whereby anastomoses are coagulated in a 
specific order. The theoretical benefit is to obliterate the anastomoses in a sequence that 
allows, at least partly, an intraoperative correction of the hypoperfusion of the donor 
and hyperperfusion of the recipient. This is achieved by first closing the arteriovenous 
anastomoses from donor to recipient, starting with the largest ones, followed by the 
occlusion of the arteriovenous anastomoses from recipient to donor and finally occlusion 
of the arterioarterial (AA) and the venovenous (VV) anastomoses, if present.
According to Quintero et al. [9], this sequential strategy improves the rate of double survival. 
However, the quality of evidence to support this finding is limited and well-controlled 
trials are lacking. Evaluation of technical or other adaptations of surgical techniques using 
historic controls is hampered by bias caused by increasing experience over time, the learning 
curve effect. In order to assess the potential benefit of this technique, we performed a 
meta-analysis based on the published studies comparing the sequential selective with the 
(standard) selective technique.
DATA SOURCES
Prior to the meta-analysis, we created a detailed protocol that included the search 
strategies, inclusion and exclusion criteria, outcome parameters, and methods of statistical 
analysis. This meta-analysis of selective versus sequential laser in TTTS was performed 
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according to the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) [10], and 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
[11].
Literature Search
An initial literature search on studies comparing selective laser versus sequential laser 
was conducted in MEDLINE, EMBASE and the Cochrane Library using PubMed and OVID 
search engines without restriction on the language of publication. Key words and free 
text searches were performed with combinations of the following key words: twin-to-twin 
transfusion syndrome, TTTS, fetofetal transfusion, laser, laser ablation, SLPCV, SQLPCV, 
sequential laser, selective laser, fetoscopy, FLOC and photocoagulation. Additionally, 
reference sections of eligible studies were hand-reviewed for potential eligible studies.
Figure 1 Flow diagram according to the PRISMA statement.
Inclusion and Exclusion Criteria
Randomized trials and comparative studies, as well as prospective and retrospective, were 
considered eligible for inclusion. Reasons for exclusion were studies with irrelevant or 








No comparison or no outcome
data available: 6
Selected for meta-analysis
3 arcles provided clear survival






Leer, editorial, poster or 
conference abstract: 3
Duplicate references: 1115 reference tles and 
abstracts screened
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Selection and Data Extraction
Studies presenting data on twin pregnancies with confirmed monochorionicity by first-
trimester ultrasound, affected by TTTS according to either the Eurofetus criteria [12] or 
the criteria described by Quintero et al. [13], treated with either selective or selective 
sequential fetoscopic laser coagulation of vascular anastomoses were included.
Studies were selected when presenting the number of patients treated, inclusion dates, 
laser technique used, survival rate of both twins, survival rate of one twin and overall 
survival defined as alive at 28 days after birth. Other important parameters were donor 
fetal demise, recipient fetal demise, gestational age at surgery and at birth and operative 
characteristics such as placenta localization and operating time. Studies that presented 
incomplete data were excluded.
Primary and Secondary Outcomes
Series were primarily analyzed for differences in survival of at least one twin, of both twins, 
and recipient or donor fetal demise with respect to treatment allocation. Furthermore, 
analyses were performed on operating time, gestational age at laser and at birth.







2007 sequential 137 2003 - 
2005
101 (74%) 23 (17%) 91% 33.7 (4.4) 5
selective 56 32 (57%) 17 (30%) 87% 33.6 (4.3)
Nakata 
et al.
2009 sequential 23 2002 - 
2006
15 (65%) 8 (35%) 100% 32.2 (4.1) 6
selective 29 10 (34%) 14 (48%) 82% 31.8 (4.2)
Chmait 
et al.
2010 sequential 64 2006 - 
2008
51 (80%) 7 (11%) 91% 32.8 (4.7) 5
selective 35 20 (57%) 12 (34%) 91% 31.6 (4.3)
Table 1 Characteristics of studies comparing sequential versus selective laser therapy. GA = Gestational age (in 
weeks). Data are presented as n (percentage) and mean (standard deviation).
Quality Assessment and Statistical Analysis
All selected observational studies were assessed for the level of evidence provided 
according to criteria proposed by the Newcastle-Ottawa Quality Assessment Scale 
(NOQAS) [14]. We assessed the studies for methodological quality and appropriateness for 
inclusion without consideration of results. The studies were not assessed blindly. The review 
authors (J.A., S.H.P.) knew the authors’ names, institutions and the sources of publication. 
We resolved disagreement by discussion until consensus was reached.
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A meta-analysis was performed using Review Manager (RevMan) 5.2 Version 5.0 (The Nordic 
Cochrane Centre/The Cochrane Collaboration, Copenhagen 2008). Continuous variables 
were reported as the median (range) or mean (SD), and for synthesis of data, medians 
(range) were recalculated as mean (SD) using the method described by Hozo et al. [15]. 
Continuous data are presented as mean differences (MD) using inverse variance statistics 
with 95% confidence intervals (CI). For dichotomous data, we presented results as summary 
risk ratio (RR) with 95% CI.
In order to estimate the overall effect, the fixedand random-effect models were used 
(significance set at p = 0.05). The I2 statistic was used to assess statistical heterogeneity. 
An I2 value <25% was considered as low heterogeneity and an I2 value >50% as high 
heterogeneity. In case of low heterogeneity the fixed-effects model was used.
Statistical analysis was performed using SPSS (IBM SPSS Statistics 20 for Windows; IBM, 
New York 2011) and MS Excel (Microsoft Excel 2010; Microsoft, Redmond 2010). Being a 
literature review, no approval from our ethics committee was required before performing 
this study.
RESULTS
Flow of Study Inclusion
Figure 1 shows a flow diagram according to the Quality of Reporting of Meta-analyses 
statement [11] with the total number of citations retrieved by the search strategy and the 
number included in the meta-analysis. A total of three studies clearly compared selective 
with sequential laser technique [9, 16, 17]. These three studies were pooled for meta-
analysis of survival. Two excluded studies described sequential laser as the technique used 
in a proportion of their cohort but did not provide separate survival data [18, 19]. One of 
the excluded studies described a cohort of patients primarily treated with sequential laser 
surgery [20] but did not compare this with a selective laser cohort.
Study Characteristics
None of the studies enrolled were randomized controlled trials (RCTs). The three included 
studies were prospective cohort studies comparing the standard selective technique to the 
sequential technique [9, 16, 17]. A total of 344 women were included; the study sample size 
ranged from 52 to 193 pregnancies. The studies were conducted in the USA and Japan. The 
primary outcomes, neonatal survival of at least one or both twins as well as fetal demise 
were well defined in all included studies.
3
META-ANALYSIS ON SEQUENTIAL LASER TECHNIQUE   73
Quintero et al. [9] prospectively compared the selective technique with the sequential 
technique by using the latter as intended surgery technique in all cases. All cases where 
the sequence could not be met due to technical limitations or cases that were treated 
out-of-sequence were classified as standard selective.
Nakata et al. [17] prospectively compared selective versus sequential technique in a subgroup 
of TTTS cases complicated with absent or reversed end-diastolic flow in the umbilical 
artery. If the sequence of coagulation was not consistent with the defined sequence, 
the procedure was categorized as the standard selective laser group. If the sequence of 
coagulation was not recorded completely because of the difficulty of identification of 
blood flow direction or lack of recording, the procedure was also categorized as selective.
Chmait et al. [16] attempted a sequential laser technique in all patients. The group of 
patients categorized as having had selective laser failed the sequential process at some 
point during surgery for technical reasons. Each case was categorized as having had 
sequential versus selective treatment directly after surgery.
All three studies used the Quintero criteria for the diagnosis of TTTS defined as the 
presence of polyhydramnios (maximum vertical pocket of ≥8 cm) and oligohydramnios 
(maximum vertical pocket of ≤2 cm). The mean gestational age at time of surgery was 
20.6 weeks (SD 2.3). Two of the included studies [9, 16] used the sequential technique as 
proposed by Quintero et al. Nakata et al. [17] used a modification of this technique in which 
AA and VV anastomoses were occluded first.
Quality of Included Studies
The risk of bias in the observational studies was evaluated using the NOQAS (table 1). In 
the study by Chmait et al. [16] there were important baseline differences between the 
compared groups with significantly earlier gestational age at surgery (p < 0.05), less anterior 
placentae (p = 0.03) and shorter operating time (p = 0.01) in the sequential laser group. This 
problem was also seen in the publication of Quintero et al. [9] with less anterior placentae 
(p < 0.01), less arteriovenous anastomoses (p < 0.01) and a shorter operating time (p < 0.01) 
in the sequential laser group.
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Figure 2 Comparison of selective versus sequential laser technique, main outcomes. Effects displayed as RR 
using Mantel-Haenszel (M-H) statistics.
Synthesis of Results
Survival
Pooling the data of the 344 cases in the included studies, we found an increased neonatal 
survival of both twins from 52% (n = 62/120) after use of the selective technique to 75% (n 
= 162/224) using the sequential technique; with an RR of 1.39; 95% CI 1.16–1.67; p < 0.01 (fig. 
2a). No significant difference between the two techniques was observed for survival of at 
A: Two survivors
B: At least one survivor
C: Donor fetal demise
A: Recipient fetal demise
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least one twin: 88% (n = 105/120) for the selective technique versus 92% (n = 205/224) for 
the sequential technique; RR 1.05; 95% CI 0.97–1.13; p = 0.23 (fig. 2b).
Fetal Demise
Donor demise decreased from 34% (n = 41/120) in the selective to 10% (n = 23/224) in the 
sequential group with an RR 0.34; 95% CI 0.21–0.54; p < 0.01 (fig. 2c). Recipient demise 
decreased from 16% (n = 19/120) to 7% (n = 15/224) after sequential treatment with an RR 
of 0.45; 95% CI 0.22–0.88; p = 0.02 (fig. 2d).
Secondary Outcomes
Meta-analysis of secondary outcomes is shown in figure 3. Mean gestational age at surgery 
and at birth was 21.3 (2.4) and 32.3 (4.3) weeks in the selective group versus 20.6 (2.2) and 
32.9 (4.4) weeks in the sequential group. There was a significant difference in gestational 
age at surgery (MD –0.68; 95% CI –1.24 to –0.13; p = 0.02) between selective and sequential 
treatment but no difference in gestational age at birth (MD 0.47; 95% CI –0.51 to 1.44; p 
= 0.35). Median operating time was 60.4 min (range 47.0–90.1) in the selective group and 
45.4 min (range 38.0–75.2) in the sequential group. A significant difference in mean operating 
time was found between the two groups (MD –12.16; 95% CI –18.22 to –6.10; p < 0.01).
Sensitivity Analysis
The findings were similar whether fixedor randomeffects models were used.
DISCUSSION
Our meta-analysis systematically summarizes the available evidence on outcomes of MC 
twin pregnancies complicated by TTTS undergoing either standard selective or sequential 
laser treatment. Unfortunately, to date, no RCTs have been published on this subject.
Primary Outcomes
Data from three prospective cohort studies [9, 16, 17] suggest that the sequential technique 
is beneficial over the standard selective technique with respect to dual survival and single 
fetal demise of donor or recipient. No significant difference was seen in survival of at least 
one fetus.
The theory behind the sequential laser technique is based on the concept of an intraoperative 
retrograde transfusion leading to hemodynamic stabilization or at least improvement of 
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both twins. This could especially aid the severely hypovolemic donor resulting in less donor 
demise. However, concomitant acute volume depletion in the recipient twin might lead to 
higher recipient demise. The results from this meta-analysis show significant lower donor 
and recipient demise, which confirms the first hypothesis and appears to reject the latter.
Figure 3 Comparison of selective versus sequential laser technique, secondary outcomes. Effects displayed as 
MD using inverse variance (IV) statistics.
However, there were considerable differences in baseline characteristics between 
the two groups, hampering comparability. The study design used in the three studies is 
prone to selection bias based on the difficulty of the procedure which is shown by a 
significantly higher proportion of anterior placentae and longer operating time in the 
selective subgroup. Furthermore, Nakata et al. [17] described a method that is slightly 
different from the sequential laser technique described by Quintero et al. [9]. Instead of 
coagulating the arteriovenous anastomoses first, Nakata et al. [17] started with the AA and 
VV anastomoses. Although the underlying theory is the same, with this adaptation the 
theoretical protective function of AA anastomoses is omitted [21]. In their study, design 
allocation was dependent on the physician performing the procedure. Additionally, all 
cases where a full sequential technique could not be achieved or was not well recorded 
were categorized as standard selective. Furthermore, they only included TTTS cases with 
A: Gestaonal age at laser
B: Gestaonal age at birth
C: Operang me
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absent or reversed end-diastolic flow in the umbilical artery. Due to the above-mentioned 
forms of bias in the included studies, we believe that with the present available evidence, 
a clear benefit of sequential laser over standard selective is still lacking.
Secondary Outcomes
We found significant differences in gestational age at laser treatment which shows one of 
the important baseline differences due to the non-randomized nature of the studies. There 
was no significant difference in gestational age at birth, an important factor with respect 
to neonatal morbidity [22]. Another significant difference was seen in operating time. This 
parameter is largely influenced by the complexity of the procedure. We anticipated a 
longer operating time in the sequential group due to the more advanced form of placental 
mapping needed for this technique. In contrast, operating time was significantly lower in the 
sequential group, which could be explained by the above-mentioned methodology in the 
included studies where more difficult cases or unsuccessful sequential procedures were 
coded as selective procedures.
Evidence-Based Medicine
The sequential technique, where arteriovenous connections from donor to recipient are 
coagulated first, has gradually been adopted by an increasing number of centers. Although 
the rationale for this technique sounds solid, proper evidence for clinically relevant benefit 
is still lacking. Mathematical simulation by van Gemert et al. [23] supports the concept of 
sequential selective laser surgery. Nevertheless, the authors raise an important concern 
that the diameter of the anastomoses is an essential factor in defining the ideal sequence 
and that it might not always be beneficial to coagulate all arteriovenous anastomoses 
from donor to recipient first.
The ideal study design to assess the benefits of this technique would be randomization, with 
intention-totreat analysis, between sequential and standard selective laser coagulation of 
vascular anastomoses in TTTS. In 2010, Chmait et al. [16] mentioned that a multicenter 
randomized trial was in the making.
Due to the upsurge in fetal therapy centers providing laser therapy for TTTS resulting in 
more patients being treated, the importance of a solid evidence-based approach is essential. 
To date only three RCTs on laser therapy have been published. In 2004, Senat et al. [12] 
published an RCT comparing serial amnioreduction to fetoscopic laser ablation of placental 
vessels for the treatment of TTTS. This trial was stopped at the second interim analysis 
due to a significantly higher survival rate in the laser arm. In 2007, Crombleholme et al. 
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[24] published data on an RCT also comparing amnioreduction to laser treatment. This trial 
was halted by request of the investigators due to reluctance of referring clinicians to refer 
to centers only offering laser treatment through randomization as part of a trial. At the 
same time a statistical trend in adverse outcome affecting the recipient twin in the laser 
treatment arm was detected that ratified the decision.
In 2014, the Solomon trial [25] was published; five European fetal therapy centers including 
ours randomized 274 pregnancies with TTTS to receive either the standard selective 
(sequential) laser coagulation or the ‘Solomon’ method whereby following, either selective 
or sequential, coagulation of the anastomoses, a line was drawn with the laser across the 
placenta connecting the laser spots. The new technique was found, in an intention-to-
treat analysis, to significantly reduce the incidence of twin anemia-polycythemia sequence 
and recurrence of TTTS [25]. A study with a similar design, and likely similar numbers of 
patients and centers, could provide more solid evidence for a benefit of the sequential 
technique. Whether such an effort and associated costs are considered worthwhile is 
open for discussion. With a theoretical and in some studies possible benefit of sequential 
laser and a thus far apparent lack of disadvantages, adopting this strategy without further 
studies could be acceptable. However, we would urge the use of a strict, prospective 
quality monitoring and audit system to enable reconsideration in case of an unexpected 
rise of adverse events.
Limitations
The clinical relevance of these results must be interpreted with caution. No RCTs were 
available. Most of the included studies were prospective cohort studies with designs at risk 
for several types of bias, as outlined above. The only option to address such limitations is 
to be very careful not to draw too optimistic conclusions from the meta-analysis.
Conclusion
The results of our meta-analysis show that there may be a true increased double survival 
rate and a decrease in the fetal demise of donor or recipient in pregnancies where the 
sequential technique was actually used compared to pregnancies treated with selective 
laser surgery. However, since the included studies comparing selective and sequential 
techniques were limited in number, and prone to several forms of bias, a possible benefit of 
sequential laser is still unproven.
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What is the Impact of Placental Tissue 
Damage after Laser Surgery for 
Twin-Twin Transfusion Syndrome? 
A Secondary Analysis of the Solomon Trial
ABSTRACT
Background
The introduction of the Solomon technique for the treatment of twin-twin transfusion 
syndrome (TTTS) increased placental exposure to laser energy. This study aims to identify 
the impact of power and energy used in laser treatment on placental tissue and pregnancy 
outcome. 
Methods
Pictures of all dye-injected placentas since the start of the Solomon trial were analyzed. 
Placental damage was scored using a grading system including visual scar depth and 
affected proportion of the vascular equator. Parameters analyzed included laser power 
and total energy, gestational age (GA) at laser, GA at birth, laser-to-delivery interval and 
preterm premature rupture of membranes (PPROM).
Results
We included 122 cases in the analysis. More placental damage occurred more often in the 
Solomon group (42%) compared to the selective group (15%) (p<0.001).  In multivariate 
analysis, more placental damage was associated with higher laser energy (regression 
coefficient B 0.002) but not with higher power setting (regression coefficient B -0.442). 
More damage was associated with earlier GA at birth (regression coefficient B -0.167), 
higher incidence of PPROM <32 weeks (regression coefficient B 0.003) and a shorter laser-
to-delivery interval (regression coefficient B -0.168).
Conclusions
Placental damage is positively associated with more laser energy but negatively associated 
with higher power setting. More placental damage was associated with a lower GA at 
birth, shorter laser-to-delivery interval and higher PPROM rate. Whether these results 
should lead to a change in surgical technique requires more research, both further ex-vivo 
experiments on human placentas and clinical studies.
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INTRODUCTION
Monochorionic (MC) twin pregnancies are high-risk pregnancies, often (10%) complicated 
by twin-twin transfusion syndrome (TTTS). Untreated, this condition is associated with 
approximately 90% perinatal mortality and severe morbidity.[1-3] Survival rates increase 
significantly after treatment with fetoscopic laser therapy up to 88% for at least one twin 
and 62% for survival of both twins, in experienced centers.[4] 
In 2008, the Solomon technique was introduced as an adaptation of the selective 
fetoscopic laser coagulation technique for the treatment of TTTS complicated MC 
pregnancies. [5] The rationale behind the Solomon technique is to eliminate even the 
smallest anastomoses by coagulating a line between the visible anastomoses, thereby 
avoiding residual anastomoses leading to recurrence of TTTS or occurrence of post-laser 
twin anemia polycythemia sequence (TAPS). We concluded that the Solomon technique 
significantly reduces the incidences of recurrent TTTS and post-laser TAPS.[5] 
A possible drawback of the Solomon technique is a larger surface area of the placenta being 
exposed to laser energy, compared to the selective laser coagulation technique (Figure 1). 
Animal studies suggest that superficial coagulation, in time, may lead to functional loss 
of the entire underlying cotyledon.[6] Little research has been conducted on the impact of 
laser energy and laser power setting (wattage) on the human placental tissue. Emery et al. 
described the effect of Solomon laser treatment after pathological analysis on a human 
placenta. They concluded that solomonization leads to devitalization of the chorionic 
plate with shallow devitalization of the underlying villi. [7] 
 
A worldwide expert survey showed significant variation in laser power settings between 
centers.[8] Furthermore, it showed that the Solomon technique is gaining popularity. We 
therefore consider it important to investigate the impact of laser power and laser energy 
on placental tissue. Laser power is defined as the output wattage of the laser device 
that can be set by the operator. The total amount of laser energy (joule) used during a 
procedure is calculated automatically by the laser device and is the result of laser power 
and the laser time. This study aims to identify the impact of the level of laser power and 
the amount of energy used in laser treatment on placental tissue and pregnancy outcome.
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METHODS
Data source
For this study, all cases from the Leiden University Medical Center included in the Solomon 
Trial[5] were used, as well as all cases treated in our national referral center after the 
Solomon study was concluded. 
All subjects treated between 2008 and 2014 at the Leiden University Center during 
the Solomon trial were eligible for this study. Inclusion criteria for laser surgery were: 
monochorionic pregnancy, gestational age between 13 and 28 weeks, TTTS Quintero stage 
1 with severe clinical symptoms of polyhydramnios, or TTTS Quintero stage ≥2. For the 
analyses we extracted data on laser treatment specifics (including laser power, laser time 
and total energy usage), clinical outcome parameters and postpartum color-dye injected 
placenta pictures. Details on the color-dye procedure were previously reported [9]. 
Inclusion and exclusion criteria
All cases with an available placenta picture after selective or Solomon laser were included. 
Exclusion criteria were: missing documentation on both total energy and laser power setting, 
missing scale on the picture, single fetal demise and re-intervention laser therapy after the 
initial laser procedure. Cases with single fetal demise were excluded because placental 
maceration hampers color-dye injection. Cases with a re-intervention laser procedure were 
excluded because the visible damage could not be directly linked to either one of the laser 
procedures. Pictures from cases with a laser-to-delivery interval under seven days were 
excluded from grading, because these pictures showed no or little scarring.
Scoring placental tissue damage
In the absence of a validated scoring system for placental tissue damage, we developed 
one (Table 1) based on validated scar scales.[10, 11] The amount of damage of each grade 
was measured in millimeters length and expressed as percentages of the total lasered line 
in Solomon cases, or lasered sections in selective cases of the placenta. In pictures that 
had a missing scale but showed an umbilical cord clamp, the clamp was used to gauge 
the scale. Measurements were performed using ImageJ 1.47v software (ImageJ, National 
Institutes of Health, Bethesda, Maryland, USA). Placental tissue damage was defined as the 
summed up value of grade 2 and 3 tissue damage. These two categories most likely cover 
the damage that is considered to be more severe than intended with laser coagulation. Two 
observers (SdV and JA) assessed all pictures independently and blinded from outcome, 
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patient and procedural parameters. Inter-observer variability was assessed calculating the 
intraclass correlation coefficient. In cases with an inter-observer scoring difference of >5% 
of the tissue damage score, the case was discussed by the observers until consensus was 
achieved. We used the mean value of the tissue damage scores of both observers combined 
for analyses. 
Analysis
The influence of laser power and laser energy on placental tissue damage was analyzed. 
Further analyses were conducted to determine the relation of placental tissue damage, 
laser power and laser energy to various outcome parameters. These included gestational 
age (GA) at birth, laser-to-delivery interval and preterm prelabor rupture of membranes 
(PPROM) before 32 weeks’ gestation.
Statistical analysis 
Analyses were conducted using SPSS Statistics (IBM Corp. Released 2011. IBM SPSS Statistics 
for Windows, Version 20.0. Armonk, NY: IBM Corp.). Analysis for risk factors, visual placental 
tissue damage, laser power and laser energy, influencing either the gestational age at 
birth, laser-to-delivery interval and PPROM under 32 weeks gestation was conducted using 
univariate and multivariate regression methods. Normality of all variables was asessed prior 
to moddeling. The potential risk factors for each of the three outcomes were studied in a 
univariate linear regression model. The multivariate regression model included all factors 
that showed significant association in the univariate analysis. Results are expressed as 
regression coefficients (B) with 95% confidence intervals (95%CI). Numerical variables with 
a normal distribution were expressed in mean (SD) and variables with a skewed distribution 
were expressed in median (range). A p-value of <0.05 was considered statistically significant. 
RESULTS
Selected Cases
A total of 159 placenta pictures, documented after selective (n=44 (28%)) or Solomon 
(n=115 (72%)) laser coagulation, were available for this study. Included selective laser cases 
were treated between March 2008 – June 2012 and included Solomon cases between 
January 2008 – January 2014. Four cases were excluded because of single fetal demise with 
partial placental maceration, and three because a second laser procedure was performed. 
No pictures of double demise cases were available. Data on both laser power setting and 
total energy was missing in 17 cases, all in the Solomon group. Another 10 cases were 
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excluded due to missing scale or inadequate quality of the picture. Finally, three pictures 
were excluded from grading because of a laser-to-delivery interval within 7 days. These 
cases were lasered at 25+3, 22+0 and 25+5 weeks GA and could not be scored due to 
insufficient visual placental scarring. In total, 122 placenta pictures were included in this 
study, 44 (36%) after selective laser and 78 (64%) after Solomon laser.
 
Selective Technique Solomon Technique
Category Definition median % (range) median % (range) P-value
Grade 0 No visible signs of laser coagulation 70,1 (13-94) 3,4 (0-89) <0.001
Grade 1 Membranes intact, white/brownish 15,1 (0-58) 46,2 (0-98) <0.001
Grade 2 Membranes perforated, red 4,6 (0-31) 19,0 (0-87) <0.001
Grade 3 Underlying tissue damaged, irregular 
surface
7,5 (0-59) 13,0 (0-100) 0.021
Grade 2+3 Grade 2 and 3 combined 15,1 (0-59) 41,8 (0-100) <0.001
Table 1 Placental damage grading system with median damage scored per category and technique. Proportion 
expressed in percentages of total vascular equator. Mann-Whitney U test. The numbers in the pictures correspond 
with the damage grading category
Case Characteristics
The mean GA at laser was 20 (±3) weeks and mean GA at birth was 32 (±5) weeks (Table 
2). Seven cases were lasered after 26 weeks’ gestation, with a maximum GA at laser of 
28+4 weeks. The placenta was localized posterior in 57% of the cases. Most lasers were 
performed for TTTS with Quintero stage 3 (49%). One of the cases involved a dichorionic 
triplet pregnancy, with a monochorionic component. Two placentas were lasered for the 
treatment of TAPS. The Nd:YAG laser (Dornier Fibertom 5100) was replaced by a diode laser 
(Dornier Medilas D Multibeam) in May 2013 due to regular replacement of equipment. 
Thirteen of the 78 Solomon cases in this study were lasered using the diode laser, generally 
with lower power levels compared to the Nd:YAG laser, in sub analyses laser type had no 
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effect on the outcome of this study. All case characteristics and procedural parameters 









  Stage 1 15 (12) 7 (16) 8 (10) 0.762
  Stage 2 38 (31) 12 (27) 26 (33)
  Stage 3 60 (49) 23 (52) 37 (47)
  Stage 4 6 (5) 2 (5) 4 (5)
Placenta localization
  Anterior 48 (39) 17 (39) 31 (40) 0.375
  Posterior 69 (57) 27 (61) 42 (54)
  Lateral 4 (3) 0 (0) 4 (5)
  Anterior and posterior 1 (1) 0 (0) 1 (1)
Laser type
  YAG 109 (89) 44 (100) 65 (83) 0.004*
  Diode 13 (11) NA 13 (17)
GA at laser 142 (±22) 141 (±20) 143 (±23) 0.633
GA at birth 229 (±23) 228 (±26) 229 (±21) 0.775
Pregnancy prolongation 86 (±30) 87 (±29) 86 (±31) 0.900
Procedural Parameters
Fetoscopy time (min) 28 (±11) 23 (±9) 30 (±11) 0.004
Maximum power setting (watt) 53 (±15) 55 (±12) 53 (±16) 0.477
  YAG 55 (±14) 55 (±12) 56 (±15) 0.665
  Diode 36 (±14) NA 36 (±14) NA
Total laser energy (joule) 5668 (673-32300) 2704 (673-20500) 7171 (797-32300) <0.001*
  YAG 5998 (673-32300) 2704 (673-20500) 8070 (2285-32300) <0.001*
  Diode 4175 (797-14924) NA 4175 (797-14924) NA
Amount anastomoses 6 (2-23) 6 (2-19) 6 (2-23) 0.841
Table 2 Baseline characteristics All categorical values are expressed as N(%). All numerical values are expressed 
as mean (SD) or median (range). GA laser, GA birth and Pregnancy prolongation are reported in number of days. 
Pregnancy prolongation is defined as the number of days of pregnancy prolongation after laser therapy until 
the delivery.
Grading 
The 122 pictures were scored using the tissue damage grading system. The mean proportion 
of damage, expressed as the percentage of the total vascular equator for each grade 
4
THE IMPACT OF PLACENTAL LASER DAMAGE   89
is shown in Table 1 for both selective and Solomon cases.  Placental tissue damage was 
found more frequently in the Solomon group (42%) compared to the selective group (15%) 
(p<0.001). Inter observer variability in defining grade 2 and 3 damage was good with an 
intraclass correlation of 0.997 (95%CI 0.995-0.998). In 5 cases we found an inter-observer 
grading difference of >5%, these cases were discussed by both observers blinded from 
procedural and outcome parameters until consensus was reached.
Variable Univariate analysis B 
(95% CI)
SE P Multivariate analysis B 
(95% CI)
SE P
Laser power -0,256 (-0,596 - -0,070) 0,166 0,022 -0,442 (-0,833 - -0,050) 0,198 0,027
Laser energy 0,001 (0,000 - 0,002) 0,000 <0,01 0,002 (0,001 - 0,003) 0,000 <0,01
GA at laser -0,106 (-0,335 - 0,123) 0,116 0,361 -0,072 (-0,327 - 0,183) 0,129 0,577
Table 3 Analysis of factors contributing to grade 2 and 3 damage. Values are regression coefficient B (95%CI, 
standard error (SE) and P.
Associations with placental damage
Analysis of factors associated with grade 2 and 3 placental tissue damage is shown in 
Table 3. Since gestational age at laser was strongly correlated with laser power (Pearson 
correlation 0.468; p<0.001), laser energy (Spearman correlation 0.297; p<0.001) and the 
laser-to-delivery interval (Spearman correlation -0.635; p<0.001), multivariate analyses 
were performed. Multivariate analysis showed that laser energy (p<0.01) was positively 
associated and that laser power (p=0.027) was negatively associated with more placental 
damage (grade 2 and 3 damage combined). The amount of grade 2 and 3 placental damage 
negatively affected the GA at birth as shown in Table 4 (p=0.020). Table 4 also shows that 
less grade 2 and 3 placental damage (p=0.020) and a lower GA at laser (p<0.01) were both 
associated with a longer laser-to-delivery interval in multivariate analysis. This finding was 
the same for PPROM <32 weeks’ gestation. More grade 2 and 3 damage (p=0.031) and a 




In this study, we evaluated the impact of gestational age of laser, laser power, laser 
total energy and post-partum visual placental damage after laser treatment for TTTS 
on pregnancy outcome. Visual tissue damage appeared to be a significant risk factor for 
a higher incidence of PPROM under 32 weeks’ gestation and a shorter laser-to-delivery 
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interval and a lower GA at birth. Cases with more extensively damaged placentas more 
often developed PPROM and had a lower GA at birth compared to cases with less placental 
tissue damage. Anterior placenta localization did not lead to use of more laser energy or 
more placental tissue damage. More laser energy used during the procedure was associated 
with more extensive placental damage, whereas a higher power setting was found to lead 
to less damage. Furthermore, we found a significant correlation between GA at laser with 
laser power and laser energy used. 
Variable Univariate analysis B 
(95% CI)
SE P Multivariate analysis B 
(95% CI)
SE P
Factors associated with gestational age at birth
Laser power 0,045 (-0,233 - 0,323) 0,140 0,750 -0,021 (-0,362 - 0,319) 0,172 0,901
Laser energy 0,000 (-0,001 - 0,001) 0,000 0,821 0,000 (-0,001 - 0,001) 0,000 0,944
Grade 2 and 
3 damage
-0,163 (-0,296 - -0,029) 0,067 0,017 -0,167 (-0,307 - -0,026) 0,071 0,020
GA at laser 0,093 (-0,098 - 0,283) 0,096 0,338 0,063 (-0,158 - 0,284) 0,111 0,563
Factors associated with the laser-to-delivery interval
Laser power -0,646 (-0,997 - -0,296) 0,177 <0,01 -0,036 (-0,388 - 0,315) 0,177 0,838
Laser energy -0,001 (-0,002 - 0,000) 0,000 0,244 0,00 (-0,001 - 0,001) 0,000 0,871
Grade 2 and 
3 damage
-0,137 (-0,314 - -0,041) 0,090 0,130 -0,168 (-0,306 - -0,026) 0,071 0,020
GA at laser -0,907 (-1,098 - -0,717) 0,096 <0,01 -0,937 (-1,161 - -0,713) 0,113 <0,01
Factors contributing to PPROM before 32 weeks’ gestation
Laser power 0,010 (-0,016 - 0.036) 0,010 0,450 0,032 (-0,003 - 0,067) 0,018 0,073
Laser energy 0,000 (0,000 - 0,000) 0,000 0,457 0,000 (0,000 - 0,000) 0,000 0,711
Grade 2 and 
3 damage
0,015 (0,001 - 0,028) 0,007 0,030 0,016 (0,001 - 0,030) 0,007 0,031
GA at laser -0,016 (-0,036 - 0,003) 0,010 0,049 -0,026 (-0,05 - -0,003) 0,012 0,029
Table 4 Analysis of factors associated with different outcomes. Values are regression coefficient B (95%CI, 
standard error (SE) and P.
Interpretation
The correlation of GA at laser with laser power, and total energy is most likely explained 
by the fact that the superficial placental vessels increase in diameter over time, and 
concurrently the fetal blood volume increases during pregnancy. [12] Larger vascular 
diameter requires more energy to achieve successful coagulation of the vessel and a higher 
power setting delivers this energy more rapidly. The significant association between laser 
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power and laser-to-delivery interval in the univariate linear regression model is explained 
by the strong correlation of both variables with GA at laser. Higher laser power settings 
are used in cases with more advanced GA and these cases are associated with shorter 
pregnancy prolongation than cases with laser therapy at earlier GA. 
With the results of this study, we speculate that higher total energy use in laser treatment 
for TTTS leads to significantly more placental tissue damage. Higher laser power showed 
the opposite effect. We hypothesize that, with a higher power setting, energy transfer 
is more effective and takes shorter time and less energy than with a lower wattage. In 
addition, the energy is less dispersed than in a low power setting and thus leads to less 
collateral damage.
This study is the first to systematically evaluate and score placental damage in relation to 
laser power, time and total energy. Previous studies showed a relation between laser power 
setting and tissue damage in tissues other than placenta. Kirschbaum et al.[13] showed a 
significant positive correlation between laser power output and the mean cutting depth in 
paracardiac lung lobes of pigs.  Likewise, an ex-vivo experiment on kidney models by Khoder 
et al. [14] showed a nearly linear increase of ablation depth with increasing laser power 
output. These studies were performed in an experimental setting and used interstitial laser 
techniques. In contrast to the laser therapy for TTTS, interstitial laser treatment is used 
for direct tissue destruction. Hence, tissue damage could be analyzed more precise because 
the effect is directly visible after treatment. With the interstitial laser technique, the 
transfer of energy to the tissue is direct, whereas in laser therapy for TTTS the distance 
between the tip of the laser fiber to the placenta highly impacts effective energy transfer.
[14] 
Firing distance and angle are thought to be important factors influencing effective energy 
transfer to the tissue. These factors are difficult to control and hard to measure in vivo. 
Khoder et al. [14] showed a significant reduction in ablation depth with increasing tissue 
distance in experimental setting. A higher power setting is necessary in order to achieve 
tissue ablation because laser energy is lost in the distance between the laser fiber and 
tissue. The true influence of firing angle is unclear. Theoretically, because the vessels are 
localized on the placental surface, a wide range of angles should lead to comparable 
energy transmission onto the vessel. Future studies should provide more knowledge about 
the optimal distance and angle for laser therapies. 
The optimal laser power setting for laser coagulation of placental vessels is unknown. 
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A wide range of laser power setting and technique is used worldwide.[8] It is also unclear 
whether coagulating with a high laser power setting for a short time span would lead to 
different results than coagulating longer with a lower laser power. It is plausible that 
various settings lead to different tissue effects. Branisteau et al. addressed the effect 
of laser coagulation on placental tissue using an in-vivo ovine placenta model.  Results 
showed that the tissue effects, in time, spread beyond the surface and induces complete 
functional elimination of the involved cotyledon.[6] The results of this study might imply 
that the operator should strive towards superficial coagulation of the placental tissue in 
order to obtain complete cotyledon elimination while avoiding the risk of complications as 
PPROM or early delivery. 
In order to decrease the amount of energy used during a Solomon procedure for 
treating TTTS one could lower the laser power setting during coagulation between true 
anastomoses. More research on human placentas is necessary in order to confirm this, the 
results of this study, and to determine the optimal laser power setting.
Limitations
An important limitation in this study is the case selection of treated pregnancies with two 
live born children. This prevents us from drawing conclusions about the strong outcome 
measure of survival. Furthermore, documentation on laser power included only the 
maximum used setting. In most of the cases this is the predominant setting used during a 
procedure, however, in some cases the results might be influenced because the maximum 
setting was used for only a short time span. 
Another limitation of this type of study is the retrospective nature, based on placenta 
pictures and not live tissue preventing us to use other anticipated important factors as 
number, type and caliber of anastomoses and placental weight. Finally, a wide range of 
pregnancy prolongation after laser was present in our sample. Scar tissue develops in time 
and therefore it is possible that cases with a short prolongation are graded differently 
than ones with a longer prolongation, even though perhaps the same scarring would have 
developed within more time. 
 
Conclusion
We found a significant association between laser power and total energy used during laser 
treatment for TTTS and postpartum placental tissue damage. More energy leads to more 
damage whereas a higher power setting leads to less damage. In this study, greater tissue 
damage was associated with a lower GA at birth, a higher PPROM rate under 32 weeks’ 
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gestation and a shorter laser-to delivery interval. These early results of our research into 
detailed technical aspects of fetoscopic laser surgery should be interpreted with caution, 
we do not recommend changes in practice at this time. We do believe more in-depth analysis 
of all details of fetoscopic surgery may ultimately lead to improvements in outcome. 
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Chapter 5
Impact of Laser Power and Firing Angle on 
Coagulation Efficiency in Laser Treatment for 
Twin-Twin Transfusion Syndrome? 




To assess the impact of laser power and firing angle on coagulation efficiency for closing 
placental anastomoses in the treatment of twin-twin transfusion syndrome (TTTS).
Methods
We used an ex-vivo blood-perfused human placenta model to compare time to complete 
coagulation using 30W versus 50W of Nd:YAG laser power, and using a 90° versus a 45° 
firing angle. Placentas were perfused with pig blood at 5mL/min. Differences were analyzed 
using an independent samples T-test, Mann-Whitney U test and Chi-square test where 
appropriate.
Results
Coagulation took less time and energy using 50W(n=53) compared to 30W(n=52); 11s vs. 
22s, p<0.001, and 557J vs. 659J, p=0.007. Perpendicular coagulation (n=53) took less time 
and energy compared to a 45°-degree angle(n=21); 11s vs. 17s, p=0.004 and 557J vs. 871J, 
p=0.004. Bleeding complicated 2(3%) measurements in the 50W group, 5(10%) in the 30W 
and 3(14%) in the 45o group.
Discussion
In a highly controlled model, a 50W laser power setting was more energy efficient than 
30W in coagulating a placental vein.  A more perpendicular laser firing angle resulted in 
more efficient coagulation. Furthermore, bleeding due to vessel wall disruption occurred 
more often with lower power and a more tangential approach. 
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INTRODUCTION
Fetoscopic laser surgery (FLS) is currently the best treatment modality for twin-twin 
transfusion syndrome (TTTS). De Lia et al. first proposed fetoscopic laser surgery in 1990. 
[1] In 2004 a randomized trial showed FLS to be superior to serial amnioreduction[2] and 
since then FLS has been widely adopted as the ‘first-choice’ treatment for TTTS.
Different types of laser and power settings have been used for this procedure. Most 
centers now use either a Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) laser with a 
1064nm wavelength or a diode laser with a 940nm wavelength and power setting between 
20 and 80 watts.[3] Both laser systems are continuously emitting laser systems with similar 
absorption properties. However, the optical penetration depth of the photons emitted by 
the diode laser is substantially lower than that of the Nd:YAG laser.[4]
In 2014 Slaghekke et al. showed that the Solomon technique, laser coagulation of the 
total vascular equator from one placenta margin to the other, was superior to the selective 
technique where only visible anastomoses are coagulated, in respect to recurrence of 
TTTS and incidence of post-laser twin-anemia-polycythemia sequence (TAPS).[5] With the 
Solomon technique, a larger surface area of the placenta is exposed to laser energy (time 
x power) and, in total, more energy is used during a procedure.  
Laser firing angle is believed to be of importance for successful efficient coagulation.[6] 
The more perpendicular the laser fiber is pointed at the vessel, the faster coagulation is 
achieved. This is one of the reasons that choosing the optimal introduction site for the 
fetoscope is found to be one of the most important steps in the procedure.[7] However, 
the actual impact of a tangential approach has never been evaluated.
We hypothesized that faster, more efficient laser coagulation of placental vascular 
anastomoses would increase the safety and improve outcome in the treatment of TTTS. 
This study is a first step in proving this hypothesis, aiming to analyze the impact of laser 




This ex-vivo experimental human placenta study was conducted at the Department of 
Fetal Therapy of the Leiden University Medical Center between March 2015 and July 2015. 
After informed consent, term placentas from women with uncomplicated vaginal deliveries 
were obtained. Placentas were rinsed and stored at room temperature in a sodium chloride 
0.9% solution directly after delivery. All experiments took place within 8 hours after 
delivery of the placenta.
Three groups of measurements were performed comparing laser power setting and laser 
firing angle. Group 1 consisted of measurements perpendicular to the vein with a power 
setting of 50 Watt. Group 2 consisted of measurement perpendicular to the vein with a 30-
watt power setting and the third group of measurements was performed at a 45o angle to 
the vein with a 50-watt power setting. All placentas were randomly assigned to each group.
Laser system
A Medilas Fibertom 5100 Nd:YAG laser (Dornier MedTech Europe Gmbh, Weßling, Germany) 
with a 1064nm wavelength was used for all experiments. A 600μm bare-tip laser fiber 
was used which was replaced after every 25 measurements. The laser was serviced and 
calibrated before the study was started.
Tissue preparation
All placentas were screened for eligible veins with a diameter of approximately 1.5 – 
2.0mm, relatively straight and without branches over a 2cm length. These vessels were 
dissected on both ends and cannulated with a 1.4mm plastic cannula. The cannulas were 
kept in place with a surgical stich. The placenta samples were casted in a 2% agar solution 
(Sigma-Aldrich Chemie B.V., Zwijndrecht, The Netherlands) filled 12cm petri dish with the 
maternal side downward with a layer of agar preventing the placenta to touch the bottom 
of the petri dish. The adhesive character of the agar solution prevented leakage from minor 
defects of the basal plate. A high-definition photograph was taken of each cannulated 
vessel. All vessel diameters were measured using ImageJ 1.47v software (ImageJ, National 
Institutes of Health, Bethesda, Maryland, USA).
Experimental set-up
A diagram of the experimental set-up are shown in Figure 1. The placenta samples were 
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placed in a sodium chloride 0.9% bath, kept at a steady 37oC temperature. The cannulated 
vein was connected to the circulation system that consisted of a calibrated syringe pump 
(Fresenius-Kabi Pilot C, Zeist, The Netherlands) with ± 2% flow rate accuracy, connected to 
a P10EZ-1 pressure sensor (Becton Dickinson Medical, Franklin Lakes, USA) and a flow sensor 
(Transonic clamp-on 2pxl flow sensor with a Transonic TS410 amplifier).
The laser fiber was kept in place by a system that allowed for easy and accurate adjustment, 
and was pointed either perpendicular or at a 45o angle at the vein. The distance between 
the laser fiber tip and the vein was kept at 4.0mm for each experiment.
Fresh heparinized (5.000 IU/L) pig blood with a 37oC temperature was used to circulate the 
placental vein. Flow rate was set at 5ml/min. The entire circulation was checked for leaks 
before each experiment.
Figure 1 Diagram of the experimental set-up.
A computer program continuously measured the flow and the pressure in the circulation 
and the modus of the laser system (on/off). Results of these measurements were plotted 
on a screen in real-time. Measurements started when the laser was activated and continued 
until successful coagulation of the vein was achieved. Successful coagulation was defined 
by a drop of the flow speed below 2.5mL/min without recovery. The noise on the flow 
sensor signal combined with the already low flow prevented us from using a flow of 0mL/
min to define stagnation of flow. Time was automatically measured between activation of 
the laser and stagnation of flow. Concurrently, the total energy used in each experiment 
was calculated based on the power setting.








Comparisons were made between group 1 and group 2, and between group 1 and group 3, 
with respect to time and energy used for successful coagulation defined as cessation of 
flow. Cases that were complicated by vessel wall disruption and bleeding were omitted 
from the analyses. Analyses were conducted using SPSS Statistics (IBM Corp. Released 
2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp.). Normally 
distributed data were expressed as mean ± standard deviation (SD) and compared using an 
independent samples T-test. Skewed data were expressed as median with range and were 
compared using a Mann-Whitney U test. For comparison of categorical data, a Chi-square 
test was used. A p-value of <0.05 was considered statistically significant.
RESULTS
Out of 37 fresh human placentas, a total of 126 viable samples were retrieved. A total of 
126 measurements were conducted, successful coagulation was achieved in 116 samples. 
All results and comparisons between groups are shown in Table 1. Figure 2 shows a sample 
before and during successful coagulation.
Group 1
In total 53 measurements were performed perpendicular to the vein with a 50 Watt laser 
power setting. In two samples (3%), bleeding occurred during coagulation of which in one 
case successful coagulation was achieved. 51 cases were eligible for analysis. Mean vessel 
diameter was 1.60 (SD 0.14) millimeter. Median time needed for cessation of flow in the 
vein was 11.1 seconds ranging from 1.4 to 32.8, which lead to a median energy used of 557 
Joule ranging from 72 to 1639.
Group 2
Fifty-two measurements were performed perpendicular to the vein at 30 Watt power. Five 
cases (10%) were complicated by bleeding and in two cases successful coagulation could 
not be achieved. 47 cases were analyzed. Mean vessel diameter in this group was 1.6 (SD 
0.12) millimeter. Median coagulation time was 22.0 seconds ranging from 8.5 to 314.4. 
Median energy used for coagulation was 659 Joule and ranged from 254 to 9431.
Group 3
At a 45o angle using 50 Watts laser power, 21 measurements were performed. Three 
samples (14%) were complicated by vessel wall disruption and in none of these successful 
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coagulation could be accomplished. Mean vessel diameter was 1.65 (SD 0.12) millimeter 
and median time for coagulation was 17.4 seconds ranging from 2.6 to 78.1 leading to a 
median total energy used of 871 Joule, ranging from 132 to 3906.
Coagulation took significantly less time and energy using 50W laser compared to 30W 
(11.1 vs. 21.0s, p<0.001 and 556 vs. 659 Joule, p=0.007). Perpendicular coagulation took 
significantly less time and energy compared to a 45o-degree angle (11.1s vs. 17.4s, p=0.004 
and 556 vs. 871 Joule, p=0.004). Vessel diameter did not differ between 50W and 30W 
samples (1.6 vs. 1.6 p=0.347) or between 90o and 45o samples (1.6 vs. 1.6mm p=0.223).
Group 1  n=53 Group 2 n=52 Group 3 n=21 P-value P-value
50 watt 90o 30 watt 90o 50 watt 45o 1 vs 2 1 vs 3
Laser duration 
(seconds)
11.13 (1.43 - 32.77) 21.98 (8.49 - 314.39) 17.42 (2.64 - 78.13) <0.001* 0.004*
Laser energy 
used (Joule)
556.50 (71.50 - 
1638.50)
659.40 (254.70 - 
9431.70)





1.61 ±0.14 1.63 ±0.12 1.65 ±0.12 0.347 0.223
Complications, 
bleeding
2 (3%) 5 (10%) 3 (14%) 0.116** 0.104**
Table 1 Analysis of laser duration and total energy for each group. Values expressed as median (range), mean 
±SD or as n(%). * Mann-Whitney U test used. ** Chi-square test used. All cases where bleeding occurred were 
excluded in the analyses.
DISCUSSION
This is the first study reporting on an ex-vivo perfused human placenta model to evaluate 
laser coagulation efficiency of different power settings for obliterating superficial placental 
vessels. To date, despite more than 25 years of laser surgery for TTTS, the ideal power 
setting for coagulation of anastomosis is unknown. Different strategies are being used, e.g. 
lower power setting at early gestational age at treatment or power setting dependent on 
size of the anastomosis.[3]
In this study we found that a higher power setting was associated with more efficient 
coagulation, shown by a shorter coagulation time and less energy used. In addition, we 
found that the firing angle significantly impacts the coagulation efficiency. A 45° angle 
almost doubles the amount of energy and time needed for successful coagulation 
compared to a perpendicular approach. With currently used equipment, optimization of 
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the angle of approach can only be achieved by careful selection of the site of entry of 
the fetoscope. Innovations in instrument design may be needed to optimize the efficiency 
of laser coagulation in difficult cases with anterior placenta or suboptimal position of the 
donor. 
Bleeding due to vessel wall disruption, although rare, occurred slightly more often with 
lower power settings and with a more tangential laser angle. We hypothesize that a low 
power setting used for a longer period of time causes more endothelium damage[8] and 
without swift occlusion of the vessel by coagulated blood, this might increase the risk of 
vessel wall disruption and bleeding. 
Recently, Zhao et al. showed that, after a laser procedure, more chorioamnionitis and 
funisitis is seen compared to non-lasered monochorionic (MC) twin pregnancies. [9] A 
possible explanation for this finding is the iatrogenic placental tissue necrosis caused by 
laser coagulation that may induce a maternal inflammatory response. In their study, a 
trend was seen towards more chorioamnionitis with higher energy use (p=0.06).  A previous 
study looked at the impact of laser coagulation on the ovine placenta with respect to 
local, collateral and peripheral damage at different time points after treatment.[10] This 
study showed that the tissue effect, especially collateral and peripheral, increases over 
time. Superficial vessel coagulation induced complete functional elimination of the involved 
cotyledon caused either by direct tissue damage and/or from arrest of cotyledonary flow, 
leading to ischemic necrosis. In this study, the impact of the amount of energy delivered 
and the relation to the tissue damage was not reported. A study evaluating different 
Nd:YAG power settings for the cutting and coagulation of pulmonary parenchyma with 
interstitial laser found that reducing the exposure time reduces local tissue coagulation 
even when the laser power output was increased.[11] Combining our results with previous 
research suggests that efficiency in the use of laser energy for laser treatment of TTTS 
might be beneficial and that a higher power setting and a perpendicular approach are more 
energy efficient, and safer, in attaining successful coagulation.
Although the highly realistic ex-vivo human placenta model we used eliminated many 
confounding factors, some limitations exist. The most important limitations of the model 
are the flow rate and the resistance of the circulation. It is difficult to accurately measure 
and control flow at flow rates below 5 milliliters per minute in a model. Not much is 
known about single anastomotic blood flow rates. Two studies reporting on anastomotic 
blood flow showed very different results, between 11.6mL/min with intra-amniotic Doppler 
measurements[12] and 5.6mL/24h based on calculation on decreasing hemoglobin levels 
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between intrauterine transfusion and birth[13]. The first one being highly unlikely due to the 
fact that the amount of flow exceeds the total blood volume of a mid-gestation fetus. 
Currently no reliable technique exists to assess single anastomotic blood flow. The higher 
flow rate used in this model, compared to true TTTS anastomotic flow, leads to longer 
coagulation time due to the heat sink phenomenon, constant dissipation of laser energy 
caused by blood flow from the coagulation site. Also, higher flow rate may result in higher 
pressure buildup during coagulation leading to a higher incidence of vessel wall disruption 
compared to in vivo coagulation of anastomoses in TTTS. Furthermore, the model uses 
pig blood instead of human blood, although this is similar to human in respect to size of 
red blood cells, red blood cell life span and hemoglobin content and structure.[14] These 
limitations cause that time and energy results may not exactly correspond to reality. 
However, the use of the model ensures that all measurements are performed under 
constant conditions. We do not expect that the limitations mentioned to have influenced 
the effect we showed. Future studies using the model will focus on using diode laser and 
multiple power settings to identify the optimal power setting for different types and size 
anastomoses.
Conclusion
This study demonstrates that, in a highly controlled, though realistic, environment, a 50 
Watt laser power setting is more efficient in coagulating a placental vein in respect to 
time and total energy needed compared to a 30 Watt laser power setting. In addition, we 
showed that the firing angle of the laser has a great impact on coagulation efficiency. The 
more perpendicular the approach the more efficient coagulation is achieved.
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Chapter 6
Identification of Essential Steps in Laser Procedure 
for Twin-Twin Transfusion Syndrome Using the 




To determine, by expert consensus, the essential substeps of fetoscopic laser surgery (FLS) 
for twin–twin transfusion syndrome (TTTS) that could be used to create an authority-
based curriculum for training in this procedure among fetal medicine specialists.
Methods
A Delphi survey was conducted among an international panel of experts (n = 98) in FLS. 
Experts rated the substeps of FLS on a five-point Likert-type scale to indicate whether 
they considered them to be essential, and were able to comment on each substep, using 
a dedicated online platform accessed by the invited tertiary care facilities that specialize 
in fetal therapy. Responses were returned to the panel until consensus was reached 
(Cronbach’s α ≥ 0.80). All substeps that were rated  ≥ 4 by 80% of the experts were 
included in the evaluation instrument.
Results
After the first iteration of the Delphi procedure, a response rate of 74% (73/98) was 
reached, and in the second and third iterations response rates of 90% (66/73) and 81% 
(59/73) were reached, respectively. Among a total of 81 substeps rated in the first round, 
21 substeps had to be re-rated in the second round. Finally, from the initial list of substeps, 
55 were agreed by experts to be essential. In the third round, the 18 categorized substeps 
were ranked in order of importance, with ‘coagulation of all anastomoses that cross the 
equator’ and ‘determination of fetoscope insertion site’ as the most important.
Conclusions
A total of 55 substeps of FLS for TTTS were defined by a panel of experts to be essential in 
the procedure. This list is the first authority-based evidence to be used in the development 
of a final training model for future fetal surgeons. 
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INTRODUCTION
A randomized trial, published in 2004, established fetoscopic laser surgery (FLS) as the 
best treatment modality for twin–twin transfusion syndrome (TTTS).1 With an incidence of 
10% in monochorionic twin pregnancies, TTTS is rare and treatment is offered in a limited 
number of specialized maternal–fetal medicine (MFM) expert centers around the world.2 
With the economic growth of developing countries and the identification of new potential 
indications for FLS, such as twin anemia–polycythemia sequence and selective fetal growth 
restriction, the expectation is that, in the future, a greater number of FLS procedures will be 
performed. Objective assessment of technical performance is essential for such complex 
procedures. In order to maintain optimal performance and quality of care, increasing 
attention is being given to the teaching, training, retention of skills and quality control of 
FLS. Even large fetal treatment centers have limited numbers of TTTS cases,3 therefore 
the teaching and training of this procedure are challenging. Currently, standardized surgical 
training programs for FLS are unavailable. As surgical errors and suboptimal technique are 
also yet to be defined, teachers often base their training on personal experience and 
individual preference. Learning technical skills from an experienced mentor will probably 
continue to play a significant role in future training. However, there is an increasing need for 
a standardized tool to train and evaluate trainees. Similar issues have been raised in other 
invasive obstetric procedures and surgical areas, such as endoscopy.4,5
An essential first step towards the creation of a training curriculum is to determine the 
items that need to be assessed, preferably by using quality indicators.6 These indicators 
can be derived from the outcomes of studies, historical data and expert opinions. The 
elements need to be measurable, so they can be used in the assessment of trainees during 
their learning process, to monitor performance and maintain quality control. Authority-
based indicators for FLS can be obtained using the Delphi method for international expert 
consensus. The Delphi methodology is an internationally-accepted tool that allows a 
group of individuals to achieve consensus on a complex problem effectively, by structuring 
the group communication process.7,8
The aim of this study was to achieve expert consensus regarding the substeps that are 
considered to be essential in performing FLS for TTTS, which can be used as a framework 
for standardized training. Furthermore, we aimed to create an instrument that could be 
used to evaluate a surgeon’s technical performance during FLS, both in a high-fidelity 




This study is part of the SILICONE project (SImulator for Laser therapy and Identification 
of Critical steps of Operation: New Education program), conducted with the aim of 
developing a standardized training program for FLS in cases of TTTS. In the first part of the 
project, we intended to develop an evaluation instrument based on the essential steps of 
treatment. In the second part of the project, not included in this study, the instrument will 
be validated and used to evaluate a training session that uses a SILICONE simulator.
The Delphi methodology was used to achieve expert consensus on which substeps of 
FLS performed for TTTS are essential. The Delphi methodology is, in essence, a series of 
sequential questionnaires or ‘rounds’, followed by controlled feedback, that seeks to gain 
the most reproducible consensus among a panel of experts.9 Consensus occurs because 
the views of the participants converge through a process of informed decision-making.8 The 
Delphi method was first developed by the Research ANd Development (RAND) Corporation, 
a non-profit global policy think-tank, formed in 1950 to offer research and analysis to 
the USA armed forces.10-12 It is an anonymous process in which ideas are expressed to the 
participants in the form of a questionnaire. In repeated rounds, respondents are questioned 
individually, with self-administered surveys. In each subsequent round, the results of the 
previous round are provided, thus enabling the range of answers to converge towards a 
consensus. An overview of the study design is presented in Figure 1.
A panel of experts in FLS was presented with a list of substeps of the procedure and asked 
to rate each substep, using a Likert scale from 1 (strongly disagree) to 5 (strongly agree), 
with the level at which they believed the step should be included in an evaluation tool. 
In addition, all participants were encouraged to clarify their ratings in a comments box. 
Each round started with a new questionnaire consisting of a list of these substeps. The 
participation of the FLS experts was not disclosed to the other experts (quasi-anonymity). 
The total response rate was based on the number of fully completed surveys.
We identified an initial list of possible substeps of FLS during the first iteration of the 
survey from three sources: expert opinion, textbooks on fetal therapy and published 
peer-reviewed literature. Each substep of FLS that was identified from any of these three 
sources was included in the survey. Before the first iteration of the study, an international 
pilot panel meeting took place that consisted of senior FLS experts from several large 
international centers, with extensive experience in fetoscopic surgery. They assessed the 
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survey for comprehensiveness and integrity. After taking into account their comments, 
invitations to participate in the survey were sent out.
Figure 1. Overview of study design to achieve expert consensus on substeps of fetoscopic laser surgery (FLS) for 
twin–twin transfusion syndrome (TTTS) that are essential to the procedure.
Selection of experts
All FLS experts included in the study were selected through membership lists of MFM 
organizations (Society for Maternal-Fetal Medicine (SMFM), Eurofoetus, USFetus, North 
American Fetal Therapy Network (NAFTnet), International Fetal Medicine and Surgery 
Society (IFMSS), International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), 
World Association of Perinatal Medicine (WAPM), The American Congress of Obstetricians 
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Figure 1 Overview of study design to achiev expert consensus on substeps oetoscopic laser surgery (FLS) for twin–twin transfusion
syndrome (TTTS) that are essential to the procedure.
from 23 dierent countries to participate. The size of
Delphi panels can vary widely and there is disagreement
about what constitutes an appropriate panel size. Panel
size in Delphi studies is considered to be researcher- and
situation-specific. For this study, we aimed to contact the
entire international community of MFM specialists who
had extensive experience with FLS.
Surveys
Delphi round 1
At the start of the first round, an e-mail was sent to all
FLS experts that included: the invitation, background,
short instructions and the link to the first survey. Later,
for each round, multiple reminders were sent out to
non-responders. The first survey consisted of two parts:
in Part I (Appendix S1), the participants were asked to
rate each possible substep of FLS for TTTS; in Part II, the
experience and surgical practices of the survey respondent
and of their center were obtained. The estimated time to
complete Round 1 was 15 min.
The first round of data was analyzed and results
were pooled. Two f the authors (M.W. and S.P.)
independently categorized the comments on the basis
of the presence of essential elements. For each substep
we ascertained if the essential element of the comment
consisted of an addition or a substitution to the substep.
A third author (J.A.) assessed the categorized comments
and the revised substeps independently for clarification
and to make sure all further areas were explored. Figure 2
shows how the comments were incorporated into the
second round of the survey.
Delphi round 2
In the second round, the results of the first round were
made available to the FLS experts (Appendix S2).
The second Delphi round was sent out 1 month
after the first, to optimize the response rate and ensure
Copyright  2014 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2015; 45: 439–446.
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and Gynecologists (ACOG), North American Society of Obstetrics Medicine (NASOM) and 
Society of Obstetric Medicine of Australia and New Zealand (SOMANZ)). We defined an 
expert as someone who currently performs FLS for TTTS. Furthermore, all experts were 
identified as leaders in the field of fetal therapy as evidenced by their role as opinion 
leaders within their MFM organizations and supported by their track record of publications 
in peer-reviewed literature. The expert panel was selected specifically to represent a wide 
geographic area including Australia, Asia, Canada, Europe, South America and the USA. We 
invited 98 individuals from 23 different countries to participate. The size of Delphi panels 
can vary widely and there is disagreement about what constitutes an appropriate panel 
size. Panel size in Delphi studies is considered to be researcher- and situation-specific. For 
this study, we aimed to contact the entire international community of MFM specialists 
who had extensive experience with FLS.
Surveys
Delphi round 1
At the start of the first round, an e-mail was sent to all FLS experts that included: the 
invitation, background, short instructions and the link to the first survey. Later, for each 
round, multiple reminders were sent out to non-responders. The first survey consisted of 
two parts: in Part I (Appendix S1), the participants were asked to rate each possible substep 
of FLS for TTTS; in Part II, the experience and surgical practices of the survey respondent 
and of their center were obtained. The estimated time to complete Round 1 was 15 min.
The first round of data was analyzed and results were pooled. Two of the authors (M.W. 
and S.P.) independently categorized the comments on the basis of the presence of essential 
elements. For each substep we ascertained if the essential element of the comment 
consisted of an addition or a substitution to the substep. A third author (J.A.) assessed 
the categorized comments and the revised substeps independently for clarification and 
to make sure all further areas were explored. Figure 2 shows how the comments were 
incorporated into the second round of the survey.
Delphi round 2
In the second round, the results of the first round were made available to the FLS 
experts (Appendix S2). The second Delphi round was sent out 1 month after the first, to 
optimize the response rate and ensure that participants remained interested in the process. 
In accordance with the Delphi method, participants were asked to re-rate substeps for 
which no consensus had been achieved. In this round, some of the substeps were altered 
on the basis of the feedback of the FLS experts from the first round. The substeps for 
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which consensus had been achieved in the first round could not be re-rated in the second 
questionnaire, but were available for review.
Figure 2. Method of incorporating survey respondents’ comments for development of second round of Delphi 
survey.
Delphi round 3
Based on the results from the first two rounds, a list of all essential substeps of FLS 
for TTTS was defined. In order to use this final list for evaluation and training with the 
SILICONE simulator, a third round of the Delphi procedure was carried out to determine 
the appropriate distribution of importance of the steps. For the purpose of Part 2 of 
the SILICONE project, only the substeps that could be simulated were included in this 
round. The included substeps were categorized into 18 items, and those categorized within 
the domains ‘diagnostic procedure’, ‘presurgical management’ and ‘follow-up ultrasound 
examination’ were excluded. All respondents rated the level of importance of the 18 
categorized substeps on a Likert scale of 0–10, with respect to each other. With this order 
of importance, we were able to give a certain value to each separate substep, and we 
incorporated this into the evaluation tool.
Statistical analysis
For this study, the concept of consensus was predefined as a condition of homogeneity 
or consistency within the opinions of the FLS experts. There are no established criteria for 
determining consensus using a Delphi methodology.6,12
Cronbach’s α was chosen as the statistical index for quantifying the reliability of a 
summation of entities, in this case the view of the experts in FLS. In this study, an α-value 
of 0.80 defined an acceptable and high level of consensus.6,13
Rate of agreement
To ascertain whether consensus was reached for each substep separately, the rate of 
agreement (RoA) was used. The RoA is defined as:







Figure 2 Method oncorporating survey res onde ts’ comment f r velopment of sec n round of Delphi urvey.
that participants remained interested in the process. In
accordance with the Delphi method, participants were
asked to re-rate substeps for which no consensus had
been achieved. In this round, some of the substeps were
altered on the basis of the feedback of the FLS experts
from the first round. The substeps for which consensus
had been achieved in the first round could not be
re-rated in the second questionnaire, but were available for
review.
Delphi round 3
Based on the results from the first two rounds, a list of
all essential substeps of FLS for TTTS was defined. In
order to use this final list for evaluation and training with
the SILICONE simulator, a third round of the Delphi
procedure was carried out to determine the appropriate
distribution omportance of the steps. For the purpose
of Part 2 of the SILICONE project, only the substeps
that could be simulated were included in this round.
The included substeps were categorized into 18 items,
and those categorized within the domains ‘diag ostic
procedure’, ‘presurgical management’ and ‘follow-up
ultrasound examination’ were excluded. All respondents
rated the level omportance of the 18 categorized
substeps on a Likert s ale of 0–10, with respect to each
other. With this order omportance, we were able to
give a certain value to each separate substep, and we
incorporated this into th evaluation tool.
Statistical analysis
For this study, the oncept of cons nsus was predefined
as a condition of homogeneity or consistency within the
opinions of the FLS experts. There are no established
criteria for determining consensus using a Delphi
methodology6,12 .
Cronbach’s α was chosen as the statistical index for
quantifying the reliability of a summation of entities, in
this case the view of the experts in FLS. In this study, an
α-value of 0.80 defined an acceptable and high level of
consensus6,13 .
Rate of agreement
To ascertain whether consensus was reached for each
substep separately, the rate of agreement (RoA) was used.
The RoA is defined as:
RoA (% )
=
(strongly) agree (n) – (strongly) disagree(n)
(strongly) agree (n) + (strongly) disagree (n)
+ indierent (n)
× 100
Scaled responses to the categorical items (strongly
disagree to strongly agree) were analyzed as percentages
(Appendix S2). Feedback to the panel of experts included
providing the Cronbach’s α score of the previous round,
percentages and means of the answers to all items and the
RoA for each item separately. After reaching a consensus
(Cronbach’s α≥ 0.80), only subs eps with an RoA
of 80% or higher were included in the final evaluation
tool. Substeps with an RoA oess than 20% were not
reassessed and were removed from the evaluation tool.
In the second round of the Delphi procedure, the
substeps with 20% < RoA < 80% were re-rated. After
the final round, only items with an RoA ≥ 80% were
included in the final evaluation t ol. The ther substeps
were excluded from the list.
Data were collected using our online survey tool,
www.deltafetus.nl, and analyzed using SPSS version 21.0
(IBM SPSS Statistics for Windows, Version 21.0, IBM
Corp., Armonk, NY, USA).
The study was performed by the Departments of
Obstetrics and Pediatrics at the Leiden University
Medical Center, Leiden, The Netherlands, in association
with Hospital Italiano de Buenos Aires, Buenos Aires,
Argentina; Jackson Fetal Therapy Institute, Miami, FL,
USA; University of Southern California, Keck School of
Medicine, Los Angeles, CA, USA; Liverpool Hospital,
Liverpool, Australia; and the University Hospitals KU,
Leuven, Belgium. The data were collected between
February 2014 and July 2014.
RESULTS
In the first round, a response rate of 74% (73/98) was
reached. Table 1 presents a summary of characteristics
of the FLS experts. The majority of the participants
(77%; 56/73) worked at university hospitals. Most of
the responding experts were MFM specialists, a minority
(7%; 5/73) were pediatric surgeons. All the experts also
performed other antenatal procedures besides FLS for
Copyright  2014 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2015; 45: 439–446.
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     (strongly) agree (n) - (strongly) disagree (n)
RoA (%) = ---------------------------------------------------------------------------------------   x 100%
  (strongly) agree (n) + (strongly) disagree (n) + indifferent (n)
Scaled responses to the categorical items (strongly disagree to strongly agree) were 
analyzed as percentages (Appendix S2). Feedback to the panel of experts included 
providing the Cronbach’s α score of the previous round, percentages and means of the 
answers to all items and the RoA for each item separately. After reaching a consensus 
(Cronbach’s α≥ 0.80), only the substeps with an RoA of 80% or higher were included in the 
final evaluation tool. Substeps with an RoA of less than 20% were not reassessed and were 
removed from the evaluation tool.
In the second round of the Delphi procedure, the substeps with 20% < RoA < 80% were 
re-rated. After the final round, only items with an RoA ≥ 80% were included in the final 
evaluation tool. The other substeps were excluded from the list. Data were collected 
using our online survey tool, www.deltafetus.nl, and analyzed using SPSS version 21.0 (IBM 
SPSS Statistics for Windows, Version 21.0, IBM Corp., Armonk, NY, USA).
The study was performed by the Departments of Obstetrics and Pediatrics at the Leiden 
University Medical Center, Leiden, The Netherlands, in association with Hospital Italiano 
de Buenos Aires, Buenos Aires, Argentina; Jackson Fetal Therapy Institute, Miami, FL, USA; 
University of Southern California, Keck School of Medicine, Los Angeles, CA, USA; Liverpool 
Hospital, Liverpool, Australia; and the University Hospitals KU, Leuven, Belgium. The data 
were collected between February 2014 and July 2014.
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RESULTS
In the first round, a response rate of 74% (73/98) was reached. Table 1 presents a summary 
of characteristics of the FLS experts. The majority of the participants (77%; 56/73) worked 
at university hospitals. Most of the responding experts were MFM specialists, a minority (7%; 
5/73) were pediatric surgeons. All the experts also performed other antenatal procedures 
besides FLS for TTTS. Almost all had more than 5 years’ experience performing FLS, except 
for two who had been performing the procedure for only 2 and 4 years, respectively. The 
mean length of experience with FLS of the participating experts was 10.2 years. The most 
frequently mentioned teaching centers for FLS were King’s College Hospital, London, UK 
(n = 15); University Hospitals KU Leuven, Belgium (n = 15); University Hospital Center Paris - 
Hôpital Necker-Enfants Malades, Paris, France (n = 10); and Jackson Fetal Therapy Institute, 
Miami, FL, USA (n = 7). In the subsequent rounds of the survey, the response rate was 90% 
(66/73) for round 2 and 81% (59/73) for round 3.
Substeps
After the first round of the Delphi procedure, a Cronbach’s α score of 0.911 was reached, 
and consensus was attained, on 52 of the 81 substeps (Figure 3). In the second round 
(Appendix S2), the 28 substeps for which no consensus was reached were merged and 
rephrased into 21 substeps, because, according to most FLS experts, these substeps were 
not well formulated. One clearly inappropriate substep, ‘mark recipient with laser spot 
on left upper leg’, was purposely incorporated into the first survey round as a check for 
validity. This item was excluded after the first round. After the second round, consensus 
was reached on another four substeps (RoA ≥ 80%). One substep was removed from the 
final list owing to duplication. Table 2 shows the list of substeps that were included in the 
evaluation end tool.
Some substeps were considered more important than others. ‘Coagulation of all vascular 
anastomoses that cross the vascular equator’ and ‘determine site of insertion of fetoscope’ 
were items that were considered as most important during FLS. Table 3 shows a list of 




Type of hospital  
university hospital 56/73 (77%)
private hospital/tertiary care facility 11/73 (15%)
public hospital 5/73 (7%)
other 1/73 (1%)
Medical specialty  
obstetrics and gynecology 6/73 (8%)
pediatric surgery 5/73 (7%)
Maternal Fetal Medicine (MFM) 62/73 (85%)
Antenatal invasive procedures  
amniocentesis 69/73 (95%)
chorionic villus sampling 59/73 (81%)
intrauterine transfusion 64/73 (88%)
fetal shunt placement 62/73 (85%)
bipolar cord occlusion 50/73 (68%)
open fetal surgery 16/73 (22%)
Experience  
years currently working as MFM specialist (mean; range) 17.3 (5.0 - 36.0)
years performing FLS for TTTS (mean; range) 10.2 (2.0 - 25.0)














years laser performed at center (mean; range) 10.5 (1.0 - 25.0)
no. of surgeons performing laser (median; range) 2 (1 - 5)
no. of trainees (median; range) 1 (0 - 9)
Table 1. Experience and surgical practice and center characteristics of the 73 experts in fetoscopic laser surgery 
(FLS) who responded to the survey. MFM: maternal fetal medicine FLS: fetoscopic laser surgery TTTS: twin-to-
twin transfusion syndrome
6
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No. Domain and substeps
1. Diagnostic procedure
1.1 Make sure advanced ultrasound scan is performed to exclude fetal anomalies
1.2 Confirmation of monochorionicity, diagnosis, Quintero stage of TTTS
1.3 Consider cervical length measurement
1.4 Consider risk of complications (cervix shortening, fetal deterioration etc)
1.5 Determine whether laser is best treatment option (and consider alternatives)
1.6 Determine whether laser procedure should be performed as soon as possible or expectant 
management can be an option
1.7 Obtain full informed consent
2. Pre-surgical management 
2.1 Blood group and Rhesus typing should be known, respect local protocols concerning Rh-D 
prophylactics
2.2 Prescribe all procedure-related medications (tocolytics, antibiotics etc)
2.3 Determine and arrange type of anesthesia
3. Preparation in operating room 
3.1 Knowledge of technical equipment (ultrasound, scopy tower, laser, instruments)
3.2 Positioning of screens, assistants and lights
3.3 Determine laser modus and power settings 
3.4 Positioning of patient
4. Ultrasound examination (together with sonographer) 
4.1 Identification of both fetuses, presentation and position
4.2 Visualize placenta localization, umbilical cord insertions
4.3 Assess deepest pockets of amniotic fluid
4.4 Determine expected position of vascular equator
4.5 Determine site of insertion of fetoscope
4.6 Choose type of introduction (set) and type of fetoscope
5. Sterile procedure and anesthesia
5.1 Surgical briefing (time out) about (complete) procedure to fetal therapy team
5.2 Aseptic procedure for surgeon, scrub nurse and sonographer 
5.3 Monitoring maternal condition (during complete procedure)
5.4 Placement of sterile covers over patient and instruments
6. Positioning and connection of instruments (pre-insertion) 
6.1 Connection of fetoscope (orientation, focus and white balance)
6.2 Connection of laser fiber to laser machine, insertion of fiber in fetoscope
7. Insertion 
7.1 Performance of all manipulations under ultrasound visualization
7.2 In case of local anesthesia: administer anesthetic to skin and peritoneum
7.3 Make adequate-size skin incision with surgical knife
7.4 Correct use of (Seldinger or trocar) technique for insertion
7.5 Awareness of location of maternal uterine vessels and intestines, and placental edge during insertion
7.6 Insertion of shaft/scope
8. Orientation 
8.1 Assess visibility (optional: score visibility)
8.2 Determine need for amniotic exchange
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No. Domain and substeps
8.3 Confirm position of placenta, fetuses and cord insertions
8.4 Identification of intertwin dividing membrane (and use for reference)
8.5 Mapping of placental surface and vascular equator
9. Laser coagulation
9.1 Coagulation of all vascular anastomoses that cross the vascular equator
9.2 Prevent the unnecessary sacrifice of placental tissue
10. Assessment during procedure 
10.1 Prevent unnecessary delay during procedure
10.2 Check for complications(e.g. bleeding, rupture intertwin membranes
10.3 Identify and record number and type of anastomoses coagulated 
11. Amniodrainage
11.1 Controlled drainage of polyhydramnios
11.2 Assess adequate drainage (ultrasound guided) until pre-defined level to decrease uterine distention 
and promote patient comfort
12. Closure 
12.1 Closing skin incision (suture or suture free adhesive product) 
13. Direct post-operative management 
13.1 Inform patient, partner/family and referring specialist
13.2 Administration (surgical report, fetal therapy database)
13.3 Instructions for monitoring of maternal and fetal condition
14. Follow up ultrasound examination 
14.1 Knowledge of follow-up until delivery of (un)complicated monochorionic pregnancies
14.2 Assessment of fetal condition including bladder filling, deepest vertical pockets and Doppler flows
14.3  Knowledge of MCA-PSV measurement to detect post-laser TAPS
14.4 Signs of iatrogenic perforation of the intertwin membrane
14.5 Signs of amnion-chorionic separation
14.6 Record which fetus is former donor and recipient, respectively
14.7 Knowledge of signs and options with regards to iatrogenic PPROM
Table 2. The 55 essential substeps of fetoscopic laser surgery (FLS), performed in cases of twin–twin transfusion 
syndrome (TTTS), to be included in an evaluation and training instrument. FLS: fetoscopic laser surgery TTTS: 
twin-to-twin transfusion syndrome PPROM: preterm premature rupture of membranes, MCA-PSV: middle 
cerebral artery peak systolic velocity, TAPS: twin anemia polycythemia sequence.
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Substeps
1 Coagulation of all vascular anastomoses that cross the vascular equator
2 Determine site of insertion of fetoscope
3 Ultrasound identification of placenta, fetuses, umbilical cord insertions and expected vascular equator
4 Mapping of placental surface and vascular equator
5 Identification of intertwin dividing membrane (and use for reference)
6 Prevent the unnecessary sacrifice of placental tissue
7 Confirm position of placenta, fetuses and cord insertions
8 Choose and prepare type of introduction (set) and type of fetoscope
9 Connection of fetoscope and laser equipment (including white balance and orientation of the scope)
10 Prevent unnecessary delay during procedure
11 Controlled amniodrainage until pre-defined level (to decrease uterine distention and promote patient 
comfort)
12 Placement of sterile covers over patient and instruments
13 In case of local anesthesia: administer anesthetic to skin and/or peritoneum
14 Identify and record number and type of anastomoses coagulated 
15 Performance of all manipulations under ultrasound visualization
16 Make adequate-size skin incision with surgical knife
17 Assess visibility (optional: score visibility)
18 Closing skin incision (suture, or suture free adhesive product)
Table 3. The 18 substeps of fetoscopic laser surgery (FLS) for twin–twin transfusion syndrome, determined to be 
essential by expert consensus, in order of importance.
DISCUSSION
We achieved an international expert consensus on the technical approach and identification 
of the essential steps of FLS for TTTS. We produced a list of 55 substeps that are deemed 
to be essential during FLS. All items were ranked in order of importance, with ‘coagulation 
of all vascular anastomoses that cross the vascular equator’, ‘determination of site of 
insertion of fetoscope’ and ‘ultrasound identification of placenta, fetuses, umbilical cord 
insertions and expected vascular equator’ as the most important substeps. This list can be 
used as a reference guide to improve the standardization of training in fetoscopic techniques.
A large number of FLS experts participated in our Delphi procedure; 74% of all FLS 
experts worldwide took part in the first round. We were pleasantly surprised by how 
involved and interested the international group of FLS experts was. The high Cronbach’s α 
score – 0.911 – after the first round of the Delphi procedure confirms homogeneity within 
the panel of experts.
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In 1988, Julian De Lia first performed laser therapy as treatment for severe TTTS.14 Over 
the last two decades, the procedure has undergone many changes. The era in which a 
handful of pioneers performed and personally adjusted fetoscopic laser surgery in their 
own centers has now moved into a time in which there is a need for a more standardized 
approach, enabling the training of many next-generation fetal surgeons worldwide with 
comparable quality of work. The curriculum suggested here, based on expert consensus, 
provides the best available basis for such a training program.
Specific operative situations may require deviation from the recommended standard 
technique. Therefore, strict adherence to the teaching instrument developed may not 
always be desirable. We suggest that these guidelines should be used primarily as an 
instrument for training.
Figure 3. Flowchart of the selection 
of substeps determined by expert 
consensus to be essential in fetoscopic 
laser surgery (FLS) for twin–twin 
transfusion syndrome to be included in 
an evaluation instrument. RoA, rate of 
agreement.
Similar research has not been performed previously in fetal therapy. However, in other 
surgical fields the Delphi methodology has been used to create an authority-based 
curriculum for evaluation and training.5,6 As such, the Delphi methodology has been an 
effective method of achieving expert consensus in the first phase of developing a training 
model for laparoscopic surgery.6,15
Essential steps in laser surgery for TTTS 443
Table 1 Experience and surgical practice and center characteristics




Type of hospital at which working
)77(65latipsohytisrevinU















As MFM specialist (mean (range)) 17.3 (5.0–36.0)
Performing FLS for TTTS (mean (range)) 10.2 (2.0–25.0)













Years of performing FLS (mean (range)) 10.5 (1.0–25.0)
Number of surgeons performing FLS
(median (range))
2 (1–5)
Number of trainees (median (range)) 1 (0–9)
Data are given as n (%) except where indicated. MFM,
maternal–fetal medicine; TTTS, twin–twin transfusion syndrome.
TTTS. Almost all had more than 5 years’ experience
performing FLS, except for two who had been performing
the procedure for only 2 and 4 years, respectively.
The mean length of experience with FLS of the par-
ticipating experts was 10.2 years. The most frequently
mentioned teaching centers for FLS were King’s College
Hospital, London, UK ( n = 15); University Hospitals KU
Leuven, Belgium ( n = 15); University Hospital Center
Paris - H ôpital Necker-Enfants Malades, Paris, France
(n = 10); and Jackson Fetal Therapy Institute, Miami, FL,
USA ( n = 7).
In the subsequent rounds of the survey, the response
rate was 90% (66/73) for round 2 and 81% (59/73) for
round 3.
Substeps
After the first round of the Delphi procedure, a Cronbach’s
α score of 0.911 was reached, and consensus was attained,
Consensus on 55 essential
substeps of FLS for TTTS 
Unchanged substeps (n = 8)
Rephrased substeps ( n = 9)
One substep rephrased into two substeps ( n = 2)
Two substeps merged into one substep ( n = 1)
Eight substeps regarding introduction technique
   merged into one substep ( n = 1) 
Merging and rephrasing 
Delphi round 2
21 substeps 
No consensus ( n = 28)
0.2 < RoA < 0.8 
Accepted (n = 52)




Rejected ( n = 1)
RoA < 0.2 
Rejected ( n = 17)
Merged owing to
duplication ( n = 1) 
Accepted (n = 4) 
Figure 3 Flowchart of the selection of substeps determined by
expert consensus to be essential in fetoscopic laser surgery (FLS) for
twin–twin transfusion syndrome to be included in an evaluation
instrument. RoA, rate of agreement.
on 52 of the 81 substeps (Figure 3). In the second round
(Appendix S2), the 28 substeps for which no consensus
was reached were merged and rephrased into 21 substeps,
because, according to most FLS experts, these substeps
were not well formulated. One clearly inappropriate
substep, ‘mark recipient with laser spot on left upper leg’,
was purposely incorporated into the first survey round as
a check for validity. This item was excluded after the first
round. After the second round, consensus was reached
on another four substeps (RoA ≥ 80%). One substep
was removed from the final list owing to duplication.
Table 2 shows the list of substeps that were included in
the evaluation end tool.
Some substeps were considered more important than
others. ‘Coagulation of all vascular anastomoses that cross
the vascular equator’ and ‘determine site onsertion
oetoscope’ were items that were considered as most
important during FLS. Table 3 shows a list of the 18
most important substeps that can be used for training and
evaluation in order omportance.
DISCUSSION
We achieved an international expert consensus on the
technical approach and identification of the essential steps
of FLS for TTTS. We produced a list of 55 substeps that
Copyright  2014 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2015; 45: 439–446.
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In this study, FLS items were ranked to determine their order of importance. In the eyes 
of an expert, some substeps are a natural part of the procedure and are performed 
automatically, however, for a novice, attention to these substeps is vitally important. By 
assigning value to the specific elements, we were able to emphasize certain substeps in the 
list of objectives to attain during training.
The Delphi methodology can be used to develop a curriculum that reflects international 
consensus as opposed to simply local expertise. Studies employing Delphi make use of 
individuals who are presumed to have the best knowledge of the topic being investigated. 
Usually, consensus is only achieved among experts after protracted discussions. The Delphi 
method does not require the panel to meet, and thus largely avoids these discussions. 
Also, experts from different geographic locations can be recruited,11 as in this study, 
which recruited a large panel from 23 different countries. In the Delphi methodology, 
participants have access to the group’s responses, and may change their views in line with 
what others are saying.16 Providing a summary of opinions ensures that consensus is reached 
quickly, by two, or at most three, rounds.8 The web-based design speeds up the process, 
improves feasibility and lowers associated costs. In addition, the anonymous nature ensures 
that outcomes are not influenced inappropriately by a single dominant group member and 
allows the opportunity to re-evaluate one’s own ‘answers’.11
It is important to note that the existence of a consensus does not mean that the correct 
answer, opinion or judgment has been found,16 however, by using an expert panel, an 
acceptable accuracy is created. A potential limitation of the methodology is that the 
significance of each step, in terms of outcome, is not addressed. Although consensus was 
reached for a specific substep, this study does not provide information on whether this 
substep is associated with better or worse outcomes when performed.
One of the substeps that did not meet our consensus criteria concerned the laser 
technique used. In a recent multicenter randomized controlled trial, the Solomon laser 
technique (complete dichorionization of the vascular equator) was shown to reduce 
postoperative fetal morbidity in severe TTTS.17 Although this study provides the highest 
level of evidence, which might imply that all centers should adopt this new technique, not 
all experts considered this step to be essential in an evaluation instrument for future fetal 
surgeons. Moreover, steps such as ‘check for limb abnormalities of recipient’ and ‘determine 
placental sharing’ were considered to be time-consuming rather than contributory, and 
therefore were not included.
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Another limitation is that it is lengthy and quite time-consuming for the facilitator and 
the participant to take part in a Delphi procedure, compared to a single-round survey. Even 
though each round took only 5–15 min to complete, not all panel members maintained 
interest and responded in the second and third rounds of our survey, which is probably 
related to the relatively time-consuming process and the fact that it was a web-based 
questionnaire that participants can ignore or avoid more easily.
In summary, attention must be paid to the evaluation and training of fetal surgeons, to 
maintain a high standard of clinical performance. This study provides a first step towards 
an authority-based training curriculum and an evaluation tool for FLS performed in cases 
of TTTS. Further research should focus on the applicability of the instrument in simulator 
training as well as in real-life situations.
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APPENDICES
 
No. Domain and substeps Mean RoA
1. Diagnostic procedure    
1.1 Make sure advanced ultrasound scan is performed to exclude fetal anomalies 4.71 91.8
1.2 Confirmation of monochorionicity, diagnosis, Quintero stage of TTTS 4.89 97.3
1.3 Endovaginal ultrasound examination for cervical length measurement 4.38 75.3
1.4 Consider risk of complications (cervix shortening, fetal deterioration etc) 4.70 94.5
1.5 Consider relevant maternal factors (i.e. BMI) and medical history 4.08 72.6
1.6 Determine whether laser is best treatment option (and consider alternatives) 4.63 93.2
1.7 Determine whether laser procedure should be performed as soon as possible or ex-
pectant management can be an option
4.62 97.3
1.8 Obtain full informed consent 4.85 95.9
2. Pre-surgical management    
2.1 Consider need for anti-D prophylaxis to minimize sensitization 4.21 71.2
2.2 Prescribe all procedure-related medications (tocolytics, antibiotics etc) 4.55 87.7
2.3 Arrange maternal (and depending on gestational age; fetal) monitoring 4.29 79.5
2.4 Determine and arrange type of anesthesia 4.51 84.9
3. Preparation in operating room    
3.1 Knowledge of technical equipment (ultrasound, scopy tower, laser, instruments) 4.86 97.3
3.2 Positioning of screens. assistants and lights 4.66 95.9
3.3 Determine laser modus and power settings 4.70 93.2
3.4 Positioning of patient 4.81 97.3
4. Ultrasound examination (together with sonographer)    
4.1 Identification of both fetuses, presentation and position 4.78 95.9
4.2 Visualize placenta localization, umbilical cord insertions 4.90 98.6
4.3 Assess deepest pockets of amniotic fluid 4.47 80.8
4.4 Determine expected position of vascular equator 4.71 94.5
4.5 Determine site of insertion of fetoscope 4.95 98.6
4.6 Choose type of introduction (set) and type of fetoscope 4.67 90.4
5. Sterile procedure and anesthesia    
5.1 Surgical briefing (time out) about (complete) procedure to fetal therapy team 4.48 90.4
5.2 Aseptic procedure for surgeon. scrub nurse and sonographer 4.78 93.2
5.3 Monitoring maternal condition (during complete procedure) 4.60 90.4
5.4 Placement of sterile covers over patient and instruments 4.68 93.2
6. Positioning and connection of instruments (pre-insertion)    
6.1 Connection of fetoscope (orientation, focus and white balance) 4.79 98.6
6.2 Connection of laser fiber to laser machine, insertion of fiber in fetoscope 4.68 91.8
6.3 Connect amnio-infusion and/or cooling system to fetoscope 4.26 79.5
7. Insertion    
7.1 Performance of all manipulations under ultrasound visualization 4.44 80.8
7.2 Avoid damage to maternal bowel, blood vessels and placental edge 4.89 97.3
7.3 Administration of local anesthesia skin - peritoneum 4.19 75.3
7.4 Make adequate-size skin incision with surgical knife 4.59 91.8
7.5 Correct use of (Seldinger or trocar) technique for insertion 4.63 86.3
7.6 Drain 10-20 cc amniotic fluid for prenatal testing 3.92 56.2
7.7 Determine need for pre-surgical amnio-infusion 4.18 71.2
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7.8 Insertion of shaft/scope 4.64 91.8
  Use of Seldinger technique  
7.8.1.1 Awareness of location maternal uterine vessels and intestines 3.81 76.7
7.8.1.2 Insert needle percutaneously in the uterine cavity 3.67 71.2
7.8.1.3 Introduction of soft J-tipped guide wire through the needle 3.64 69.9
7.8.1.4 Removal of needle 3.62 68.5
7.8.1.5 Introduction of cannula loaded with dilator over the guide wire 3.64 69.9
7.8.1.6 Insert shaft with scope percutaneously in the uterine cavity 3.60 67.1
  Use of direct insertion  
7.8.2.1 Awareness of location maternal uterine vessels and intestines 4.36 86.3
7.8.2.2 Insert shaft with scope percutaneously in the uterine cavity 4.21 79.5
8. Orientation    
8.1 Assess visibility (optional: score visibility) 4.21 80.8
8.2 Determine need for amniotic exchange 4.18 82.2
8.3 Confirm position of placenta, fetuses and cord insertions 4.68 90.4
8.4 Identification of intertwin dividing membrane (and use for reference) 4.70 97.3
8.5 Mapping of placental surface and vascular equator 4.75 95.9
8.6 In case of using separate scope to map equator. change scope 2.73 31.5
9. Laser coagulation    
9.1 Use of selective laser technique (only coagulation of anastomoses) 4.45 83.6
9.1.1 In case of selective laser technique: use sequential technique 3.54 32.9
9.2 Use of Solomon technique 3.54 35.6
9.2.1 In case of Solomon technique: use sequential technique 3.26 41.1
9.3 Prevent the unnecessary sacrifice of placental tissue 4.42 83.6
10. Assessment during procedure    
10.1 Prevent unnecessary delay during procedure 4.40 91.8
10.2 Check for complications (e.g. bleeding, rupture intertwin membranes) 4.48 91.8
10.3 Check fetal condition regularly 4.05 68.5
10.4 Identify and record number and type of anastomoses coagulated 4.29 82.2
10.5 While finishing procedure check for amniotic leakage in maternal abdomen 3.82 54.8
10.6 Check for amnion-chorion dehiscence 4.00 67.1
10.7 Determine placental sharing 3.48 34.2
10.8 Check limb abnormalities recipient 3.42 28.8
10.9 Mark recipient with laser spot on left upper leg 1.23 -94.5
11. Amniodrainage    
11.1 Controlled drainage of polyhydramnios 4.53 95.9
11.2 Assess adequate drainage (ultrasound guided) until pre-defined level to decrease 
uterine distention and promote patient comfort
4.36 87.7
12. Closure    
12.1 Closing skin incision (suture or Steri-strip) 4.19 79.5
13. Direct post-operative management    
13.1 Inform patient. partner/family and referring specialist 4.71 93.2
13.2 Administration (surgical report, fetal therapy database) 4.59 90.4
13.3 Instructions for monitoring of maternal and fetal condition 4.73 98.6
13.4 Inform patient of peritoneal irritation due to leakage of amniotic fluid 4.07 72.6
13.5 Consider administration of postoperative tocolytics 4.15 76.7
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14. Follow up ultrasound examination    
14.1 Knowledge of follow-up until delivery of (un)complicated monochorionic pregnancies 4.67 94.5
14.2 Assessment of fetal condition including bladder filling. deepest vertical pockets and 
doppler flows
4.78 98.6
14.3  Knowledge of MCA-PSV measurement to detect post-laser TAPS 4.73 93.2
14.4 Signs of iatrogenic perforation of the intertwin membrane 4.48 90.4
14.5 Signs of amnion-chorionic separation 4.41 90.4
14.6 Record which fetus is former donor and recipient. respectively 4.64 97.3
14.7 Order follow up cervical length measurement 3.89 56.2
14.8 Knowledge of signs and options with regards to iatrogenic PPROM 4.52 90.4
Appendix 1. Round 1 of Delphi survey: Summary of initial substeps and results of ratings. 
If RoA > 80 (Rate of Agreement coefficient) the substep was included in the evaluation instrument. 
Mean: mean scores of panel ratings on 5-point Likert scale. BMI: Body Mass Index. Rh-D: Rhesus-D. CS: cesarean 
section. TTTS: Twin-Twin Transfusion Syndrome. TAPS: Twin Anemia Polycythemia Sequence. sIUGR: selective 
Intrauterine Growth Restriction. MCA-PSV: Middle cerebral artery- peak systolic velocity measurement. PPROM: 
preterm premature rupture of membranes.. 
No. Rounds Domain and substeps Mean RoA
1.   Diagnostic procedure    
1.3 Round 1 Endovaginal ultrasound examination for cervical length 
measurement
4.38 75
  Comments The panel mentioned no clear evidence exists on the use of 
endovaginal versus abdominal ultrasound. the consequences of a 
short cervix and the right timing of the endovaginal measurement.
 
  Action Round 1 Rephrased  
1.3 Round 2 Consider cervical length measurement 4.68 88
  Action Round 2 Item included  
1.5 Round 1 Consider relevant maternal factors (i.e. BMI) and medical history 4.08 73
  Comments This item was considered to generic. It was separated into two 
items.
 
  Action Round 1 Rephrased  
1.5.1 Round 2 Consider maternal factors as possible exclusion criteria for laser 
therapy according to centers protocol. (i.e. maternal condition 
mandating delivery)
4.18 74
  Action Round 2 Item deleted  
1.5.2 Round 2 Consider relevant maternal factors (that may influence surgery and 
post-operative management (i.e. maternal BMI) )
4.20 77
  Action Round 2 Item deleted  
2.   Pre-surgical management    
2.1 Round 1 Consider need for anti-D prophylaxis to minimize sensitization 4.21 71
  Comments According to textual suggestions by respondents that blood group 
and Rhesus typing should be known this item was adjusted.
 
  Action Round 1 Rephrased  
2.1 Round 2 Blood group and Rhesus typing should be known; with respect local 
protocols concerning Rh-D prophylactics
4.83 95
  Action Round 2 Item included  
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2.3 Round 1 Arrange maternal (and depending on gestational age; fetal) 
monitoring 
4.29 79
  Comments The panel noted fetal monitoring often is irrelevant at GA of 
laser. The panel also noted that the decision for laser as preferred 
management has been made (instead of emergency CS in cases 
with advanced gestational age). Statement was considered 
confusing regarding timing of maternal monitoring.
 
  Action Round 1 Included comments for consideration, rephrased and partly deleted 
substep
 
2.3 Round 2 Consider pre-operative maternal monitoring 4.03 65
  Action Round 2 Item deleted  
3.   Preparation in operating room    
  Round 1 Consensus on all items  
4.   Ultrasound examination (together with sonographer)    
  Round 1 Consensus on all items  
5.   Sterile procedure and anesthesia    
  Round 1 Consensus on all items  
6.   Positioning and connection of instruments (pre-insertion)    
6.3 Round 1 Connect amnio-infusion and/or cooling system to fetoscope 4.26 79
  Comments The words “cooling system” were considered confusing by the panel; 
therefore a textual change was made. 
 
  Action Round 1 Rephrased  
6.3 Round 2 Connect amnio-infusion and/or flushing system to fetoscope 4.15 71
  Action Round 2 Item deleted  
7.   Insertion    
7.3 Round 1 Administration of local anesthesia skin - peritoneum 4.19 75
  Comments Panel responded: In case regional of general anesthesia is used, 
local anesthesia is not administered.
 
  Action Round 1 Rephrased  
  Round 2 In case of local anesthesia: administer anesthetic to skin and 
peritoneum
4.65 92
  Action Round 2 Item included  
7.6 Round 1 Drain 10-20 cc amniotic fluid for prenatal testing 3.92 56
  Comments The panel members noted differences in timing (beginning or end 
of procedure). and that this item is not always applicable due to the 
consent of the parents and/or gestational age of pregnancy.
 
  Action Round 1 Included comments for consideration. panel asked to re-rate 
substep
 
  Round 2 Drain 10-20 cc amniotic fluid for prenatal testing 4.00 56
  Action Round 2 Item deleted  
7.7 Round 1 Determine need for pre-surgical amnio-infusion 4.18 71
  Comments Comments of the panel mentioned this item is rarely necessary in 
TTTS (originally in protocol in cases of TAPS or sIUGR). Also some 
doubt on the timing was mentioned: with needle of Seldinger 
inside or with trocar.
 
  Action Round 1 Included comments for consideration, panel asked to re-rate 
substep
 
  Round 2 Determine need for pre-surgical amnio-infusion 3.91 59
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  Action Round 2 Item deleted  
7.8 Round 1 Insertion using Seldinger technique  
7.8.1.1 Awareness of location maternal uterine vessels and intestines 3.81 77
7.8.1.2 Insert needle percutaneously in the uterine cavity 3.67 71
7.8.1.3 Introduction of soft J-tipped guide wire through the needle 3.64 70
7.8.1.4 Removal of needle 3.62 69
7.8.1.5 Introduction of cannula. loaded with dilator over the guide wire 3.64 70
7.8.1.6 Insert shaft with scope percutaneously in the uterine cavity 3.60 67
  Direct insertion  
7.8.2.2 Insert shaft with scope percutaneously in the uterine cavity 4.21 79
7.9 Comments Panel members did not reach consensus on the insertion technique. 
Comments included that “Awareness of location of maternal uterine 
vessels and intestines during insertion” was considered relevant 
by respondents, though not in relation to insertion technique (e.g. 
Seldinger or direct). 
 
  Action Round 1 We rephrased the item regardless of the technique used.  
  Round 2 Awareness of location of maternal uterine vessels and intestines 
during insertion
4.7 94
  Action Round 2 Items on type of introduction rejected. “awareness of location 
maternal uterine vessels and intestines during insertion” merged 
with other item on this topic. 
 
8.   Orientation    
8.6 Round 1 In case of using separate scope to map equator, change scope 2.73 32
  Comments Most panel members responded they do not use a separate scope 
for mapping
 
  Action Round 1 Included comments for consideration. panel asked to re-rate 
substep
 
8.6 Round 2 In case of using separate scope to map equator, change scope 2.47 9
  Action Round 2 Item deleted  
9.   Laser coagulation    
9.1.1 Round 1 Use of selective laser technique (only coagulation of anastomoses) 4.45 84
9.2 In case of selective laser technique: use sequential technique 3.54 33
9.2.1 Use of Solomon technique 3.54 36
  In case of Solomon technique: use sequential technique 3.26 41
  Comments Responses of the panel with respect to laser technique included 
comments on technique that was used locally, and the benefits 
of the different techniques in detail. The panel mentioned there 
is little evidence for the sequential laser technique, and that use 
of this technique should not prolong the scopy time. The panel 
commented that there is level 1 evidence for use of the Solomon 
technique and perhaps dichorionization could be preferred 
terminology.
 
  Action Round 1 We rephrased the items, included comments and asked to re-rate 
these items
 
9.1 Round 2 Coagulation of all vascular anastomoses that cross the vascular 
equator
4.44 79
  Action Round 2 Item merged with “use of selective laser technique (only coagulation 
of anastomoses)”
 
9.2.1 Round 2 Use sequential technique 3.29 30
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  Action Round 2 Item deleted  
9.2.2 Round 2 Use of Solomon technique (complete dichorionization) 3.89 62
  Action Round 2 Item deleted  
10.   Assessment during procedure    
10.3 Round 1 Check fetal condition regularly 4.05 69
  Comments Responses of panel included: Assessment of fetal condition must 
not prolong the procedure, you cannot stop halfway the procedure, 
only applicable in viable time period. not much you can do in case 
of deterioration
 
  Action Round 1 Included comments for consideration. re-rate substep  
  Round 2 Check fetal condition regularly 3.74 56
  Action Round 2 Item deleted  
10.5 Round 1 While finishing procedure check for amniotic leakage in maternal 
abdomen
3.82 55
  Comments Comments on this item included: this is not a predictor of outcome, 
no treatment options are available, may occur after finishing 
procedure.
 
  Action Round 1 Included comments for consideration, panel asked to re-rate 
substep
 
  Round 2 While finishing procedure check for amniotic leakage in maternal 
abdomen
3.24 23
  Action Round 2 Item deleted  
10.6 Round 1 Check for amnion-chorion dehiscence 4.00 67
  Comments The panel mentioned this item is also displayed in follow up 
ultrasound and that no treatment option is available
 
  Action Round 1 Included comments for consideration panel asked to re-rate substep  
  Round 2 Check for amnion-chorion dehiscence 3.85 61
  Action Round 2 Item deleted  
10.7 Round 1 Determine placental sharing 3.48 34
  Comments The panel noted no standardized assessment exists for this item: it 
is considered a rough estimation and it has questionable value for 
treatment management
 
  Action Round 1 Included comments for consideration, panel asked to re-rate 
substep
 
  Round 2 Determine placental sharing 3.09 11
  Action Round 2 Item deleted  
10.8 Round 1 Check limb abnormalities recipient 3.42 29
  Comments The panel mentioned it is better to check this (pre-op or follow up) 
with ultrasound, that it prolongs scopy time, that no direct clinical 
implications exist and that it will not provide any information on the 
donor
 
  Action Round 1 Included comments for consideration, panel asked to re-rate 
substep
 
  Round 2 Check limb abnormalities recipient 3.02 -2
  Action Round 2 Item deleted  
10.9 Round 1 Mark recipient with laser spot on left upper leg 1.23 -95
  Comments This item was incorporated on purpose in the first survey round as a 
check for validity. 
 
6
IDENTIFICATION OF ESSENTIAL STEPS FOR LASER   135
No. Rounds Domain and substeps Mean RoA
  Action Round 1 Panel members were informed about this check. Item was excluded 
from subsequent rounds.
 
11.   Amniodrainage    
  Round 1 Consensus on all items  
12.   Closure    
12.1 Round 1 Closing skin incision (suture or Steri-strip) 4.19 79
  Comments Panel included comments on steri-strip equivalents. considers this 
basic surgical care. 
 
  Action Round 1 Rephrased  
  Round 2 Closing skin incision (suture or suture free adhesive product) 4.39 82
  Action Round 2 Item included  
13.   Direct post-operative management    
13.4 Round 1 Inform patient of peritoneal irritation due to leakage of amniotic 
fluid
4.07 73
  Comments The panel noted this already has been mentioned at 13.1. (post-
operative information to the patient. family and referring specialist). 
Not every complication should be displayed as a separate item.
 
  Action Round 1 Included comments for consideration, panel asked to re-rate 
substep
 
  Round 2 Inform patient of peritoneal irritation due to leakage of amniotic 
fluid
3.74 61
  Action Round 2 Item deleted  
13.5 Round 1 Consider administration of postoperative tocolytics 4.15 77
  Comments Comments included: depending on gestational age, clinical signs 
and according to local protocol. Therefore this step was edited.
 
  Action Round 1 Rephrased  
  Round 2 Consider administration of postoperative tocolytics (based on local 
protocol or clinical signs.)
4.18 74
  Action Round 2 Item deleted  
14.   Follow up ultrasound examination    
14.7 Round 1 Order follow up cervical length measurement 3.89 56
  Comments The panel noted no evidence or therapeutic implications exist and 
that it should not be performed without clinical signs.
 
  Action Round 1 Rephrased  
  Round 2 Order follow up cervical length measurement when indicated 4.02 65
  Action Round 2 Item deleted  
Appendix 2. Summary of the evaluation and selection process of substeps in round 2 of the Delphi survey. 
If RoA > 80 (Rate of Agreement coefficient). the substep was included in the evaluation instrument. 
Mean: mean scores of panel ratings on 5-point Likert scale. BMI: Body Mass Index. Rh-D: Rhesus-D. CS: cesarean 
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Chapter 7
Operator Competence in Fetoscopic Laser Surgery 
for Twin-Twin Transfusion Syndrome: Validation of 




Fetoscopic laser surgery for twin–twin transfusion syndrome is a procedure for which no 
objective tools exist to assess technical skills. To ensure that future fetal surgeons reach 
competence prior to performing the procedure unsupervised, we developed a performance 
assessment tool. The aim of this study was to validate this assessment tool for reliability 
and construct validity.
Methods 
We made use of a procedure-specific evaluation instrument containing all essential steps 
of the fetoscopic laser procedure, which was previously created using Delphi methodology. 
Eleven experts and 13 novices from three fetal medicine centers performed the procedure on 
the same simulator. Two independent observers assessed each surgery using the instrument 
(maximum score: 52). Interobserver reliability was assessed using Spearman correlation. We 
compared the performance of novices and experts to assess construct validity.
Results 
The interobserver reliability was high (Rs = 0.974, P < 0.001). Checklist scores for experts 
and novices were significantly different; the median score for novices was 28/52 (54%), 
whereas that for experts was 47.5/52 (91%) (P < 0.001). The procedure time and fetoscopy 
time were significantly shorter (P < 0.001) for experts. Residual anastomoses were found 
in 1/11 (9%) procedures performed by experts and in 9/13 (69%) procedures performed by 
novices (P = 0.005). Multivariable analysis showed that the checklist score, independent of 
age and gender, predicted competence.
Conclusions 
The procedure-specific assessment tool for fetoscopic laser surgery shows good 
interobserver reliability and discriminates experts from novices. This instrument may 
therefore be a useful tool in the training curriculum for fetal surgeons. Further intervention 
studies with reassessment before and after training may increase the construct validity of 
the tool.
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INTRODUCTION
Fetoscopic laser therapy is the preferred treatment modality for twin–twin transfusion 
syndrome (TTTS)1–3 , but is only offered in a few highly specialized fetal medicine centers 
around the world4. Although fetoscopic laser surgery is a complex procedure that has been 
in use for more than two decades, standardized surgical training programs for fetoscopic 
interventions are non-existent and performance is often authority based, i.e. based on 
personal experience, belief and individual preferences. Also, the learning curve is ill-defined, 
and varies between 21 and 75 cases (based on different survival outcome measures such as 
minimal double survival rates of 54% or at least one survivor in 70% of cases) to acquire the 
necessary skills5–8 . Therefore, there is a need for a reliable assessment tool for technical 
performance. Such a tool would be useful to monitor progress, provide constant feedback 
along the learning curve, serve as an instrument for (re)certification and offer standardized 
training.
We previously reported on a list of steps judged essential to the laser procedure based 
on the Delphi methods9. These steps were consensus based by a sample of international 
experts, making the final tool representative of international, rather than local, practice. 
The aim of this prospective cohort study was to assess the reliability and validity of this 
instrument in the context of simulated operating room performance. We hypothesized 
that, based on the systematic manner in which this tool was created, we would obtain an 
acceptable level of interobserver reliability and that the instrument would discriminate the 
performance of experts from that of novices.
METHODS
Participants and study design
This study is part of the SILICONE project (SImulator for Laser therapy and Identification of 
Critical steps of Operation: New Education program), conducted to develop a standardized 
training program for fetoscopic laser surgery for TTTS. In the first part of the project, we 
determined the essential steps of treatment to develop an assessment instrument9. In the 
current part of the project, this instrument was validated using a silicone simulator involving 
the complete laser procedure. The Medical Ethics committee of the Leiden University 
Medical Center declared that no formal ethical approval or written informed consent was 
needed for this study.
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Figure 1 Participant performing procedure on simulator for fetoscopic laser surgery
This study was conducted in three fetal medicine centers: Leiden University Medical Center 
(The Netherlands), University Hospitals KU Leuven (Belgium) and Karolinska Institutet, 
Stockholm (Sweden) from September 2014 to December 2014. We recruited 24 volunteers 
with special interest in fetal therapy to participate in the study. All participants completed 
a questionnaire to establish the baseline demographic characteristics and previous 
experience in fetoscopic surgery to measure potential confounding factors that affect 
performance. Participants were stratified into three groups with regard to the level of 
previous experience: expert, novice or intermediate.
An expert was defined as a physician who currently practices fetoscopic laser surgery 
for TTTS and has performed at least 25 fetoscopic laser procedures independently8 . 
Novices included fetal medicine specialists without practical fetal therapy experience, 
obstetricians attending a fellowship in perinatology or senior residents with a special 
interest in perinatology and minimal invasive therapy. All novices were experienced 
sonographers and had appropriate knowledge of TTTS and its treatment options, but had 
never performed a fetoscopic laser procedure and had little or no previous experience with 
other ultrasound-guided invasive procedures (amniocentesis, chorionic villus sampling and/
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or intrauterine transfusion). Practicing fetal surgeons who were still on their learning curve 
(e.g. having performed 1–25 fetoscopic laser procedures) were considered intermediates 
and were excluded. For secondary analyses, experts were categorized into two groups: 
intermediate expert level (having performed < 50 procedures) and senior expert level 
(having performed > 50 procedures).
Assessment
All participants (irrespective of the level of expertise) performed a similar assignment 
on the simulator. The scenario involved a patient of 17weeks’ gestation with Stage III 
TTTS referred for laser therapy. The assignment included the complete fetoscopic laser 
procedure, starting from the moment that the operation room was entered, until the 
surgery was finished and direct postoperative management was ordered. Three different 
items were scored: ‘time’, ‘checklist with essential steps of procedure’ and ‘complete 
identification of vascular equator’.
All participants were evaluated by two independent observers (S.H.P.P. and J.A.), using the 
assessment instrument created by the Delphi consensus9. This list of essential steps was 
modified into a checklist adjusted to the simulated scenario. A detailed description of the 
instrument is available in Appendix S1. Each item was awarded 1 point if it was performed 
properly (range, 0–52). The procedure time, defined as ‘the moment the surgeon enters 
the operating room until the moment that direct postoperative management is ordered’, 
and fetoscopy time, defined as ‘the moment the fetoscope is introduced for the first time 
until final removal’, were recorded. A map of the placental architecture was used by the 
assessors to mark the coagulated anastomoses.
Scenario and simulator characteristics
To explain the task, all participants were shown a standardized multimedia presentation 
outlining the background and aim of the study, as well as the performance metrics (time, 
missed essential steps and complete coagulation of the vascular equator). Finally, the 
context of the scenario (including patient characteristics, findings of diagnostic procedure 
and presurgical management) was presented.
The simulator used for this study has been described previously10 (Francis LeBouthillier, 
Surgical Touch, Toronto, Canada), but was modified with a highly realistic silicone copy 
of a 17-week monochorionic twin placenta and twin fetuses (R. Bakker, Manimalworks, 
Rotterdam, The Netherlands). The silicone topping on the model mimics the abdominal wall. 
Inside there is a mimic of a uterus, which contains water and the placenta. The individual 
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layers of the abdominal wall, the uterus and placenta have sonographic and compliance 
properties that mimic the clinical situation. The model allows an operator to practice 
ultrasound examination of a monochorionic pregnancy, being required to select the best 
site for introduction of the instruments. The model also provides a realistic intrauterine 
environment, optimal for the practice of manual dexterity skills and to train navigation 
along the placental surface. Moreover, the addition of a ‘stuck’ donor twin on the placenta 
simulates the inability to oversee the complete vascular equator.
Demographics Expert Novices p value
  n=11 n=13  
Gender      
Male 8 (73) 3 (23) 0.015
Female 3 (27) 10 (77)  
Age      
  (median in years, range) 52 (35-59) 32 (28-42) <0.001
Experience with invasive obstetric procedures      
Has experience with invasive obst. procedures 11 (100) 4 (31) 0.001
years (median, range) 15 (7-23) 3 (1-8) 0.003
Type of invasive obstetric procedures  
Amniocentesis 11 (100) 3 (23)  
Chorionic villus sampling 11 (100) 3 (23)  
Intrauterine transfusion 8  (73) 1 (8)  
Fetal shunt placement 8  (73) 0  
Bipolar cord occlusion 11 (100) 0  
Open fetal surgery 4 (36) 0  
Other 4 (36) 0  
No. of FLS attended *    
None 0 2 (15) 0.001
< 10 procedures 0 7 (54)  
10-25 procedures 0 0  
25-50 procedures 1 (9) 2 (15)  
50-100 procedures 1 (9) 0  
>100 procedures 9 (82) 2 (15)  
Experience with simulator training      
Never 2 (18) 1 (8) 0.447
A few times 4 (36) 8 (62)  
Regularly 5 (46) 4 (30)  
Table 1 Demographic characteristics of study participants: 11 experts and 13 novices using a fetoscopic laser 
simulator. Data are given as n (%) or median (range). *Including assisting or watching procedure. FLS, fetoscopic 
laser surgery; No., number.
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The addition of a ‘free-floating’ recipient simulates a realistic complex situation of floating 
fetal extremities and umbilical cord in the recipient’s sac. All necessary instruments (i.e. 
fetoscope, introduction set, endoscopy tower, etc.) were from the local fetal medicine 
center so that participants performed their tasks in a setting that was identical to their 
clinical environment. Figure 1 shows a participant performing the procedure on the simulator 
model.
Statistical analysis
The demographics, procedure and fetoscopy time, checklist score and presence of residual 
anastomoses were compared between experts and novices. Due to the small sample size 
and non-normality of the data, the Mann–Whitney U-test was used to test for differences 
between groups for the continuous variables. Fisher’s exact test was used to test for 
differences between groups on non-ordinal categorical outcomes, such as the presence 
or absence of experience. Spearman’s correlation coefficient was used to measure the 
interobserver reliability. A correlation of 0.9 or higher was considered to be indicative of 
excellent agreement.
In order to assess the construct validity of the instrument, we used multivariable logistic 
regression analysis to determine whether any independent predictors other than checklist 
score were associated with experience level (i.e. expert vs novice). Construct validity refers 
to the degree to which any measurement approach or instrument succeeds in describing or 
quantifying what it is designed to measure. Moreover, it reflects the accuracy with which 
scores on a given instrument can classify groups that are already known to differ on a 
criterion measure (i.e. experts and novices). In other words, if experts are those with the 
construct (surgical skills) and novices are those without the construct; construct validity 
determines whether the instrument identifies the presence or absence of the construct 
(surgical skills).
A two-sided P < 0.05 was considered to indicate statistical significance. Statistical analyses 
were performed with SPSS version 21.0 (SPSS Statistics for Windows, IBM Corporation, 
Armonk, NY, USA). As no patients were involved, no formal ethical approval and written 
informed consent was needed for this study.
RESULTS
In this study, 24 fetoscopic simulated laser surgeries were analyzed. They were performed 
by 11 (46%) experts and 13 (54%) novices. Eleven participants were male and 13 were female. 
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Although 4/13 (31%) of the novices in the study had previous limited experience with invasive 
obstetric procedures (e.g. amniocentesis, chorionic villus sampling, intrauterine transfusion, 
etc.), none had previously performed the fetoscopic laser procedure for TTTS. In the group 
of experts, 5/11 (45%) had performed > 100 procedures with a median of 10 procedures 
(range, 8 – 20) annually. The demographics of the participants are shown in Table 1.
  Domain No. of steps Rs p value
A Preparation in operating room 7 0.956 <0.001
B Ultrasound examination (together with sonographer) 7 0.862 <0.001
C Pre-operative preparations 7 0.943 <0.001
D Positioning and connection of instruments (pre-insertion) 6 0.977 <0.001
E Insertion 5 0.947 <0.001
F Orientation 8 0.857 <0.001
G Laser coagulation 4 0.862 <0.001
H Assessment during procedure 3 0.789 <0.001
I Amniodrainage 2 1.000 <0.001
J Closure 1 0.845 <0.001
K Direct post-operative management 2 0.722 <0.001
  Overall 52 0.974 <0.001
Table 2 Interobserver reliability, according to domain of the evaluation instrument for fetoscopic laser surgery 
for twin–twin transfusion syndrome. Rs : Spearman correlation coefficient.
The overall median procedure time was 40 min (range, 26 – 50 min). Experts were able to 
complete the procedure in 32 min vs 43 min by novices (P = 0.003). The fetoscopy time 
was also significantly different between the groups. The median fetoscopy time for all 
participants was 17 min (range, 10 – 27 min), 11 min for experts vs 20 min for novices (P < 
0.001). Residual anastomoses were found in 10/25 (40%) procedures, 1/11 (9%) performed 
by experts and 9/13 (69%) performed by novices (P = 0.005).
Secondary analyses were performed with regard to the level of expertise in the expert 
group comparing the results for intermediate and senior experts. The procedure time and 
fetoscopy time were not significantly different between the groups (32 vs 31min, P=0.776 
and 12 vs 11 min, P = 0.376), and neither was the surgical performance score (45/52 (87%) vs 
49/52 (94%), P = 0.630).
Reliability
The overall interobserver reliability of the two (J.A. and S.H.P.P.) total scores for the 
fetoscopic laser procedure was excellent (Rs = 0.974; P < 0.001) (Figure 2). Agreement was 
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less but was still strong in the domains concerning ‘direct postoperative management’ (Rs 
= 0.722; P < 0.001) and ‘assessment during procedure’ (Rs = 0.789; P < 0.001) as displayed 
in Table 2. Agreement for the two raters remained high amongst intermediate experts (Rs 
= 0.866) and senior experts (Rs = 0.938). The interobserver variability did not significantly 
change over time (data not shown).
Figure 2 Scatterplot showing 
correlation between checklist 
scores of the two observers 
using fetoscopic laser simulator, 
according to level of experience: 
novice ( o ) or expert ( • ). Scores for 
experts were overlapping in two 
cases.
Construct validity
Observer 1’s median score for novices on the assessment tool was 29/52 (56%) (range, 
20 – 43) compared with a median expert score of 47/52 (90%) (range, 44 – 50) (P < 0.001). 
Observer 2’s median novice score similarly demonstrated statistically significant differences 
between novice and expert performance (30/52 (58%) (range, 19 – 45) vs 48/52 (92%) (range, 
43 – 52)) (P < 0.001).
The overall median checklist scores (combining the scores by taking the average of the 
two observers) were 28/52 (54%) (range, 20 – 44) in novices vs 47.5/52 (91%) (range, 44 – 
51) in experts (P < 0.001) and scores were also significantly associated with the presence 
of residual anastomoses as demonstrated in Figure3 (P=0.002). Receiver–operating 
characteristics analysis showed an area under the curve of 0.861 for the use of checklist 
score to identify experience level. Multivariable analyses showed that the age (b1 = 0.203; 
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Figure 2 Scatterplot showing correlation between checklist scores
of the two observers using fetoscopic laser simulator, according to
level of experience: novice ( ) or expert ( ). Sc res for expert were
overlapping in two cases.
novices (P < 0.001). Residual anastomoses were found in
10/25 (40%) procedures, 1/11 (9%) performed by experts
and 9/13 (69%) performed by novices ( P = 0.005).
Secondary analyses were performed with regard to
the level of expertise in the expert group comparing
the results for intermediate and senior experts. The
procedure time and fetoscopy time were not significantly
dierent between the groups (32 vs 31 min, P = 0.776
and 12 vs 11 min, P = 0.376), and neither was the
surgical performance score (45/52 (87%) vs 49/52 (94%),
P = 0.630).
Reliability
The overall interobserver reliability of the two (J.A.
and S.H.P.P.) total scores for the fetoscopic laser pro-
cedure was excellent (R s = 0.974; P < 0.001) (Figure 2).
Agreement was less but was still strong in the
domains concerning ‘direct postoperative management’
(R s = 0.722; P < 0.001) and ‘assessment during proce-
dure’ (R s = 0.789; P < 0.001) as displayed in Table 2.
Agreement for the two raters remained high amongst
intermediate experts (R s = 0.866) and senior experts
(R s = 0.938). The interobserver variability did not sig-
nificantly change over time (data not shown).
Construct validity
Observer 1’s median score for novices on the assessment
tool was 29/52 (56%) (range, 20–43) compared with
a median expert score of 47/52 (90%) (range, 44–50)
(P < 0.001). Observer 2’s median novice score similarly
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Figure 3 Boxplots of checklist score according to presence or
absence of residual anastomoses in 11 experts and 13 novices using
a fetoscopic laser simulator ( P = 0.002). Boxes with internal lines
represent median and interquartile range, whiskers are range, and
outliers are plotted.
demonstrated statistically significant dierences between
novice and expert performance (30/52 (58%) (range,
19–45) vs 48/52 (92%) (range, 43–52)) ( P < 0.001).
The overall median checklist scores (combining the
scores by taking the average of the two observers)
were 28/52 (54%) (range, 20–44) in novices vs 47.5/52
(91%) (range, 44–51) in experts ( P < 0.001) and scores
were also significantly associated with the presence
of residual anastomoses as demonstrated in Figure 3
(P = 0.002). Receiver–operating characteristics analysis
showed an area under the curve of 0.861 for the use of
checklist score to identify experience level. Multivariable
analyses showed that the age (b1 = 0.203; P = 0.351) and
gender (b1 = 0.088; P = 0.539) of participants were not
significantly associated with level of experience given the
checklist score.
Copyright  2015 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2016; 47: 350–355.
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P = 0.351) and gender (b1 = 0.088; P = 0.539) of participants were not significantly associated 
with level of experience given the checklist score.
Figure 3 Boxplots of checklist 
score according to presence or 
absence of residual anastomoses 
in 11 experts and 13 novices 
using a fetoscopic laser simulator 
(P = 0.002). Boxes with internal 
lines represent median and 
interquartile range, whiskers are 
range, and outliers are plotted.
DISCUSSION
This study assessed the interobserver reliability and construct validity of a procedure-
specific evaluation tool for fetoscopic laser surgery of TTTS, created using the Delphi 
methodology9. Our instrument effectively distinguished the performance of experts and 
novices with an acceptable level of interobserver reliability.
Any discussion of evaluation or assessment must address issues of validity and reliability. 
The instrument will only be useful to educators or surgeons as a measure of competence 
when it does measure the construct that it intends to measure (validity) and when the 
results that are obtained are consistent and therefore meaningful (reliability). Interobserver 
reliability refers to the degree to which a difference in score on the tool reflects a 
difference in quality of performance rather than a difference between the raters. A high 
level of interobserver reliability allows the evaluation of skills by different observers and 
will be minimally affected by the variability of the rater11.
Trainees in fetal surgery have to date been educated according to the ‘master–apprentice’ 
principle. Direct observation by experts alone may not be a reliable method of assessment 
and may lead to recall bias due to the retrospective nature of the evaluation. Use of fixed 
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P = 0.630).
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Agreement was less but was still strong in the
domains concerning ‘direct postoperative management’
(R s = 0.722; P < 0.001) and ‘assessment during proce-
dure’ (R s = 0.789; P < 0.001) as displayed in Table 2.
Agreement for the two raters remained high amongst
intermediate experts (R s = 0.866) and senior experts
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criteria such as a validated checklist by observing experts can address these concerns12,13. 
Additionally, task-specific checklists provide trainees with detailed methods on how to 
perform the procedure and enable formative feedback and deliberate practice. To achieve 
standardization and wide implementation, an assessment tool must be reflective of 
practice among many institutions; we therefore included participants from three major 
fetal medicine centers.
The validation of assessment tools for training has been performed frequently in other 
medical areas14–17 , but never in the field of fetal therapy. The observation of surgical skills 
without structured criteria has poor reliability and will result in a low level of agreement 
among the raters18. The values for interobserver reliability in this study indicate that our 
evaluation tool reaches the cut-off of 0.8 deemed acceptable for assessment11.
The purpose of this study was to validate the evaluation tool for a surgeon’s technical 
performance using a highly realistic simulator. Objective feedback to fetal surgeons on 
their performance based on highly reliable assessment tools could also be of great value 
for ongoing assessment and lifelong learning. Developing similar assessment tools for other 
invasive obstetric procedures will make it possible to teach and evaluate procedures using 
disseminated learning materials. As we want to make the curriculum competency based, it 
is also important to define expert benchmark levels of proficiency for the final curriculum.
Procedure-specific checklists have been shown to be less reliable and less construct valid 
than global rating scales19. However, a global assessment scale can make an instrument 
indistinct despite having an apparent precision, as items are rated on scales (e.g. 1 – 10) 
instead of ‘achieved’ or ‘failed’. For feedback purposes it is sufficient to know at a glance 
which elements need improvement (instead of adding values to the assessed items).
The procedure time and fetoscopy time were significantly lower in the expert group 
compared with novices. This may be explained by the often interrupted flow of thoughts 
when performing a procedure for the first time. Surgical steps need to be carried out 
consciously for novices, as opposed to automatically for experts, making a procedure-
specific tool that combines efficacy (closing all anastomoses) with safety (avoiding 
complications) even more valuable for training purposes.
A limitation of this study is that a few items identified through the prior Delphi consensus 
could not be analyzed during the simulator experiments as they take place in the diagnostic 
and preoperative phase of the procedure. These steps include: ‘diagnostic procedure’ (e.g. 
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ultrasound examination at outpatient clinic confirming the diagnosis and determining 
treatment options), ‘presurgical management’ (e.g. prescription of procedure-related 
medication, etc.) and ‘follow-up ultrasound examination’. Therefore, our assessment of 
the construct validity and reliability of this tool does not include these particular steps.
Due to the nature of the procedure, we were unable to assess the validity of the instrument 
in surgery on real patients and therefore the simulator was used. Although the simulator 
is regarded as highly realistic, clinical features such as ‘tissue reaction after firing the laser’ 
and ‘complications such as bleeding’ could not be simulated. However, assessment using a 
simulator model can also be advantageous, as the lack of standardization in real patients 
makes the consistent assessment of technical skills difficult. Advantages of the simulator 
model include the fact that tasks can be presented consistently to many trainees, who 
can operate independently, objective assessment by more than one faculty member is 
possible and there is no intrusion on operating room time, which has financial and ethical 
advantages20.
Quite often, even experienced operators work as a team, and the effect of the collective 
experience of such a team may be greater than the sum of its individual parts. This effect 
is difficult to quantify and was not measured in this study. For this study, participants were 
assessed live in the operating room and therefore observers were able to oversee all steps, 
in contrast to only fetoscopic view or single camera position. This allowed us to evaluate 
the complete procedure, including all of its facets, such as sterility and handling of the 
instruments. Unfortunately, this element of our study prevented blinding the raters for 
the level of experience.
The construct validity of the instrument could be further assessed with a study with 
a pretraining and post-training design. Correlation of the score with the progress of 
inexperienced operators along a learning curve would further support its validity. Future 
studies should focus on the development and validation of a training curriculum aimed at 
improving the operative and technical skills of trainees in fetal therapy. Finally, additional 
studies should be performed to assess how well instructors can evaluate clinical skills 
when observing surgeons working with real patients and how to implement this into clinical 
practice.
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No. Domain and substeps Score
A Preparation in operating room 7
1 Ultrasound correct settings  
2 Endoscopy tower settings  
3 Positioning of screens  
4 Adjusting lights  
5 Correct laser modus  
6 Correct power settings  
7 Positioning of patient  
B Ultrasound examination (together with sonographer) 7
8 Identification of donor  
9 Identification of recipient  
10 Identification localization placenta  
11 Identification cord insertions  
12 Assess deepest pockets  
13 Determine expected position equator  
14 Determine insertion site fetoscope  
C Pre-operative preparations 7
15 Surgical briefing (time out) about (complete) procedure to fetal therapy team  
16 Aseptic procedure for surgeon, scrub nurse and sonographer  
17 Mention maternal condition  
18 All instrumentation remains sterile  
19 All is sufficiently covered  
20 Pre-insertion connection scope - shaft  
21 Pre-insertion connection light cable  
D Positioning and connection of instruments (pre-insertion) 6
22 Choose fetoscope  
23 Fetoscope: orientation  
24 Fetoscope: focus  
25 Fetoscope: white balance  
26 Connection of laser fiber  
27 Correct loading of laser fiber in fetoscope  
E Insertion 5
28 Preparation of introduction method  
29 Performance of all manipulations under ultrasound visualization  
30 Correct administration of local anesthetic  
31 Make adequate-size skin incision with surgical knife  
32 Awareness of location of maternal uterine vessels and intestines, and placental edge during insertion
F Orientation 8
33 Assess visibility (optional: score visibility)  
34 Determine need for amniotic exchange  
35 Fetoscopic view of placenta  
36 Fetoscopic view of donor  
37 Fetoscopic view of cord insertion recipient  
38 Identification of placental edges  
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No. Domain and substeps Score
39 Difference between artery and vene  
40 Find (part of ) vascular equator  
G Laser coagulation 4
41 Coagulation of all vascular anastomoses that cross the vascular equator  
42 Laser fiber correct position in fetoscope  
43 Laser fiber correct distance from vessel during coagulation  
44 Prevent the unnecessary sacrifice of placental tissue  
H Assessment during procedure 3
45 Prevent unnecessary delay during procedure  
46 Check for complications(e.g. bleeding, rupture intertwin membranes)  
47 Identify and record number and type of anastomoses coagulated  
I Amniodrainage 2
48 Controlled drainage of polyhydramnios  
49 Assess adequate drainage (ultrasound guided) until pre-defined level  
J Closure 1
50 Closing skin incision (suture or suture free adhesive product) 
K Direct post-operative management 2
51 Inform patient, partner/family and referring specialist  
52 Instructions for monitoring of maternal and fetal condition  























Simulator Training in Fetoscopic Laser Surgery for 
Twin–Twin Transfusion Syndrome: 




To evaluate the effect of a newly developed training curriculum on the performance of 
fetoscopic laser surgery for twin – twin transfusion syndrome (TTTS) using an advanced 
high-fidelity simulator model.
Methods 
Ten novices were randomized to receive verbal instructions and either skills training using the 
simulator (study group; n = 5) or no training (control group; n = 5). Both groups were evaluated 
with a pre-training and post-training test on the simulator. Performance was assessed by 
two independent observers and comprised a 52-item checklist for surgical performance 
(SP) score, measurement of procedure time and number of anastomoses missed. Eleven 
experts set the benchmark level of performance. Face validity and educational value of 
the simulator were assessed using a questionnaire.
Results 
Both groups showed an improvement in SP score at the post-training test compared with 
the pre-training test. The simulator-trained group significantly outperformed the control 
group, with a median SP score of 28 (54%) in the pre-test and 46 (88%) in the post-test 
vs 25 (48%) and 36 (69%), respectively (P = 0.008). Procedure time decreased by 11 min 
(from 44 to 33 min) in the study group vs 1 min (from 39 to 38 min) in the control group 
(P=0.69). There was no significant difference in the number of missed anastomoses at the 
post-training test between the two groups (1 vs 0). Subsequent feedback provided by the 
participants indicated that training on the simulator was perceived as a useful educational 
activity.
Conclusions 
Proficiency-based simulator training improves performance, indicated by SP score, for 
fetoscopic laser therapy. Despite the small sample size of this study, practice on a 
simulator is recommended before trainees carry out laser therapy for TTTS in pregnant 
women.
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INTRODUCTION
Twin–twin transfusion syndrome (TTTS) is a serious complication affecting approximately 
10% of monochorionic twin pregnancies1. Treatment is offered at specialized fetal therapy 
centers around the world2. Fetoscopic laser surgery enables both twins to survive in 60–
70% of cases, and at least one twin in 80–90%3, but few studies have been performed to 
gain more insight into the learning curves and pitfalls of this complex procedure4–8.
We anticipate that in the coming years an increasing number of fetal surgeons will begin 
training in fetoscopic laser surgery. With the economic growth in developing countries, and 
increasing knowledge of this treatment option through better access to online information, 
the interest of both patients and doctors in fetoscopic laser surgery will continue to 
grow. In addition, the next generation of fetal surgeons will gradually take over practice 
from the pioneers in the established centers. Therefore, focus is gradually shifting from 
pregnancy outcomes per center towards appropriate training and exposure of surgeons to 
a sufficient number of procedures. This will ensure proper skills and satisfactory results. 
To support this process, an evidence-based training curriculum and a continuous process of 
reporting and monitoring of outcomes are highly desirable.
Since fetoscopic procedures are performed on an infrequent basis, a surgeon-in-training 
is required to undergo a lengthy and expensive stay in an (often distant) fetal therapy 
center to accumulate, at least some, hands-on experience. Even large centers have limited 
numbers of cases, therefore teaching and training in this procedure are challenging. A 
growing need for alternative methods to train surgical skills through simulation has been 
recognized4,5,9 . Several attempts have been made to develop simulators for invasive fetal 
procedures with various levels of physical resemblance and functional task alignment9–13 
, but most simulators that have been reported on have been used for teaching in the 
absence of well-planned and comprehensive training curricula.
A procedure-specific simulator for fetoscopic laser surgery has not yet been developed, 
and standardized surgical training programs are non-existent. Therefore, the aim of this 
study was to demonstrate face (appearance) and construct validity of a highly realistic 
simulator and training for fetoscopic laser surgery for TTTS.
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METHODS
For the study we recruited volunteers with a special interest in fetal therapy and no 
practical experience with the fetoscopic laser procedure (novices), from a population of 
currently active fetal therapy experts in three maternal–fetal medicine centers: Leiden 
University Medical Center (The Netherlands), University Hospitals KU Leuven (Belgium) and 
Karolinska University Hospital, Stockholm (Sweden), from September to December 2014. All 
participants completed a questionnaire to establish baseline demographic characteristics and 
previous experience in surgical/obstetrical skills to exclude potential confounding factors 
that might have affected performance. Volunteers, hereafter referred to as ‘novices’, were 
eligible if they were a fetal medicine specialist without practical fetal therapy experience 
or an obstetrician/ gynecologist currently undergoing a perinatology fellowship or a senior 
obstetrics/gynecology resident with a special interest in perinatology and/or minimally 
invasive therapy. In addition, the participant was required to have high levels of skill in 
diagnostic ultrasound, appropriate knowledge of TTTS and its treatment options, but little 
or no previous experience with other ultrasound-guided invasive procedures (amniocentesis, 
chorionic villus sampling, cordocentesis and/or intrauterine transfusion).
A training curriculum using a simulator for fetoscopic laser surgery was generated based on 
an evaluation instrument developed previously5. We conducted a non-blinded randomized 
controlled trial using a parallel study design.
For randomization, we used a block randomization list (non-stratified, with the same block 
lengths), generated sequentially by www.random.org (School of Computer Science and 
Statistics, Trinity College, Dublin, Ireland). Novices were assigned randomly to either the 
training group (study group) or the no-training group (control group). Owing to the nature 
of the intervention, blinding for randomized allocation was not possible. Lack of data 
regarding training for fetoscopic laser surgery prevented a formal sample size calculation. 
Given the rarity of the procedure and the estimation that in the coming years two eligible 
trainees per fetal center will be trained, a sample size of 12 was chosen for the study. 
A pre-test/post-test research design was used to evaluate the effect of simulator-based 
training on surgical performance. Performance was assessed by an assignment involving the 
complete fetoscopic laser procedure, comparing the two groups’ performance before and 
after training.
All currently practicing experts from the three maternal–fetal medicine centers (n=11) 
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were asked to complete the same assignment to define a benchmark level. An ‘expert’ 
was defined as an individual who was currently practicing fetoscopic laser surgery for TTTS 
and had independently performed more than 25 fetoscopic laser procedures4. Baseline 
characteristics of all study participants are listed in Table 1.
Figure 1 Flowchart of the study showing participant enrolment, randomization, allocation of interventions and 
follow-up.
An advanced simulator (Francis LeBouthillier, Surgical Touch, Toronto, Canada) that had 
previously been used in training for amniocentesis11 was modified. A monochorionic twin 
placenta model and realistic models of twin fetuses (R. Bakker, Manimalworks, Rotterdam, 
The Netherlands) were inserted. Placenta and fetuses had a size compatible with that 
of a monochorionic twin pregnancy of 17 weeks’ gestation. The silicone interface at the 
top of the model imitated the abdominal wall. The simulator contained water and had 
appropriate sonographic properties. The model allowed an operator to perform ultrasound 
examination of the monochorionic pregnancy and to select the site for introduction of 
the instruments. The model provided a realistic intrauterine environment, optimized for 
practicing manual dexterity skills and training navigation along the placental surface. 
The ‘stuck’ donor twin was positioned on the placenta. The addition of a ‘free-floating’ 
recipient twin simulated the floating fetal extremities and umbilical cord in the recipient’s 
sac. Apart from the simulator model, all standard equipment (i.e. fetoscope, introduction 
set, ultrasound machine, endoscopy tower) used clinically in the participating fetal therapy 






study or control group
(n = 12)
Allocated to simulator-based
training (study) group ( n = 6)
Allocated to no-training
(control) group ( n = 6)
Excluded:
Did not meet inclusion criteria
owing to previous experience ( n = 2)
Discontinued intervention:
Unable to complete post-training
test within 2 weeks owing to
technical diculties with
endoscopy tower ( n = 1)
Lost to follow-up:
Unable to complete post-training
test within 2 weeks owing to
busy work schedule ( n = 1)
Included in
analysis ( n = 5)
Included in
analysis ( n = 5)
Figure 1 Flowchart of study showing participant enrollment, randomization, allocation onterventions and follow-up.
Table 2 Performance of experts in fetoscopic laser surgery and novices who received simulator training or no training, assessed before and
after training
Novices
Assessment Experts ( n = 11) Simulator training ( n = 5) No training ( n = 5) P*
Surgical performance score†
Pre-training test 48 (44–51) (92) 28 (27–41) (54) 25 (20–44) (48) 0 .55
0)96()14–03(63)88()15–34(64tsetgniniart-tsoP .008












Data are given as median (range), median (range) (%) or n/N (%). *Performance of novices with vs those without simulator training.
†Maximum surgical performance score = 52.
control group after the training s ssion, with median
SP scores of 46/52 (88%) (range, 43–51) vs 36/52
(69%) (range, 30–41) ( P = 0.008). Median procedure
time decreased by 11 min in the study group compared
to only 1 min in the control group, to 33 (range, 29–44)
min and 38 (range, 27–49) min, espectively. Median
fetoscopy time improved to 14 min in both groups; study
group range, 10–20 min, control group range, 11–24 min
(P = 0.69). In the post-training test, one participant (20%)
in the study group missed 1/8 anastomoses located on the
placental margin compared with no participants in the
control group ( P = 1.00). Figure 2 shows SP scores and
procedure and fetoscopy durations for both groups in
the pre- and post-training tests, plotted against the expert
benchmark level.
Figure 3 shows that both experts and novices felt
that the simulator was useful for training to identify
the vascular equator and to practice the complete
laser procedure (score of at least 8 on a Likert
scale 1–10). All experts stated that training with the
simulator provided good preparation before starting to
operate on real patients. Except for the sonographic
Copyright  2015 ISUOG. Published by John Wiley & Sons Ltd. Ultrasound Obstet Gynecol 2015; 46: 319–326.
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Demographics Experts Novices Novices p value
    (no training) (training) * 
  n/11 (%) n/5 (%) n/5 (%)  
Gender      
Male 8 (73) 2 (40) 0 0.44
Female 3 (27) 3 (60) 5 (100)  
Age      
(median in years, range) 52 (35-59) 30 (30-34) 34 (30-37) 0.15
Experience with invasive obstetric procedures      
Has experience with invasive obstetric  procedures 11 (100) 0/5 (0) 2 (40) 0.44
Years of experience (median, range) 15 (7-23) 0 2 (1-2)  
Type of invasive obstetric procedures      
Amniocentesis 11 (100) 0 2 (40)  
Chorionic villus sampling 11 (100) 0 2 (40)  
Intrauterine transfusion 8 (73) 0 0  
Fetal shunt placement 8 (73) 0 0  
Bipolar cord occlusion 11 (100) 0 0  
Open fetal surgery 4 (36) 0 0  
Other 4 (36) 0 1 (20)  
No. of FLS attended (incl. assisting or watching procedure)      
None 0 2 (40) 0 0.28
< 10 procedures 0 2 (40) † 4 (80) †  
10-25 procedures 0 1 (20) † 0  
25-50 procedures 1 (9) 0 0  
50-100 procedures 1 (9) 0 1 (20) †  
>100 procedures 9 (82) 0 0  
Experience with simulator training      
Never 2 (18) 1 (20) 0 1.00
A few times 4 (36) 2 (40) 3 (60)  
Regularly 5 (46) 2 (40) 2 (40)  
Table 1. Demographic characteristics of study participants with expert level of experience and those with no 
practical experience with fetoscopic laser surgery (FLS) who did or did not receive simulator training. Data are 
given as n (%) or median (range). *Characteristics of novices with vs those without training. †Watched procedure 
only.
Novices and experts were evaluated by two independent observers (S.P. and J.A.), using the 
evaluation instrument created by the Delphi consensus5. The list of essential steps was 
modified into a surgical performance (SP) score, adjusted to the simulated scenario. This 
52-item list consisted of ‘achieved’ and ‘failed’ items in 11 domains pertaining specifically to 
the fetoscopic laser procedure for TTTS (Table S1). Each item was awarded 1 point if it was 
completed properly, providing a range of final SP scores of 0–52. Duration of the procedure, 
defined as the moment the surgeon entered the operating room until the moment that 
direct postoperative management was ordered, and duration of fetoscopy, defined as 
the moment the trocar was introduced until final removal, were recorded. A map of the 
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placental architecture was used by the observers to mark the coagulated anastomoses (a 
total of eight). Since there was no international consensus on the Solomon technique at 
the time of development of the checklist3, participants were instructed to coagulate all 
vascular anastomoses that connected the circulations of the donor and the recipient twin 
one by one – the ‘selective laser technique’.
The structured fetoscopic laser surgery skills training and evaluation consisted of five 
phases:
Phase 1: Introduction (experts, novices (study group), novices (control 
group))
Each participant was familiarized with the simulator by a member of the study team (S.P. 
or J.A.). All participants were shown a standardized multimedia presentation outlining the 
background and aim of the study to explain the task, including the assessed performance 
metrics. Finally, the context of the scenario was presented. No assistance was provided 
during completion of the assignment unless the participant was unable to proceed with 
the procedure. In that case (for example, ‘switch on the laser’) the item was noted but 
scored as ‘failed’.
Phase 2: Pre-training test (experts, novices (study group), novices (control 
group))
All subjects in the study participated in a pre-training test to assess baseline competency 
and technical skills in fetoscopic surgery. The participants performed an assignment on the 
simulator, including the complete fetoscopic laser procedure for a patient of 17 weeks’ 
gestation with Stage III TTTS, assessed from the moment the operating room was entered 
until the surgery was finished and direct postoperative management was ordered.
Phase 3: Training (novices (study group))
After the pre-training test, novices who were randomized to the training curriculum 
received a 1-day training session from a fetal therapy expert who was not involved in the 
evaluation process. The curriculum comprised two components: a theoretical part and a 
practical session. The procedure-specific instruments provided a framework for curriculum 
development. An instructor script and multimedia presentation, including step-by-step 
actions and decisions required to perform the fetoscopic laser surgery, were developed by 
D.O., R.D. and S.P. The theoretical part of the training consisted of a multimedia presentation 
outlining the indication for surgery, relevant anatomy, control of the instruments including 
the fetoscope and a video demonstration of the simulated steps. The purpose of this session 
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was to allow novices to understand the ‘flow’ of the procedure and to conceptualize how 
to plan and execute the fetoscopic laser surgery. The training continued with a practical 
session using the simulator in three subsequent practice rounds. In round 1, an attending 
fetal therapy expert demonstrated how to perform the procedure step-by-step; in round 
2, the trainee performed the procedure under the supervision of the expert, who provided 
direct verbal feedback. In the last round, the complete procedure was performed by the 
trainee and evaluated directly afterwards with the expert. The novices that were allocated 
to the control group did not receive feedback with regard to their performance and were 
not involved in the training sessions.
Phase 4: Post-training test (novices (study group), novices (control group))
Within 2 weeks after the training of the study group, all novices (study group and control 
group) performed a post-training test, evaluated by the same independent observers (J.A. 
and S.P.). The post-training test included a different assignment with regard to the location 
of the placenta and the fetuses, but was performed on the same simulator.
Phase 5: User experience evaluation (experts, novices (study group), novices (control group))
Participants completed a survey to collect qualitative data regarding their perceptions of 
the value of the simulation and training. Face validity was assessed by the experts in the 
context of participants’ opinions about realism (nine items). Educational value as well as 
usefulness (five items), and overall opinion about the simulator (three items) were assessed 
by experts and novices. All items were scored on an ordinal 10-point Likert scale, where 1= 
not at all realistic/useful and 10 = very realistic/useful.
Statistical analysis
Demographics, SP score, procedure time, fetoscopy time and presence of residual 
anastomoses, of both pre-training and post-training tests, were compared between the 
groups. For the SP score, a higher score signifies better performance, therefore improvement 
was reflected by a positive difference in pre- and post-test performance. For duration of 
the procedure and fetoscopy, improvement was calculated from pre-training test value 
minus post-training test value.
Owing to the small sample size and non-normal distribution of the data, the Mann–
Whitney U-test was used to test for differences between groups for continuous variables. 
To test for differences between groups on non-ordinal categorical outcomes, Fisher’s exact 
test was used. For ordinal outcomes, such as a Likert agreement scale, the χ2 test was 
used. Spearman’s correlation coefficient (r) was used to measure interobserver reliability. A 
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correlation of r ≥ 0.9 was considered to be indicative of an excellent agreement, and P ≤ 
0.05 was considered to be statistically significant. Statistical analysis was performed with 
IBM SPSS version 21.0 (IBM SPSS Statistics for Windows, Version 21.0, IBM Corp., Armonk, 
NY, USA).
RESULTS
Participant enrollment, randomization and follow-up are illustrated in Figure1. Within the 
three participating centers, 12 volunteers were included in the trial and subsequently 
randomized to the two groups. One participant was lost to follow-up and another was 
unable to complete the test owing to technical difficulties, therefore the results of 10 
participants (study group, n = 5 and control group, n = 5) were included in the analysis.
The randomized study group with training and the control group without training were well 
balanced for baseline characteristics (Table 1). Analysis revealed no differences between 
the groups regarding prior knowledge of the procedure or experience with other obstetric 
invasive procedures or simulators. In the expert group, 9/11 (82%) participants had attended 
more than 100 laser procedures and 5/11 (45%) had performed more than 100 procedures 
themselves. A median of 10 (range, 8–20) procedures per expert were performed annually.
The expert benchmark level was set with a median SP score of 48/52 (92%) (range, 44–51), 
a procedure duration of 33 (range, 26 – 46) min and fetoscopy duration of 12 (range, 10 – 
18) min. One (9%) expert missed a small arteriovenous anastomosis at the margin of the 
placenta. Results of the performance of all participants are shown in Table 2.
For the pre-training test, the median SP score for the study group was 28/52 (54%) (range, 
27 – 41) vs 25/52 (48%) (range, 20 – 44) in the control group (P = 0.55). Median procedure 
time in the study group was 44 (range, 40 – 50) min vs 39 (range, 33 – 45) min in the control 
group (P=0.06). The duration of fetoscopy was 22 (range, 18–25) min in the study group 
vs 18 (range, 16 – 20) min in the control group (P = 0.06). In the study group, 4/5 (80%) 
novices did not coagulate all anastomoses compared with 2/5 (40%) in the control group 
(P = 0.52). In the study group, three participants missed 2/8 anastomoses and one missed 
1/8 anastomoses, all located on the placental margin. In the control group, one participant 
missed 3/8 anastomoses in the center of the placenta and one missed 2/8 anastomoses 
on the placental margin.
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Expert (benchmark) Novices (study group) Novices (control group) p value
  n=11 range n=5 range n=5 range    *
SP score †              
pre-training test 48 (92%) (44-51) 28 (52%) (27-41) 25 (48%) 20-44 0.55
post-training test   46 (88%) (43-51) 36 (69%) 30-41 0.008
difference   +18 + 11  
Procedure time (minutes)              
pre-training test 33 (26-46) 44 40-50 39 33-45 0.06
post-training test   33 29-44 38 27-49 0.69
difference   - 11 - 1  
Fetoscopy time (minutes)              
pre-training test 12 (10-18) 22 18-25 18 16-20 0.06
post-training test   14 (10-20) 14 (11-24) 0.69
difference   - 8 - 4  
Missed anastomoses              
pre-training test 1/11 (9%) 4/5 (80%) 2/5 (40%) 0.52
post-training test   1/5 (20%) 0 (0%) 1.00
Table 2. Performance of experts in fetoscopic laser surgery and novices who received simulator training or no 
training, assessed before and after training. SP score: surgical performance score. Data are given as median 
(range), median (range) (%) or n/N (%). *Performance of novices with vs those without simulator training. 
†Maximum surgical performance score = 52.
For the post-training test, novices in both groups showed an improvement in SP score and 
performed the procedure in less time than they did in the pre-training tests. The study 
group significantly outperformed the control group after the training session, with median 
SP scores of 46/52 (88%) (range, 43 – 51) vs 36/52 (69%) (range, 30 – 41) (P = 0.008). Median 
procedure time decreased by 11min in the study group compared to only 1 min in the 
control group, to 33 (range, 29 – 44) min and 38 (range, 27 – 49) min, respectively. Median 
fetoscopy time improved to 14 min in both groups; study group range, 10 – 20 min, control 
group range, 11 – 24 min (P = 0.69). In the post-training test, one participant (20%) in the 
study group missed 1/8 anastomoses located on the placental margin compared with no 
participants in the control group (P = 1.00). Figure 2 shows SP scores and procedure and 
fetoscopy durations for both groups in the pre- and post-training tests, plotted against the 
expert benchmark level.
Figure 3 shows that both experts and novices felt that the simulator was useful for training 
to identify the vascular equator and to practice the complete laser procedure (score of at 
least 8 on a Likert scale 1 – 10). All experts stated that training with the simulator provided 
good preparation before starting to operate on real patients. Except for the sonographic 
properties, the simulator was judged highly realistic on all aspects.
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The overall interobserver reliability of the two raters’ total scores (J.A. and S.P.) for the 
fetoscopic laser procedure was excellent (r = 0.984, P < 0.001).
Figure 2 Pre-training and post-training 
performance, assessed by 52-item checklist 
score (a), procedure duration (b) and fetoscopy 
duration (c), of participants who received 
simulator training in fetoscopic laser surgery (---
-- ) and those who did not (- - -), plotted against ( 
expert benchmark level ( • • • • ).
DISCUSSION
This study shows that training in a life-like environment significantly improves the 
performance of fetoscopic laser surgery in a standardized simulator model. The effect 
of the training was evaluated using an SP score designed specifically to evaluate the 
performance of therapists carrying out this procedure. In this study we found no difference 
in the duration of the procedure or the presence of missed anastomoses between the 
groups. We defined expert benchmark levels for the curriculum to make it proficiency 
based. Feedback provided by the participants indicated that simulator training was perceived 
as a useful educational activity.



























































Figure 2 Pre-training and post-training performance, assessed by 52-item checklist score (a), procedure duration (b) and fetoscopy
duration (c), of participants who received simulator training in fetoscopic laser surgery ( ) and those who did not ( ), plotted against
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Figure 3 Responses to questionnaire regarding face validity (a) and educational value and user friendliness (b) of simulator according to
experts ( , n = 11) and novices ( , n = 10) in fetoscopic laser surgery.
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Figure 2 Pre-training and post-training performance, assessed by 52-item checklist score (a), procedure duration (b) and fetoscopy
duration (c), of participants who received simulator training in fetoscopic laser surgery ( ) and those who did not ( ), plotted against
expert benchmark level ( ).
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Fetoscopic laser surgery is a rarely performed, invasive procedure associated with a 
relatively high rate of fetal loss. Outcomes have been shown to be dependent on the 
operator and their experience4,8. Since the number of procedures undertaken per center 
is limited, organizing appropriate training and providing sufficient exposure are difficult2. To 
date, a standardized training curriculum is lacking. The main advantage of our simulator 
is that it enables the training of fetal surgeons and trainees, to gain experience in laser 
surgery without jeopardizing patient safety. In addition, it is readily available and allows 
training in the entire procedure, including instrumentation set-up, which may be beneficial 
for a smooth workflow.
Figure 4 Responses to questionnaire regarding face validity (a) and educational value and user friendliness (b) of 
simulator according to experts ( , n = 11) and novices ( , n = 10) in fetoscopic laser surgery.
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In other surgical fields, simulation based ex-vivo training has already been integrated 
successfully into different levels of education14–16. Several attempts have been made 
in recent years to develop simulators for invasive obstetric procedures11,12,17,18 . Most of 
these simulators are designed primarily to assess performance during critical stages of 
a procedure, rather than a complete operation. In this study we used a highly realistic 
simulator with the aim that the operators would treat the model like a real patient. There 
is evidence that physical resemblance can be reduced with minimal loss of educational 
effectiveness, provided that there is appropriate correspondence between the functional 
aspects of the simulator and the real-life situation19. However, the choice of physical 
resemblance for maximal training effectiveness depends on a number of factors, including 
the context within which the simulator is used, the sort of task that is being taught, the 
level of learning involved, the abilities and capabilities of the trainee, the difficulty of the 
task and the effect of various instructional features20.
Most reported simulators are used for teaching in the absence of well-planned and 
comprehensive curricula. A structured curriculum is designed with a logical sequence of 
learning objectives and associated activities21. The combination of our SP score and simulator 
appears to be useful for training novice fetal surgeons. In addition, the set-up can be used 
to assess the performance of practicing surgeons. Furthermore, it is ideal for testing new 
equipment or new techniques by experienced surgeons in a safe environment22. Another 
objective of this study was to set a performance standard for the laser-surgery assignment 
by using the parameters of the experts’ performance. We expected no differences in 
these parameters, since they had already achieved proficiency as demonstrated by other 
simulation studies23, therefore the experts performed the task once only. This performance 
standard can be used for training purposes and also for assessment or even certification in 
order to enhance patient safety. Performance was fairly consistent, as expressed by the 
small ranges in SP scores and procedure times.
The process of skill acquisition may reveal individual differences between trainees 
depending on cognitive capacity, perceptual speed and psychomotor abilities24. Setting a 
certain number of procedures performed on a simulator or actual patients to determine 
fetoscopic proficiency may cause bias. Furthermore, initial improvement in performance 
cannot be retained without regular repetition25. Therefore simulators provide a useful tool 
for the attainment and maintenance of trainees’ surgical skills and for immediate or late 
assessment of their proficiency in those skills. However, a validation study of the simulator 
is important for determining its capacities for training and objective assessment of the 
surgeons’ performance with different levels of experience.
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The current enthusiasm for validation of training and assessment tools and strategies is 
relatively new in the fetal-therapy community. Before implementing the use of a simulator 
in a training program, it should be ascertained whether it is actually teaching what it is 
supposed to be also known as its construct validity. In the design of a curriculum to 
teach surgical skills, specification of the training objectives, including identification of the 
procedural steps and analysis of pitfalls, is essential.
Some limitations of this study should be noted. The small sample size limits the strength 
of our conclusions. While groups were not significantly different in gender demographics 
and previous technical skills training, the small number of participants makes it difficult 
to classify the groups as fully equivalent. In our study, participants were not matched 
according to demographics and technical capabilities. We emphasize that not only ‘number of 
procedures attended’, ‘experience with other invasive obstetric procedures’ and ‘simulation 
training’, but also sonographic experience, minimally invasive skills and intrinsic qualities 
(such as spatial awareness) are of major importance when selecting a cohort for training in 
fetoscopic laser surgery. The general population of residents in obstetrics and gynecology 
is not representative of the small group of future fetoscopic surgeons-in-training.
Before training, we noticed shorter durations of the overall procedure and the fetoscopy 
itself in the control group. We emphasize that this illustrates that differences in baseline 
characteristics are probably related to many other factors than represented in our 
questionnaire. Therefore our results should be interpreted with caution. Even though a 
greater number of participants in the study may have provided further evidence of 
significant differences in outcomes and increased the power of the study, this would not 
reflect the clinical situation.
Such simulator training can be an effective tool for the improvement of technical skills 
in a safe learning environment before performing fetoscopic laser surgery in the operating 
room. Future studies are needed to establish reliability and implementation of such training 
in a wider setting. Research should be focused on validation of the curriculum to make sure 
that trainees who go through this curricular training process actually perform better in the 
operating room with greater technical proficiency. Above all, monitoring of quality of care 
is of utmost importance.
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No. Domain and substeps Score
A Preparation in operating room 7
1 Ultrasound correct settings  
2 Endoscopy tower settings  
3 Positioning of screens  
4 Adjusting lights  
5 Correct laser modus  
6 Correct power settings  
7 Positioning of patient  
B Ultrasound examination (together with sonographer) 7
8 Identification of donor  
9 Identification of recipient  
10 Identification localization placenta  
11 Identification cord insertions  
12 Assess deepest pockets  
13 Determine expected position equator  
14 Determine insertion site fetoscope  
C Pre-operative preparations 7
15 Surgical briefing (time out) about (complete) procedure to fetal therapy team  
16 Aseptic procedure for surgeon, scrub nurse and sonographer  
17 Mention maternal condition  
18 All instrumentation remains sterile  
19 All is sufficiently covered  
20 Pre-insertion connection scope - shaft  
21 Pre-insertion connection light cable  
D Positioning and connection of instruments (pre-insertion) 6
22 Choose fetoscope  
23 Fetoscope: orientation  
24 Fetoscope: focus  
25 Fetoscope: white balance  
26 Connection of laser fiber  
27 Correct loading of laser fiber in fetoscope  
E Insertion 5
28 Preparation of introduction method  
29 Performance of all manipulations under ultrasound visualization  
30 Correct administration of local anesthetic  
31 Make adequate-size skin incision with surgical knife  
32 Awareness of location of maternal uterine vessels and intestines, and placental edge during insertion
F Orientation 8
33 Assess visibility (optional: score visibility)  
34 Determine need for amniotic exchange  
35 Fetoscopic view of placenta  
36 Fetoscopic view of donor  
37 Fetoscopic view of cord insertion recipient  
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No. Domain and substeps Score
38 Identification of placental edges  
39 Difference between artery and vene  
40 Find (part of ) vascular equator  
G Laser coagulation 4
41 Coagulation of all vascular anastomoses that cross the vascular equator  
42 Laser fiber correct position in fetoscope  
43 Laser fiber correct distance from vessel during coagulation  
44 Prevent the unnecessary sacrifice of placental tissue  
H Assessment during procedure 3
45 Prevent unnecessary delay during procedure  
46 Check for complications(e.g. bleeding, rupture intertwin membranes)  
47 Identify and record number and type of anastomoses coagulated  
I Amniodrainage 2
48 Controlled drainage of polyhydramnios  
49 Assess adequate drainage (ultrasound guided) until pre-defined level  
J Closure 1
50 Closing skin incision (suture or suture free adhesive product)  
K Direct post-operative management 2
51 Inform patient, partner/family and referring specialist  
52 Instructions for monitoring of maternal and fetal condition  
Appendix 1. Surgical performance score
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This thesis consists of a series of studies on technical and procedural aspects of laser 
surgery for the treatment of twin-twin transfusion syndrome (TTTS), a causal treatment 
modality first described by De Lia et al. in 1990.[1] TTTS is caused by unbalanced blood 
flow across placental vascular communications between both twins called anastomoses.
[2] The aim of the treatment is to close of all anastomoses in order to separate both fetal 
circulations. In part one, we give a general introduction to the subject and its challenges. 
Part two consists of studies evaluating current practice with the aim to identify potential 
areas of improvement. Part three deals with several techniques, the impact of laser 
energy and placental damage and, it introduces a model to investigate different technical 
parameters of the laser procedure. Finally, in part four, we discuss the development of a 
standardized training model for fetoscopic laser surgery.
Current practice
In chapter 1 we describe a systematic review of the literature on outcome after laser 
surgery since inception of this technique. Our study showed that treatment of TTTS 
yielded a fair improvement in perinatal survival with the introduction of laser surgery. The 
review shows a significant increase in perinatal survival since then. Combining all published 
series, as a benchmark, perinatal survival of at least one twin after laser therapy can be 
achieved in 81–88% of pregnancies and survival of both twins in 52–54% of pregnancies. 
The median gestational age (GA) at delivery in these series was 32.4 weeks. We note that, 
evaluation of technical or other adaptations of surgical techniques using historic controls 
is hampered by bias caused by increasing experience over time, the learning curve effect 
and improved neonatal care. 
A survey amongst fetal therapy centers worldwide is discussed in chapter 2. In this chapter, 
we demonstrate considerable variations in patient characteristics, instrumentation and 
techniques, which appear to be, at least partially, related to the volume of patients treated, 
and geographical circumstances of the centers. Throughout the world, different criteria for 
laser therapy are used among established fetal medicine centers. In particular, there are 
differences in GA limits and cervical length at which laser therapy is offered. Differences 
in patient selection, referral and treatment options may significantly affect perinatal 
outcome data. Furthermore, 63% of fetal therapists and 48% of centers perform less 
than 20 procedures per annum. The ideal number of procedures that should be performed 
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to maintain high-quality results is difficult to determine[3], studies have investigated the 
relationship between hospital volume data and postoperative outcomes.High-volume 
institutions tend to have better outcomes for high-risk procedures.[4, 5]
Laser techniques
Over the years different (adaptations of) laser techniques have been proposed. The selective 
laser technique is currently the standard approach. Recent adaptations of this technique 
include the selective sequential technique and the Solomon technique. Unfortunately, 
only the Solomon technique has been evaluated in a randomized controlled trial.[6] 
The sequential selective laser technique[7], where anastomoses are closed in a specific 
sequence to allow for inter-procedural transfusion of blood volume from recipient to the 
donor twin has only been evaluated in relatively small non-randomized series. In chapter 
3 we performed a meta-analysis in order to assess the potential benefit of this technique 
over the standard selective laser technique. Limited evidence suggests improved double 
neonatal survival as well as decreased donor and recipient fetal demise with the use of the 
sequential technique. However, these results are based on small non-randomized studies 
with evident forms of bias and methodological limitations.
The damaged placenta
Through post-delivery color dye injection of the placentas that have been treated with 
fetoscopic laser surgery we found different degrees of placental laceration at the laser 
site. Hence, we set out to evaluate the impact of this placental damage on pregnancy 
outcome and identify possible causal factors of this damage. In chapter 4 we developed 
a scoring system for placental damage and found a higher amount of laser energy used 
during a procedure this to be positively associated with more extensive damage. On the 
other hand, higher laser output power (Wattage) setting was negatively associated with 
placental damage. Thus, more energy lead to more damage and a higher power setting lead 
to less damage. We hypothesize that, with a higher power setting, energy transfer is more 
effective and takes shorter time and less energy than with a lower wattage. In addition, 
the energy is less dispersed than in a low power setting and thus leads to less collateral 
damage. Furthermore, more placental damage was associated with a lower GA at birth, 
shorter laser-to-delivery interval and higher PPROM rate. 
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Placenta laser model
When a new technique or instrument is invented, one should first test this in a lab setting 
or animal model. In TTTS this is challenging since a good animal model is lacking, the only 
animal known to have TTTS is the nine-banded armadillo[8]. In chapter 5 we describe an 
ex-vivo perfused human placenta model for evaluation of laser surgery for TTTS. This 
model allows for standardized evaluation of different laser parameters and techniques. 
In the study, the model was used to evaluate coagulation efficiency with different laser 
power settings and firing angles. We demonstrated that, in a highly controlled, though 
realistic, environment, a 50 Watt laser power setting was more efficient in coagulating 
a placental vein in respect to time and total energy needed compared to a 30 Watt 
laser power setting. In addition, we showed that the firing angle of the laser had a great 
impact on coagulation efficiency. The more perpendicular the approach the more efficient 
coagulation is achieved. Bleeding due to vessel wall disruption, although rare, occurred 
slightly more often with lower power settings and with a more tangential laser angle. 
We hypothesize that a low power setting used for a longer period of time causes more 
endothelium damage[9] and without swift occlusion of the vessel by coagulated blood, 
this might increase the risk of vessel wall disruption and bleeding.
Laser training model
Laser surgery for TTTS is a technical skill that takes extensive training to achieve and 
maintain. In the final part of this thesis we developed and validated a training and 
evaluation tool for fetoscopic laser surgery that can aid to maintain a high standard of 
clinical performance.
In chapter 6 we present an international expert consensus on the technical approach and 
identification of the essential steps of fetoscopic laser surgery for TTTS. By means of a 
Delphi consensus method including a broad list of internationally renowned specialists in 
fetal therapy, we produced a list of 55 essential sub-steps. This study provided a first step 
towards an authority-based procedure-specific evaluation tool for fetoscopic laser surgery 
for the treatment of TTTS. In order to determine the reliability and construct validity 
of the evaluation tool developed in chapter 6, we assessed the inter-observer reliability 
and construct validity of this tool in chapter 7. We developed a realistic simulator setting 
for fetoscopic laser surgery and used the tool to score expert and novice fetal surgeons 
performing the complete procedure. The study showed that the instrument effectively 
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distinguished the performance of experts and novices with an acceptable level of inter-
observer reliability. Finally, in chapter 8 we evaluated whether fetal therapists in training 
could benefit from simulator based training based on the evaluation tool as developed 
in chapter 6. We performed a pilot randomized trial assigning novices to either simulator 
training or no training. The study showed that training in a life-like environment significantly 
improves the performance of fetoscopic laser surgery in a standardized simulator model. 
No differences in duration of the procedure or presence of missed anastomoses between 
the groups were seen. An expert benchmark levels for the curriculum was defined to make 
it proficiency based. Feedback provided by the participants indicated that simulator training 
was perceived as a useful educational activity.
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GENERAL DISCUSSION
The introduction of fetoscopic laser surgery for twin-twin transfusion syndrome (TTTS) as 
a treatment option, 25 years ago, led to a major improvement in perinatal outcome. With 
this, a causal treatment became available. Not only did this treatment prolong pregnancy, 
it also improved perinatal outcome[10] and long term neurodevelopmental outcome[11] of 
the affected twin pairs.
In this thesis, we have focused on different aspects of the treatment process. We evaluated 
inter center differences in program setup and treatment strategies, and the improvement 
of outcome over the past decades in respect to different techniques. Furthermore, we 
investigated some technical aspects of the procedure in a newly developed life-like model. 
Evaluation of current practice shows that there still is room for improvement. Although a 
big step ahead was made with fetoscopic laser surgery, since then no big improvement in 
perinatal outcome was achieved. In about 80-90% at least one twin survives and in about 
50-60% both twins survive. In order to further improve outcome of TTTS complicated 
pregnancies worldwide this thesis touches on several subjects that could aid fetal therapist 
in optimizing their treatment strategy.
Center volume and operator proficiency
Even though limited evidence concerning the ideal number of procedures that should be 
performed to maintain high-quality level of care exists[3], several studies have investigated 
the relationship between volume data and outcomes in other fields of surgery. Better 
outcomes have been reported in high-volume institutions for high-risk procedures[4, 5, 12]. 
This is in line with findings from learning-curve and monitoring studies. These show that a 
number of approximately 20 to 30 procedures per year is required to maintain a requisite skill 
level[3, 13]. To optimize surgical outcomes, concentration of care for this highly specialized 
procedure has been advocated.[14] Although, in case of TTTS geographical circumstances 
can justify the need for low-volume centers, since timely referral and treatment are 
associated with improved dual-twin survival and decreased neurodevelopmental delay.[15] 
Centralization of the treatment of monochorionic twin pregnancies in expert centers is 
preferable but largely depend on the regional referral system. Therefore, such expert 
centers not only have a responsibility in the care for the patient, but should also educate 
referring institutions in early detection and referral of TTTS complicated pregnancies.
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Evidence based evaluation of new techniques
In modern medicine an evidence based approach is crucial, new techniques and technology 
should be tested in proper (animal) studies that lead to a good level of evidence before 
adoption to clinical practice. As fetal therapy is a young, and rapidly developing subspecialty, 
new ideas are often tried out and evaluated in small series. For instance, as shown in 
chapter 2 and 3, the sequential laser technique has been adopted by a significant number 
of therapists while the evidence proving this technique to be beneficial is wafer-thin. 
Unfortunately, only few attempts have been made in performing randomized controlled 
trials, and to date, only one trial was completed.[6] 
The sequential laser technique, as described in chapter 3, is based on the following theory. 
By first coagulating anastomoses that flow towards the recipient and finally the ones that 
flow towards the donor some transfusion of blood from the recipient back to the donor 
occurs, which is thought to benefit the donor. While the actual volumetric blood flow over 
an arteriovenous anastomosis is difficult to assess, studies suggest this to be in the order 
of 5mL/24h.[16] The duration of a laser procedure from entering the womb until removing 
the scope ranges between 10-20 minutes on average, as shown in chapter 8. In 15 minutes, 
a transfusion of approximately 0.05mL will occur over one anastomosis. Based on this 
finding, one could suspect the effect of a sequential approach to be clinically insignificant. 
The only way to properly investigate such a technical adaptations is performing a proper 
randomized trial assigning participants to either selective or selective sequential  laser 
technique.
Primum non nocere: Laser damage and coagulation 
efficiency
As with many forms of surgery, also with laser surgery for TTTS some ‘harm’ is unavoidable 
or even desired. When using laser energy in a precarious situation as a pregnancy it is 
important to be aware of the risks and disadvantages. In chapter 4 we evaluated placental 
damage after laser therapy and showed that the extent of this damage is correlated with 
PPROM and gestational age at delivery. Branisteau et al. showed that by coagulating an 
anastomosis the functionality of the underlying cotyledon is compromised[17]. In contrast 
with these findings Emery et al show that the impact of the laser energy remains largely 
limited to the chorionic plate. We found the amount of damage to be related with the 
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amount of energy used.  This finding is in line with the trend seen by a recent study by Zhao 
et al., where total laser energy seemed to be associated with chorioamnionitis. This study 
showed that, after a laser procedure, more chorioamnionitis and funisitis is seen compared 
to non-lasered monochorionic (MC) twin pregnancies.[18]  A possible explanation for these 
findings could be that, due to necrosis of the lasered tissue, cytokine-release and other 
inflammatory responses occur that have an impact on PPROM and term of delivery. Most 
importantly the success of the laser treatment is defined by the completeness of the 
procedure; close all vessels off but do as little harm as possible.
A better understanding of the impact of what we do could help us improve outcome. The 
ex-vivo perfused human placenta model described in this thesis showed the difference in 
coagulation efficiency between two different power settings. We learnt that 80 Watts is 
more efficient than 50 Watts. Nevertheless, the optimal setting still has to be investigated 
and is likely highly dependent on the circumstances such as vessel type, diameter, flow and 
amniotic fluid characteristics.
Training before trying, evaluation after doing
Currently, in western countries, fetoscopy is readily available in contrast to a large part of 
the world where this treatment modality is still inaccessible. It is a matter of time when 
centers in these areas start performing laser therapy for TTTS. We anticipate a significant 
increase in fetal therapists, and with this in mind we developed a validated simulator-based 
training curriculum for fetoscopic laser surgery. Randomized trials in the field of general 
surgery literature have shown that simulation-based training leads to detectable benefits 
for trainees in clinical settings.[19, 20] 
Fetoscopy simulator courses are ideally organized by expert centers, nevertheless startup 
centers should invest in obtaining a simulator themselves in order to keep training and 
improve their skill. When starting a fetoscopy center it is of utmost importance to 
introduce a good quality control system and to evaluate short, and long-term outcome. 
Centers should not hesitate to publish their early series, even if the results are poor. Most 
of the published series are from high volume, high experience centers. It is important to 
note that these numbers are not a good benchmark for startup centers. A startup center 
benchmark is needed for quality control and evaluation of center learning curve. Therefore, 
it is important to follow up participants and persuade them to publish early results in order 
to create this benchmark.
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Conclusions
This thesis describes a, newly developed, ex-vivo human placenta model mimicking the 
intrauterine conditions of feto-placental circulation. The model allows for experiments 
to take place in a highly-controlled setting and can be used to study laser coagulation as 
presented in this thesis in chapter 5. It can be of great scientific value when it comes to 
testing new instruments and (laser) techniques. 
Chapter 4 of this thesis suggests that it is important to use as little energy (Joule) as 
possible during laser surgery for TTTS. Efficient coagulation, using less energy, decreases the 
extent of placental damage, reduces the incidence of PPROM and extends the pregnancy 
duration. In Chapter 5 we showed that the use of a higher power setting (Wattage) and a 
perpendicular approach leads to more efficient coagulation, and could be a good strategy.
Furthermore, we developed and validated a highly realistic training model that can aid 
current, and future fetal therapists to improve their skill level and keep it up to par. 
While fetoscopy is gaining popularity worldwide it is of utmost importance that the new 
generation of fetal therapists receive high level training.
Future perspectives
We believe that significant improvement opportunities prevail regarding perinatal outcome 
after laser surgery for TTTS and we see challenges in improving instrumentation and 
technology for the treatment of TTTS to increase survival of both twins and, almost 
equally important, in prolonging pregnancies beyond 34 weeks’ gestation. Survival and 
preventing short-term neonatal morbidity should not be the only goals. The ultimate goal 
should be ‘disease-free survival’ of both twins, and focus on reducing the rate of long-term 
neurodevelopmental impairment.
Our developed ex-vivo human placenta model can be used to further investigate different 
parameters of laser surgery and optimize the treatment strategy. Future experiments could 
include defining the ideal laser power setting in different situations. Also, experiments 
comparing different types of laser, different vessel diameters and types combined with 
histological studies[21] will increase our knowledge on the actual effect of laser energy 
efficiency and collateral tissue damage. The impact of the amount of energy and placental 
damage, as investigated in chapter 4, and its association with PPROM and preterm delivery 
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needs to be explored further. With a prospective study focused on energy use, histologic 
findings and pregnancy outcomes we hope to be able to shed more light on this subject.
Although, some development was seen in the field of fetoscopic instruments mainly 
focusing on decreasing scope diameter and improving image quality, we think the next 
step is developing smart instruments. Instruments that can measure vessel diameter and 
assess successful coagulation could potentially positively impact coagulation efficiency. 
Furthermore, instruments that can better reach difficult areas of the placenta or look and 
coagulate at an angle could also improve the outcome after laser surgery for TTTS. 
The anticipated increase of the availability of fetoscopic laser surgery worldwide will lead 
to an upsurge of small volume centers offering this form of treatment. In order to gain 
a proficient level of skill and expertise we think it is important that a regular training 
program is available and that quality assessment, either by cusum analysis[3] or by regular 
publication of series, is part of the procedure. Another tool that may aid these start-up 
centers in gaining expertise is telementoring. With a telementoring program a starting, or 
low-volume center can be supervised by an expert center, especially in complicated cases. 
Telementoring can be achieved at low cost wit standard AV equipment and a broadband 
internet connection.[22]
GD
SUMMARY & GENERAL DISCUSSION   187
REFERENCES
1. J.E. De Lia, D.P. Cruikshank, W.R. Keye, Jr., 
Fetoscopic neodymium:YAG laser occlusion of 
placental vessels in severe twin-twin transfusion 
syndrome, Obstet.Gynecol. 75(6) (1990) 1046-53.
2. L. Lewi, J. Deprest, K. Hecher, The vascular 
anastomoses in monochorionic twin pregnancies 
and their clinical consequences, Am.J.Obstet.
Gynecol. 208(1) (2013) 19-30.
3. S.H. Peeters, E.W. Van Zwet, D. Oepkes, E. Lopriore, 
F.J. Klumper, J.M. Middeldorp, Learning curve for 
fetoscopic laser surgery using cumulative sum 
analysis, Acta.Obstet.Gynecol.Scand.  (2014).
4. J.F. Finks, N.H. Osborne, J.D. Birkmeyer, Trends 
in hospital volume and operative mortality for 
high-risk surgery, The New England journal of 
medicine 364(22) (2011) 2128-37.
5. J.D. Birkmeyer, A.E. Siewers, E.V. Finlayson, 
T.A. Stukel, F.L. Lucas, I. Batista, H.G. Welch, 
D.E. Wennberg, Hospital volume and surgical 
mortality in the United States, N.Engl.J.Med. 
346(15) (2002) 1128-1137.
6. F. Slaghekke, E. Lopriore, L. Lewi, J.M. Middeldorp, 
E.W. van Zwet, A.-S. Weingertner, F.J. Klumper, P. 
DeKoninck, R. Devlieger, M.D. Kilby, M.A. Rustico, 
J. Deprest, R. Favre, D. Oepkes, Fetoscopic laser 
coagulation of the vascular equator versus 
selective coagulation for twin-to-twin transfusion 
syndrome: an open-label randomised controlled 
trial, The Lancet  (2014).
7. R.A. Quintero, K. Ishii, R.H. Chmait, P.W. Bornick, 
M.H. Allen, E.V. Kontopoulos, Sequential selective 
laser photocoagulation of communicating 
vessels in twin-twin transfusion syndrome, 
J.Matern.Fetal Neonatal Med. (2007) 763-768.
8. K. Benirschke, The monozygotic twinning 
process, the twin-twin transfusion syndrome and 
acardiac twins, Placenta 30(11) (2009) 923-8.
9. J. Nizard, J.P. Barbet, Y. Ville, Does the source 
of laser energy influence the coagulation of 
chorionic plate vessels? Comparison of Nd:YAG 
and diode laser on an ex vivo placental model, 
Fetal Diagnosis and Therapy 22(1) (2007) 33-37.
10. M.V. Senat, J. Deprest, M. Boulvain, A. Paupe, N. 
Winer, Y. Ville, Endoscopic laser surgery versus 
serial amnioreduction for severe twin-to-twin 
transfusion syndrome., The New England journal 
of medicine 351(2) (2004) 136-144.
11. J.M. van Klink, H.M. Koopman, D. Oepkes, 
F.J. Walther, E. Lopriore, Long-term 
neurodevelopmental outcome in monochorionic 
twins after fetal therapy, Early Hum Dev 87(9) 
(2011) 601-6.
12. S.R. Markar, A. Karthikesalingam, S. Thrumurthy, 
D.E. Low, Volume-outcome relationship in 
surgery for esophageal malignancy: systematic 
review and meta-analysis 2000-2011, Journal of 
gastrointestinal surgery : official journal of the 
Society for Surgery of the Alimentary Tract 16(5) 
(2012) 1055-63.
13. R. Papanna, D.J. Biau, L.K. Mann, A. Johnson, 
K.J. Moise, Jr., Use of the Learning Curve-
Cumulative Summation test for quantitative and 
individualized assessment of competency of a 
surgical procedure in obstetrics and gynecology: 
fetoscopic laser ablation as a model, Am.J.Obstet.
Gynecol. 204(3) (2011) 218-219.
14. R.K. Morris, T.J. Selman, M.D. Kilby, Influences of 
experience, case load and stage distribution on 
outcome of endoscopic laser surgery for TTTS - A 
review. Ahmed S et al. Prenatal Diagnosis 2010, 
Prenatal Diagnosis 30(8) (2010) 808-809.
15. M. Gandhi, R. Papanna, M. Teach, A. Johnson, 
K.J. Moise, Jr., Suspected twin-twin transfusion 
syndrome: how often is the diagnosis correct 
and referral timely?, Journal of ultrasound 
in medicine : official journal of the American 
Institute of Ultrasound in Medicine 31(6) (2012) 
941-5.
16. E. Lopriore, J.P. van den Wijngaard, J.M. 
Middeldorp, D. Oepkes, F.J. Walther, M.J. van 
Gemert, F.P. Vandenbussche, Assessment of 
feto-fetal transfusion flow through placental 
arterio-venous anastomoses in a unique case 
of twin-to-twin transfusion syndrome, Placenta 
28(2-3) (2007) 209-11.
17. I. Branisteanu-Dumitrascu, J. Deprest, V.A. Evrard, 
P.P. Van Ballaer, D. Van Schoubroeck, E. Gratacos, 
R. Pijnenborg, Time-related Cotyledonary EVects 
of Laser Coagulation of Superficial Chorionic 
Vessels in an Ovine Model, Prenatal Diagnosis 19 
(1999) 205-210.
18. D. Zhao, D. Cohen, J.M. Middeldorp, E.W. van 
Zwet, M.E. De Paepe, D. Oepkes, E. Lopriore, 
Histologic Chorioamnionitis and Funisitis 
After Laser Surgery for Twin-Twin Transfusion 
Syndrome, Obstet Gynecol  (2016).
19. F.M. Franzeck, R. Rosenthal, M.K. Muller, A. Nocito, 
F. Wittich, C. Maurus, D. Dindo, P.A. Clavien, D. 
Hahnloser, Prospective randomized controlled 
trial of simulator-based versus traditional 
in-surgery laparoscopic camera navigation 
training, Surgical endoscopy 26(1) (2012) 235-41.
188
20. V.N. Palter, T. Grantcharov, A. Harvey, H.M. 
Macrae, Ex vivo technical skills training transfers 
to the operating room and enhances cognitive 
learning: a randomized controlled trial, Annals of 
surgery 253(5) (2011) 886-9.
21. S.P. Emery, L. Nguyen, W.T. Parks, Histological 
Appearance of Placental Solomonization in the 
Treatment of Twin-Twin Transfusion Syndrome, 
AJP Rep 6(2) (2016) e165-9.
22. B. El-Sabawi, W. Magee, 3rd, The evolution of 
surgical telementoring: current applications and 





SUMMARY & GENERAL DISCUSSION   189
190
NL





DUTCH SUMMARY   193
Dit proefschrift bestaat uit een reeks van studies over technische en procedurele aspecten 
van de laserchirurgie voor de behandeling van tweeling transfusie syndroom (TTS), een 
causale behandel modaliteit, voor het eerst beschreven door De Lia et al. in 1990.[1] TTS 
wordt veroorzaakt door onevenwichtige bloedstroom over communicerende vaten tussen 
beide tweelingen (anastomosen) op het placentaoppervlak.[2] Het doel van de behandeling 
is het sluiten van alle anastomosen om zo beide foetale circulaties te scheiden. In het 
eerste deel geven we een algemene inleiding over het onderwerp en de uitdagingen. Het 
tweede deel bestaat uit studies waarin huidige praktijk wordt geëvalueerd met als doel 
mogelijke gebieden te identificeren waar verbeteringen kunnen worden aangebracht. Deel 
drie belicht verscheidene technieken, het effect van laser energie en placenta beschadiging, 
en introduceert een model om verschillende technische parameters van de laserbehandeling 
te onderzoeken. Ten slotte, in het vierde deel, bespreken we de ontwikkeling van een 
gestandaardiseerd trainingsmodel voor foetoscopische laserchirurgie.
De huidige praktijk
In hoofdstuk 1 beschrijven we een systematisch overzicht van de literatuur over uitkomst na 
laserchirurgie sinds de introductie van deze techniek. De studie toonde aan dat behandeling 
van TTS een behoorlijke verbetering in perinatale overleving doormaakte met de introductie 
van laserchirurgie. De evaluatie toont een significante toename in de perinatale overleving 
sindsdien. Combineren van alle gepubliceerde series, als benchmark, toont een perinatale 
overleving van ‘ten minste één’ tweeling na laserbehandeling van in 81- 88% van de 
zwangerschappen en overleving van beide tweelingen in 52-54% van de zwangerschappen. 
De mediane zwangerschapsduur bij geboorte in deze serie was 32,4 weken. Evaluatie van 
technische of andere aanpassingen van chirurgische technieken met behulp van historische 
controles wordt beperkt door invloed van verschillende factoren zoals een toename van 
de ervaring na verloop van tijd, het leercurve-effect en verbeterde neonatale zorg.
Een enquête onder de foetale therapie centra wereldwijd wordt besproken in hoofdstuk 2. 
In dit hoofdstuk tonen we aanzienlijke verschillen in patiëntkarakteristieken, instrumenten 
en technieken tussen de centra aan.  Ten minste gedeeltelijk, kunnen die verschillen worden 
toegeschreven aan het aantal patiënten en de geografische omstandigheden van de centra. 
Over de hele wereld worden verschillende criteria voor de lasertherapie gebruikt onder 
gevestigde foetale geneeskunde centra. Met name zijn er verschillen in beperkingen van 
zwangerschapsduur en cervixlengte waarbij lasertherapie wordt aangeboden. Verschillen 
in selectie van patiënten, verwijzing en behandelopties kunnen significante invloed hebben 
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op de perinatale uitkomst. Bovendien, voert ongeveer 63% van foetale therapeuten en 
48% van de centra minder dan 20 operaties per jaar uit. Ook al is er beperkt bewijs met 
betrekking tot het ideale aantal operaties dat moeten worden uitgevoerd om een goed 
vaardigheidsniveau en hoge kwaliteit zorg te behouden [3], toch hebben vele studies de 
relatie tussen ziekenhuis volume en postoperatieve chirurgische resultaten onderzocht in 
andere gebieden van geneeskunde. Betere resultaten zijn gerapporteerd in hoog-volume 
instellingen voor hoog-risico procedures. [4, 5]
Lasertechnieken
Door de jaren zijn verschillende (aanpassingen van) lasertechnieken voorgesteld. Helaas 
is alleen de Solomon-techniek geëvalueerd in een gerandomiseerde gecontroleerde trial. 
[6] Een andere recente techniek is de sequentiële selectieve lasertechniek [7], waarbij 
anastomosen in een bepaalde volgorde worden gesloten waardoor er inter-procedurele 
transfusie van bloedvolume van de ontvanger naar de donor tweeling kan plaatsvinden. In 
hoofdstuk 3 voerden we een meta-analyse uit om de mogelijke voordelen van deze techniek 
evalueren ten opzichte van de standaard selectieve lasertechniek. Enige aanwijzingen voor 
verbeterde neonatale overleving van beide kinderen en verminderde donor en ontvanger 
intra uteriene sterfte werd gezien bij de sequentiële techniek. Echter, deze resultaten 
berusten op kleine, niet-gerandomiseerde studies met duidelijke vormen van bias en 
methodologische beperkingen.
De beschadigde placenta
Bij injectie studies van placenta’s behandeld met laserchirurgie zagen wij verschillende 
gradaties van placenta schade ter plaatse van de laserbehandeling. Vandaar dat we de 
invloed van deze placenta schade op de zwangerschap uitkomst hebben onderzocht en 
geëvalueerd wat de mogelijke oorzakelijke factoren van deze schade zijn. In hoofdstuk 
4 ontwikkelden we een gradatie systeem voor placenta schade en toonden we aan dat 
placentaire schade een positieve associatie heeft met de hoeveelheid laserenergie die 
tijdens een procedure wordt gebruikt. Anderzijds, werd deze schade negatief geassocieerd 
met de laser vermogen instelling. Dus meer energie leidt tot meer schade en een hoger 
laser vermogen leidt tot minder schade. Onze hypothese is, dat met een hoger vermogen 
de energie-overdracht efficiënter is en dat het minder tijd en energie kost om een vat te 
coaguleren dan met een lager vermogen. Bovendien, leidt de grotere hoeveelheid benodigde 
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energie bij een laagvermogen mogelijk tot het optreden van meer collaterale schade. 
Verder werd uitgebreidere placenta schade geassocieerd met een lager zwangerschapsduur 
bij de geboorte, kortere laser-geboorte interval en hogere incidentie van PPROM onder 32 
weken. Een recente studie door Zhao et al. toonde aan dat, na een laserbehandeling, meer 
chorioamnionitis en funisitis wordt gezien in vergelijking met niet-gelaserde monochoriale 
(MC) tweelingzwangerschappen. [8] Een mogelijke verklaring hiervoor is de iatrogene placenta 
weefselnecrose veroorzaakt door lasercoagulatie dat een maternale ontstekingsreactie 
kan induceren.
Placenta laser model
Wanneer een nieuwe techniek of instrument wordt ontwikkeld, moet men dit eerst 
testen in een laboratoriumomgeving of een diermodel. In TTS blijkt dit een uitdaging, een 
goed diermodel is niet voorhanden. Het enige dier waarvan bekend is dat TTS voorkomt 
is het negenbandgordeldier[9]. In hoofdstuk 5 beschrijven we een ex-vivo geperfundeerd 
menselijke placenta model voor de evaluatie van laserchirurgie voor TTS. Dit model maakt 
gestandaardiseerde evaluatie van verschillende laser parameters en technieken mogelijk. In 
de studie werd het model gebruikt om coagulatie efficiëntie van verschillende laservermogen 
instellingen en aanvuur hoeken te evalueren. We hebben aangetoond dat, in een zeer 
gecontroleerde maar realistische opstelling, een 50 Watt laservermogen efficiënter een 
placentaire vene coaguleert met betrekking tot duur en totale energie vergeleken met een 
30 Watt laservermogen. Bovendien toonden we aan dat de aanvuurhoek van de laser een 
grote invloed op de coagulatie efficiëntie heeft. Met een loodrechte aanvuurhoek, wordt 
efficiëntere coagulatie bereikt dan met een meer tangentiële hoek. Bloeding door het 
barsten van de vaatwand, hoewel zeldzaam, deed zich iets vaker met een lager vermogen 
en met een meer tangentiële laser hoek. Onze hypothese is dat bij een laag vermogen-
instelling door de langere duur en langzamere energieoverdracht meer endotheel schade 
optreedt [10] en dat zonder snelle afsluiting van het vat door gestold bloed, dit het risico 
op een vaatwand ruptuur kan vergroten.
Laser training model
Laserchirurgie voor TTS is een technische vaardigheid waarvoor een gedegen opleiding 
nodig is om een adequaat niveau te bereiken en te handhaven. In het laatste deel van 
dit proefschrift hebben wij een training en evaluatie-instrument voor foetoscopische 
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laserchirurgie ontwikkeld en gevalideerd. Dit instrument kan helpen sneller een betere 
vaardigheid voor de laserchirurgie te ontwikkelen en te behouden.
In hoofdstuk 6 presenteren we een internationale expert consensus over de technische 
aanpak en de identificatie van de essentiële stappen van foetoscopische laserbehandeling 
voor TTS. Door middel van een Delphi consensus methode met medewerking van een 
uitgebreide lijst van internationaal gerenommeerde specialisten in foetale therapie, hebben 
we een lijst met 55 essentiële sub-stappen geproduceerd. Dit onderzoek leverde een 
eerste stap naar een op autoriteit-gebaseerd procedure-specifiek evaluatie-instrument voor 
foetoscopische laserchirurgie voor de behandeling van TTS. Om de betrouwbaarheid en de 
geldigheid van het evaluatie-instrument uit hoofdstuk 6 te onderzoeken hebben we de 
inter-observer betrouwbaarheid en validiteit van dit instrument beoordeeld in hoofdstuk 
7. We ontwikkelden een realistisch simulator model voor foetoscopische laserchirurgie 
en gebruikten het evaluatie-instrument om deskundige en beginnende foetale chirurgen 
tijdens het uitvoeren van de volledige laser procedure te scoren. De studie toonde aan 
dat het instrument effectief was in het onderscheiden van de prestaties van experts en 
beginners met een aanvaardbaar niveau van inter-observer betrouwbaarheid. Tenslotte 
werd in hoofdstuk 8 onderzocht of foetaal therapeuten in opleiding kunnen profiteren 
van simulator training op basis van de evaluatie-instrument ontwikkeld in hoofdstuk 6. We 
voerden een pilot gerandomiseerde trial uit waar beginners werden gerandomiseerd voor 
ofwel simulator training of geen training. De studie toonde aan dat de training op het 
simulatormodel in een realistische omgeving de prestaties van foetoscopische laserchirurgie 
aanzienlijk verbeterde. Er werd geen verschil in duur van de procedure of aanwezigheid 
van gemiste anastomosen tussen de groepen waargenomen. Een expert referentieniveau 
voor het curriculum werd gedefinieerd door observatie van ervaren foetaal therapeuten. 
Feedback van de deelnemers gaf aan dat simulator training werd gezien als een bruikbare 
educatieve activiteit.
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luisterend oor of een goed advies terecht. Daarnaast altijd even scherp wanneer je een 
stuk redigeert.
Dank aan het gehele foetale therapie team in het LUMC voor alle steun, data en inspiratie. 
Met name Frans, jouw combinatie van handigheid en ICT kennis is een voorbeeld voor mij. 
Dear colleagues of the Universities of Leuven, Karolinska and the Mt. Sinai hospital in 
Toronto, thank you for your collaboration. I am looking forward to our future collaboration.
Ivanka en Gladys, de jaren op K6 kan ik me niet voorstellen zonder jullie. Altijd staan jullie 
klaar om te helpen, vragen is vaak niet nodig. Dank daarvoor!
Alle collega-onderzoekers, promoveren doe je niet alleen. Ook de onderzoeksdagen, 
cursussen en zeilwedstrijden helpen mee aan een gebalanceerde promotie. Opleiders, 
gynaecologen, verloskundigen en verpleegkundigen van het HagaZiekenhuis en LUMC dank 
voor jullie interesse, motiverende woorden en opleidingsmomenten die jullie mij blijven 
bieden.
Mijn paranimfen, Suzanne en Femke. Waar moet ik beginnen, op een klein kamertje op K6. 
Synergie lijkt het juiste woord. In een relatief korte tijd hebben we veel bereikt. Veel 
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wetenschappelijke projecten hebben we bedacht en uitgevoerd, trainingen gegeven over de 
hele wereld en mooie reisjes gemaakt. Bedankt voor al deze, en toekomstige momenten.
Geert-Jan, mijn sparringpartner sinds jaren, wat heb ik jou verveeld de afgelopen jaren met 
verhalen en vragen over wetenschap en geneeskunde. Nooit heb je de indruk gewekt het 
vervelend te vinden. 
Papa, Mama, Jeroen en Robbert jullie staan aan de basis van wie ik nu ben. Jullie steun, 
vertrouwen en interesse heeft mij dit pad doen bewandelen.
Lieve Carolien zonder jou was het überhaupt niet gelukt. Jij inspireert mij, maakt me aan het 
lachen en stuurt mij op de momenten dat ik sturing nodig heb. Dank voor jouw oeverloze 
steun.
Guus en Keet dank voor jullie...
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LIST OF ABBREVIATIONS
AA-anastomosis  Arterio-arterial anastomosis
AV-anastomosis  Arterio-venous anastomosis
CLD   Chronic Lung Disease 
COLFAP   Combined Laparoscopy and Fetoscopy in cases with 
   completely Anterior Placenta
cPVL   Cystic Periventricular Leukomalacia 
CUSUM   Cumulative Sum analysis
DC   Dichorionic
DVP    Deepest Vertical Pocket
FLS   Fetoscopic Laser Surgery
GA   Gestational Age
iMAT   Iatrogenic Monoamniotic Twins 
IUFD   Intrauterine Fetal Demise
IUT   Intra Uterine Transfusion
LC-CUSUM  Learning Curve Cumulative Sum analysis
LUMC   Leiden University Medical Center
MA   Monoamniotic
MC   Monochorionic
MFM   Maternal Fetal Medicine 
NEC   Necrotizing enterocolitis 
NND    Neonatal Death
PDA    Patent ductus arteriosus
PPROM   Preterm Premature Rupture Of Membranes
RA   Residual Anastomosis 
RDS   Respiratory Distress Syndrome
RFA   Radiofrequency Ablation
ROP   Retinopathy of prematurity
RVOTO   Right Ventricular Outflow Tract Obstruction
SILICONE  SImulator for Laser therapy and Identification of Critical steps 
   of Operation: New Education program
sIUGR   selective Intrauterine Growth restriction
TAPS    Twin Anemia Polycythemia Sequence
TRAP   Twin Reversed Arterial Perfusion
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TTTS   Twin-Twin Transfusion Syndrome
TTS    Tweeling-Transfusie syndroom
VA-anastomosis  Veno-arterial anastomosis
VV-anastomosis  Veno-venous anastomosis
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